Gene Symbol | Gene ID | Gene Info |
---|---|---|
Foxj3
|
ENSMUSG00000032998.10 | forkhead box J3 |
Tbl1xr1
|
ENSMUSG00000027630.8 | transducin (beta)-like 1X-linked receptor 1 |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr4_119539731_119540697 | Foxj3 | 308 | 0.668880 | -0.23 | 7.2e-02 | Click! |
chr4_119600016_119600167 | Foxj3 | 21251 | 0.117488 | -0.01 | 9.3e-01 | Click! |
chr3_22076697_22077471 | Tbl1xr1 | 148 | 0.908927 | -0.40 | 1.4e-03 | Click! |
chr3_22079025_22079233 | Tbl1xr1 | 1845 | 0.258499 | -0.04 | 7.6e-01 | Click! |
chr3_22077600_22078228 | Tbl1xr1 | 630 | 0.630237 | 0.00 | 9.8e-01 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr16_77594640_77595970 | 31.85 |
Mir99ahg |
Mir99a and Mirlet7c-1 host gene (non-protein coding) |
403 |
0.71 |
chr16_43506052_43507411 | 25.21 |
Zbtb20 |
zinc finger and BTB domain containing 20 |
1426 |
0.51 |
chr11_57011668_57012922 | 19.72 |
Gria1 |
glutamate receptor, ionotropic, AMPA1 (alpha 1) |
339 |
0.94 |
chr3_79144294_79146166 | 17.93 |
Rapgef2 |
Rap guanine nucleotide exchange factor (GEF) 2 |
253 |
0.94 |
chr18_31445651_31446131 | 17.16 |
Syt4 |
synaptotagmin IV |
1515 |
0.34 |
chr2_52557337_52558561 | 16.86 |
Cacnb4 |
calcium channel, voltage-dependent, beta 4 subunit |
611 |
0.74 |
chr10_34299043_34301066 | 16.23 |
Tspyl4 |
TSPY-like 4 |
798 |
0.4 |
chr4_5724213_5725550 | 15.55 |
Fam110b |
family with sequence similarity 110, member B |
569 |
0.81 |
chr6_55680133_55680881 | 14.43 |
Neurod6 |
neurogenic differentiation 6 |
756 |
0.69 |
chrX_170674573_170675954 | 14.21 |
Asmt |
acetylserotonin O-methyltransferase |
2619 |
0.41 |
chr12_31711839_31712627 | 13.92 |
Gpr22 |
G protein-coupled receptor 22 |
1693 |
0.32 |
chr6_92478725_92480195 | 13.85 |
Prickle2 |
prickle planar cell polarity protein 2 |
1932 |
0.44 |
chr19_37176789_37177437 | 13.55 |
Cpeb3 |
cytoplasmic polyadenylation element binding protein 3 |
904 |
0.43 |
chr14_70627710_70629563 | 13.48 |
Dmtn |
dematin actin binding protein |
363 |
0.79 |
chr11_87759834_87761999 | 13.34 |
Tspoap1 |
TSPO associated protein 1 |
329 |
0.75 |
chr1_194623571_194625393 | 13.30 |
Plxna2 |
plexin A2 |
4657 |
0.21 |
chr13_28416755_28419194 | 13.28 |
Gm40841 |
predicted gene, 40841 |
1889 |
0.42 |
chr6_136170568_136170996 | 13.01 |
Grin2b |
glutamate receptor, ionotropic, NMDA2B (epsilon 2) |
1107 |
0.5 |
chr8_34890130_34891317 | 12.98 |
Tnks |
tankyrase, TRF1-interacting ankyrin-related ADP-ribose polymerase |
572 |
0.8 |
chr5_5264770_5266186 | 12.89 |
Cdk14 |
cyclin-dependent kinase 14 |
169 |
0.96 |
chr1_157242024_157242632 | 12.83 |
Rasal2 |
RAS protein activator like 2 |
2162 |
0.36 |
chr14_66344363_66345813 | 12.66 |
Stmn4 |
stathmin-like 4 |
707 |
0.65 |
chr12_29536509_29537451 | 12.66 |
Myt1l |
myelin transcription factor 1-like |
1758 |
0.36 |
chr17_72921491_72924008 | 12.61 |
Lbh |
limb-bud and heart |
1561 |
0.47 |
chr18_23036665_23037864 | 12.60 |
Nol4 |
nucleolar protein 4 |
1392 |
0.59 |
chr8_47334443_47334953 | 12.60 |
Stox2 |
storkhead box 2 |
17650 |
0.23 |
chrX_166346283_166346827 | 12.58 |
Gpm6b |
glycoprotein m6b |
1713 |
0.43 |
chrX_23284413_23285126 | 12.01 |
Klhl13 |
kelch-like 13 |
60 |
0.99 |
chr2_138277835_138280637 | 11.98 |
Btbd3 |
BTB (POZ) domain containing 3 |
743 |
0.81 |
chr8_41052368_41053980 | 11.92 |
Gm16193 |
predicted gene 16193 |
64 |
0.96 |
chr8_35591141_35592463 | 11.82 |
Gm16793 |
predicted gene, 16793 |
2830 |
0.24 |
chr1_187999444_187999905 | 11.81 |
Esrrg |
estrogen-related receptor gamma |
1806 |
0.42 |
chr1_164455819_164456603 | 11.77 |
Atp1b1 |
ATPase, Na+/K+ transporting, beta 1 polypeptide |
1811 |
0.27 |
chr1_157243489_157244692 | 11.72 |
Rasal2 |
RAS protein activator like 2 |
400 |
0.88 |
chr12_29528407_29529244 | 11.64 |
Myt1l |
myelin transcription factor 1-like |
424 |
0.85 |
chr6_136171003_136171483 | 11.21 |
Grin2b |
glutamate receptor, ionotropic, NMDA2B (epsilon 2) |
646 |
0.69 |
chr16_43507761_43509014 | 11.19 |
Zbtb20 |
zinc finger and BTB domain containing 20 |
124 |
0.97 |
chr6_55679226_55679709 | 11.18 |
Neurod6 |
neurogenic differentiation 6 |
1796 |
0.39 |
chr14_124677116_124677780 | 11.15 |
Fgf14 |
fibroblast growth factor 14 |
321 |
0.92 |
chr8_84770692_84772567 | 11.10 |
Nfix |
nuclear factor I/X |
1767 |
0.22 |
chr9_112234066_112234966 | 10.92 |
Arpp21 |
cyclic AMP-regulated phosphoprotein, 21 |
93 |
0.56 |
chr7_126950022_126951260 | 10.73 |
Sez6l2 |
seizure related 6 homolog like 2 |
57 |
0.89 |
chr12_88722414_88723479 | 10.69 |
Nrxn3 |
neurexin III |
40 |
0.98 |
chr6_55681271_55682057 | 10.67 |
Neurod6 |
neurogenic differentiation 6 |
401 |
0.86 |
chr2_65620767_65621991 | 10.62 |
Scn2a |
sodium channel, voltage-gated, type II, alpha |
568 |
0.82 |
chr4_116405618_116406369 | 10.61 |
Mast2 |
microtubule associated serine/threonine kinase 2 |
7 |
0.98 |
chr1_143640264_143641520 | 10.61 |
B3galt2 |
UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 2 |
228 |
0.59 |
chr18_69576097_69576977 | 10.59 |
Tcf4 |
transcription factor 4 |
13202 |
0.24 |
chr9_112232861_112233588 | 10.56 |
Arpp21 |
cyclic AMP-regulated phosphoprotein, 21 |
402 |
0.75 |
chr2_7395418_7396363 | 10.53 |
Celf2 |
CUGBP, Elav-like family member 2 |
3 |
0.99 |
chr7_87586513_87587584 | 10.50 |
Grm5 |
glutamate receptor, metabotropic 5 |
2650 |
0.4 |
chr5_103209022_103210413 | 10.49 |
Mapk10 |
mitogen-activated protein kinase 10 |
705 |
0.75 |
chr19_6499251_6500132 | 10.48 |
Nrxn2 |
neurexin II |
1856 |
0.23 |
chr6_114282516_114283979 | 10.48 |
Slc6a1 |
solute carrier family 6 (neurotransmitter transporter, GABA), member 1 |
457 |
0.87 |
chr12_86880278_86881016 | 10.45 |
Irf2bpl |
interferon regulatory factor 2 binding protein-like |
4151 |
0.21 |
chr1_66323360_66324079 | 10.43 |
Map2 |
microtubule-associated protein 2 |
1617 |
0.37 |
chr2_158606690_158608449 | 10.27 |
Gm14204 |
predicted gene 14204 |
3021 |
0.15 |
chr16_77500388_77501627 | 10.26 |
Mir99ahg |
Mir99a and Mirlet7c-1 host gene (non-protein coding) |
623 |
0.62 |
chr8_109250884_109251908 | 10.16 |
D030068K23Rik |
RIKEN cDNA D030068K23 gene |
1530 |
0.52 |
chr4_97868552_97869863 | 10.16 |
Nfia |
nuclear factor I/A |
10912 |
0.28 |
chrX_23283125_23283785 | 10.12 |
Klhl13 |
kelch-like 13 |
1374 |
0.57 |
chr1_194622071_194623282 | 10.09 |
Plxna2 |
plexin A2 |
2851 |
0.26 |
chr17_70521708_70522843 | 10.04 |
Dlgap1 |
DLG associated protein 1 |
113 |
0.98 |
chr12_113141740_113143605 | 10.04 |
Crip2 |
cysteine rich protein 2 |
136 |
0.92 |
chr10_80300884_80302968 | 10.02 |
Apc2 |
APC regulator of WNT signaling pathway 2 |
106 |
0.9 |
chr9_96731522_96733329 | 9.99 |
Zbtb38 |
zinc finger and BTB domain containing 38 |
244 |
0.91 |
chr9_50752994_50754649 | 9.99 |
Cryab |
crystallin, alpha B |
574 |
0.54 |
chr8_33747278_33748028 | 9.92 |
Smim18 |
small integral membrane protein 18 |
117 |
0.95 |
chr3_8509825_8511666 | 9.92 |
Stmn2 |
stathmin-like 2 |
1159 |
0.54 |
chr14_64834470_64835221 | 9.86 |
Gm20111 |
predicted gene, 20111 |
4255 |
0.18 |
chr16_35157395_35159144 | 9.80 |
Adcy5 |
adenylate cyclase 5 |
3392 |
0.29 |
chr11_105590925_105591452 | 9.77 |
Tanc2 |
tetratricopeptide repeat, ankyrin repeat and coiled-coil containing 2 |
1197 |
0.51 |
chr9_110051810_110053856 | 9.77 |
Map4 |
microtubule-associated protein 4 |
781 |
0.54 |
chr3_94477599_94477954 | 9.75 |
Celf3 |
CUGBP, Elav-like family member 3 |
519 |
0.57 |
chr6_13834624_13835191 | 9.73 |
Gpr85 |
G protein-coupled receptor 85 |
2334 |
0.31 |
chr5_150260534_150260992 | 9.73 |
Fry |
FRY microtubule binding protein |
996 |
0.55 |
chr2_70564530_70567543 | 9.70 |
Gad1 |
glutamate decarboxylase 1 |
341 |
0.83 |
chr15_85679298_85680211 | 9.66 |
Lncppara |
long noncoding RNA near Ppara |
24019 |
0.12 |
chr5_20228356_20229007 | 9.63 |
Magi2 |
membrane associated guanylate kinase, WW and PDZ domain containing 2 |
495 |
0.83 |
chr4_32862939_32864770 | 9.61 |
Ankrd6 |
ankyrin repeat domain 6 |
3171 |
0.24 |
chr5_43236846_43237650 | 9.47 |
Cpeb2 |
cytoplasmic polyadenylation element binding protein 2 |
67 |
0.96 |
chr2_107292125_107293014 | 9.47 |
Kcna4 |
potassium voltage-gated channel, shaker-related subfamily, member 4 |
1174 |
0.64 |
chr3_88206822_88208169 | 9.41 |
Gm3764 |
predicted gene 3764 |
183 |
0.86 |
chr4_82507895_82509049 | 9.40 |
Gm11266 |
predicted gene 11266 |
456 |
0.82 |
chr7_144238658_144240098 | 9.38 |
Shank2 |
SH3 and multiple ankyrin repeat domains 2 |
653 |
0.8 |
chr14_55114527_55116659 | 9.30 |
Jph4 |
junctophilin 4 |
41 |
0.94 |
chr4_138251495_138252773 | 9.24 |
Sh2d5 |
SH2 domain containing 5 |
1670 |
0.22 |
chr18_69521278_69522871 | 9.23 |
Tcf4 |
transcription factor 4 |
73 |
0.98 |
chr1_25226679_25227199 | 9.22 |
Adgrb3 |
adhesion G protein-coupled receptor B3 |
1887 |
0.26 |
chr2_97468266_97469202 | 9.22 |
Lrrc4c |
leucine rich repeat containing 4C |
645 |
0.83 |
chr1_72536044_72537425 | 9.20 |
Marchf4 |
membrane associated ring-CH-type finger 4 |
196 |
0.95 |
chr10_90576163_90577493 | 9.20 |
Anks1b |
ankyrin repeat and sterile alpha motif domain containing 1B |
13 |
0.99 |
chr7_51623529_51624502 | 9.19 |
Slc17a6 |
solute carrier family 17 (sodium-dependent inorganic phosphate cotransporter), member 6 |
1133 |
0.51 |
chr14_60380755_60381381 | 9.15 |
Amer2 |
APC membrane recruitment 2 |
2782 |
0.3 |
chrX_9202282_9203095 | 9.12 |
Lancl3 |
LanC lantibiotic synthetase component C-like 3 (bacterial) |
2786 |
0.21 |
chr5_103210548_103211780 | 9.12 |
Mapk10 |
mitogen-activated protein kinase 10 |
109 |
0.98 |
chr4_9269280_9270516 | 9.11 |
Clvs1 |
clavesin 1 |
551 |
0.81 |
chr13_109443973_109444887 | 9.08 |
Pde4d |
phosphodiesterase 4D, cAMP specific |
2247 |
0.46 |
chr2_45024242_45025237 | 9.06 |
Zeb2 |
zinc finger E-box binding homeobox 2 |
1069 |
0.47 |
chr10_30838746_30839745 | 9.06 |
Hey2 |
hairy/enhancer-of-split related with YRPW motif 2 |
2770 |
0.24 |
chr8_109245493_109246323 | 9.00 |
D030068K23Rik |
RIKEN cDNA D030068K23 gene |
3958 |
0.33 |
chr13_84063384_84064052 | 8.97 |
Gm17750 |
predicted gene, 17750 |
1054 |
0.58 |
chr16_5884597_5886147 | 8.94 |
Rbfox1 |
RNA binding protein, fox-1 homolog (C. elegans) 1 |
17 |
0.99 |
chr13_109442519_109443753 | 8.93 |
Pde4d |
phosphodiesterase 4D, cAMP specific |
953 |
0.73 |
chr9_44486015_44488913 | 8.93 |
Bcl9l |
B cell CLL/lymphoma 9-like |
217 |
0.81 |
chr6_39874717_39875333 | 8.93 |
Tmem178b |
transmembrane protein 178B |
1954 |
0.27 |
chr7_44592789_44594513 | 8.90 |
Kcnc3 |
potassium voltage gated channel, Shaw-related subfamily, member 3 |
344 |
0.69 |
chr2_152080491_152081480 | 8.88 |
Scrt2 |
scratch family zinc finger 2 |
544 |
0.7 |
chr13_34126566_34127191 | 8.85 |
Tubb2b |
tubulin, beta 2B class IIB |
3476 |
0.13 |
chr14_60382521_60383103 | 8.84 |
Amer2 |
APC membrane recruitment 2 |
4526 |
0.25 |
chr16_81201314_81201888 | 8.83 |
Ncam2 |
neural cell adhesion molecule 2 |
844 |
0.72 |
chr3_96181539_96182795 | 8.83 |
Sv2a |
synaptic vesicle glycoprotein 2 a |
1016 |
0.22 |
chr17_91092075_91093120 | 8.81 |
Nrxn1 |
neurexin I |
136 |
0.95 |
chr9_40344899_40346384 | 8.81 |
Gramd1b |
GRAM domain containing 1B |
649 |
0.55 |
chr14_75962509_75963193 | 8.80 |
Kctd4 |
potassium channel tetramerisation domain containing 4 |
7842 |
0.18 |
chr3_60527660_60528578 | 8.78 |
Mbnl1 |
muscleblind like splicing factor 1 |
9 |
0.98 |
chr3_13946382_13947629 | 8.74 |
Ralyl |
RALY RNA binding protein-like |
594 |
0.84 |
chr9_52676918_52677560 | 8.73 |
AI593442 |
expressed sequence AI593442 |
2190 |
0.3 |
chr8_54954519_54955779 | 8.72 |
Gpm6a |
glycoprotein m6a |
306 |
0.88 |
chr3_56179928_56180616 | 8.68 |
Nbea |
neurobeachin |
3429 |
0.25 |
chr16_43709455_43710146 | 8.68 |
Gm49735 |
predicted gene, 49735 |
1032 |
0.49 |
chr9_112231189_112232055 | 8.66 |
Arpp21 |
cyclic AMP-regulated phosphoprotein, 21 |
280 |
0.9 |
chr4_82499063_82499632 | 8.65 |
Nfib |
nuclear factor I/B |
31 |
0.98 |
chr12_61525659_61526870 | 8.64 |
Lrfn5 |
leucine rich repeat and fibronectin type III domain containing 5 |
2316 |
0.3 |
chr1_9601164_9602408 | 8.64 |
Vxn |
vexin |
587 |
0.67 |
chr17_91090702_91091377 | 8.64 |
Nrxn1 |
neurexin I |
1694 |
0.28 |
chr6_13835523_13837039 | 8.60 |
Gpr85 |
G protein-coupled receptor 85 |
960 |
0.59 |
chr8_109248831_109249717 | 8.60 |
D030068K23Rik |
RIKEN cDNA D030068K23 gene |
592 |
0.83 |
chr18_65075906_65076731 | 8.60 |
Nedd4l |
neural precursor cell expressed, developmentally down-regulated gene 4-like |
286 |
0.93 |
chr11_31874060_31874636 | 8.59 |
Cpeb4 |
cytoplasmic polyadenylation element binding protein 4 |
1073 |
0.55 |
chr2_181155937_181157234 | 8.59 |
Eef1a2 |
eukaryotic translation elongation factor 1 alpha 2 |
429 |
0.73 |
chr4_110290101_110291006 | 8.58 |
Elavl4 |
ELAV like RNA binding protein 4 |
281 |
0.95 |
chr16_23519498_23520937 | 8.57 |
Gm45338 |
predicted gene 45338 |
7 |
0.51 |
chr7_90386713_90387752 | 8.57 |
Sytl2 |
synaptotagmin-like 2 |
127 |
0.96 |
chr14_64588312_64589438 | 8.57 |
Mir124a-1hg |
Mir124-1 host gene (non-protein coding) |
341 |
0.81 |
chr16_43504464_43505047 | 8.56 |
Zbtb20 |
zinc finger and BTB domain containing 20 |
1058 |
0.61 |
chr16_43503376_43504101 | 8.56 |
Zbtb20 |
zinc finger and BTB domain containing 20 |
41 |
0.98 |
chr8_65617917_65619195 | 8.54 |
Marchf1 |
membrane associated ring-CH-type finger 1 |
31 |
0.99 |
chr3_26329790_26330404 | 8.52 |
A830092H15Rik |
RIKEN cDNA A830092H15 gene |
1053 |
0.5 |
chr5_74676974_74677904 | 8.51 |
Lnx1 |
ligand of numb-protein X 1 |
190 |
0.94 |
chr13_83739310_83740387 | 8.50 |
C130071C03Rik |
RIKEN cDNA C130071C03 gene |
985 |
0.29 |
chr17_47877478_47879368 | 8.48 |
Foxp4 |
forkhead box P4 |
530 |
0.7 |
chr2_6881874_6882908 | 8.45 |
Gm13389 |
predicted gene 13389 |
1879 |
0.3 |
chr16_13357876_13359918 | 8.42 |
Mrtfb |
myocardin related transcription factor B |
476 |
0.83 |
chr4_82496866_82497618 | 8.40 |
Nfib |
nuclear factor I/B |
2074 |
0.34 |
chr2_96319240_96319943 | 8.40 |
Lrrc4c |
leucine rich repeat containing 4C |
1375 |
0.61 |
chr15_76519928_76521866 | 8.39 |
Scrt1 |
scratch family zinc finger 1 |
1005 |
0.28 |
chr3_89521563_89522618 | 8.37 |
Kcnn3 |
potassium intermediate/small conductance calcium-activated channel, subfamily N, member 3 |
1926 |
0.28 |
chr3_100804632_100805148 | 8.31 |
Vtcn1 |
V-set domain containing T cell activation inhibitor 1 |
20569 |
0.2 |
chr10_6979289_6980565 | 8.31 |
Ipcef1 |
interaction protein for cytohesin exchange factors 1 |
216 |
0.96 |
chr11_30022183_30022992 | 8.31 |
Eml6 |
echinoderm microtubule associated protein like 6 |
3446 |
0.27 |
chr8_41054476_41055299 | 8.30 |
Mtus1 |
mitochondrial tumor suppressor 1 |
93 |
0.95 |
chr4_102256022_102256825 | 8.27 |
Pde4b |
phosphodiesterase 4B, cAMP specific |
1193 |
0.63 |
chr8_45509543_45510137 | 8.27 |
Sorbs2 |
sorbin and SH3 domain containing 2 |
1922 |
0.33 |
chr12_52009968_52010722 | 8.25 |
Dtd2 |
D-tyrosyl-tRNA deacylase 2 |
3844 |
0.19 |
chr8_109248088_109248728 | 8.25 |
D030068K23Rik |
RIKEN cDNA D030068K23 gene |
1458 |
0.54 |
chrX_152643367_152644550 | 8.23 |
Shroom2 |
shroom family member 2 |
34 |
0.98 |
chr2_6883618_6884699 | 8.21 |
Gm13389 |
predicted gene 13389 |
112 |
0.85 |
chr12_52699339_52699808 | 8.20 |
Akap6 |
A kinase (PRKA) anchor protein 6 |
190 |
0.95 |
chr5_150261018_150262108 | 8.19 |
Fry |
FRY microtubule binding protein |
1796 |
0.34 |
chr1_99772154_99773556 | 8.19 |
Cntnap5b |
contactin associated protein-like 5B |
90 |
0.98 |
chr2_65566848_65567533 | 8.19 |
Scn3a |
sodium channel, voltage-gated, type III, alpha |
302 |
0.92 |
chr5_150262108_150262988 | 8.14 |
Fry |
FRY microtubule binding protein |
2781 |
0.26 |
chr9_96729464_96730774 | 8.13 |
Zbtb38 |
zinc finger and BTB domain containing 38 |
1083 |
0.47 |
chr8_117260847_117261416 | 8.10 |
Cmip |
c-Maf inducing protein |
4014 |
0.3 |
chr16_50689551_50689950 | 8.05 |
Gm9575 |
predicted gene 9575 |
23404 |
0.17 |
chr2_96317494_96318819 | 8.03 |
Lrrc4c |
leucine rich repeat containing 4C |
13 |
0.99 |
chr11_32001099_32002296 | 8.03 |
Nsg2 |
neuron specific gene family member 2 |
1195 |
0.52 |
chr7_25180336_25182324 | 8.03 |
Pou2f2 |
POU domain, class 2, transcription factor 2 |
1604 |
0.22 |
chr12_88723574_88724074 | 8.00 |
Nrxn3 |
neurexin III |
715 |
0.73 |
chr7_19082814_19086200 | 7.97 |
Dmpk |
dystrophia myotonica-protein kinase |
203 |
0.83 |
chr7_46399823_46400899 | 7.97 |
Kcnc1 |
potassium voltage gated channel, Shaw-related subfamily, member 1 |
2713 |
0.23 |
chr5_104111427_104113181 | 7.95 |
Sparcl1 |
SPARC-like 1 |
1135 |
0.33 |
chr6_136167149_136168437 | 7.94 |
Grin2b |
glutamate receptor, ionotropic, NMDA2B (epsilon 2) |
4096 |
0.25 |
chr7_44477030_44477435 | 7.93 |
5430431A17Rik |
RIKEN cDNA 5430431A17 gene |
3694 |
0.08 |
chr11_78322615_78324056 | 7.91 |
Aldoc |
aldolase C, fructose-bisphosphate |
167 |
0.88 |
chr5_98182267_98183697 | 7.91 |
Prdm8 |
PR domain containing 8 |
2004 |
0.26 |
chr19_37177777_37178526 | 7.90 |
Cpeb3 |
cytoplasmic polyadenylation element binding protein 3 |
134 |
0.91 |
chr13_102957440_102958679 | 7.89 |
Mast4 |
microtubule associated serine/threonine kinase family member 4 |
287 |
0.95 |
chr6_116056244_116057282 | 7.89 |
Tmcc1 |
transmembrane and coiled coil domains 1 |
192 |
0.94 |
chr9_37527353_37531611 | 7.87 |
Esam |
endothelial cell-specific adhesion molecule |
701 |
0.51 |
chr5_135806693_135807939 | 7.85 |
Srrm3 |
serine/arginine repetitive matrix 3 |
419 |
0.73 |
chr10_3368375_3368998 | 7.85 |
Ppp1r14c |
protein phosphatase 1, regulatory inhibitor subunit 14C |
2142 |
0.36 |
chr1_81077232_81078427 | 7.84 |
Nyap2 |
neuronal tyrosine-phophorylated phosphoinositide 3-kinase adaptor 2 |
246 |
0.96 |
chr13_105249326_105250833 | 7.84 |
Rnf180 |
ring finger protein 180 |
20960 |
0.22 |
chr18_41860653_41861741 | 7.83 |
Gm50410 |
predicted gene, 50410 |
13637 |
0.22 |
chr4_110285468_110287125 | 7.82 |
Elavl4 |
ELAV like RNA binding protein 4 |
320 |
0.94 |
chr3_60529662_60530216 | 7.80 |
Mbnl1 |
muscleblind like splicing factor 1 |
308 |
0.91 |
chr16_81202167_81203211 | 7.79 |
Ncam2 |
neural cell adhesion molecule 2 |
1932 |
0.44 |
chr6_128399389_128400934 | 7.77 |
Nrip2 |
nuclear receptor interacting protein 2 |
113 |
0.78 |
chr6_115984719_115988278 | 7.75 |
Plxnd1 |
plexin D1 |
8507 |
0.15 |
chr6_32584464_32585789 | 7.75 |
Plxna4 |
plexin A4 |
3066 |
0.3 |
chr3_149443059_149443897 | 7.74 |
Gm30382 |
predicted gene, 30382 |
1798 |
0.48 |
chr8_94266327_94267391 | 7.72 |
Nup93 |
nucleoporin 93 |
12 |
0.96 |
chr4_109155589_109157355 | 7.71 |
Osbpl9 |
oxysterol binding protein-like 9 |
138 |
0.97 |
chr5_102844945_102846344 | 7.67 |
Arhgap24 |
Rho GTPase activating protein 24 |
637 |
0.82 |
chr2_94245067_94246249 | 7.67 |
Mir670hg |
MIR670 host gene (non-protein coding) |
2320 |
0.21 |
chr14_64589664_64590503 | 7.66 |
Mir124a-1hg |
Mir124-1 host gene (non-protein coding) |
388 |
0.55 |
chr8_54957303_54957776 | 7.63 |
Gm45263 |
predicted gene 45263 |
2280 |
0.24 |
chr9_113811975_113812935 | 7.62 |
Clasp2 |
CLIP associating protein 2 |
131 |
0.97 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
19.0 | 57.1 | GO:1901078 | negative regulation of relaxation of muscle(GO:1901078) |
18.2 | 54.7 | GO:0097118 | neuroligin clustering involved in postsynaptic membrane assembly(GO:0097118) |
11.8 | 47.4 | GO:0060486 | Clara cell differentiation(GO:0060486) |
11.4 | 34.3 | GO:0014722 | regulation of skeletal muscle contraction by calcium ion signaling(GO:0014722) |
9.8 | 29.4 | GO:1901843 | positive regulation of high voltage-gated calcium channel activity(GO:1901843) |
9.1 | 27.3 | GO:2000670 | positive regulation of dendritic cell apoptotic process(GO:2000670) |
8.3 | 24.9 | GO:2000111 | positive regulation of macrophage apoptotic process(GO:2000111) |
8.0 | 31.9 | GO:0045900 | negative regulation of translational elongation(GO:0045900) |
7.5 | 30.2 | GO:0051612 | negative regulation of neurotransmitter uptake(GO:0051581) regulation of serotonin uptake(GO:0051611) negative regulation of serotonin uptake(GO:0051612) |
7.5 | 22.4 | GO:0021986 | epithalamus development(GO:0021538) habenula development(GO:0021986) |
7.4 | 22.1 | GO:0009449 | gamma-aminobutyric acid biosynthetic process(GO:0009449) |
6.9 | 20.7 | GO:0072235 | distal convoluted tubule development(GO:0072025) DCT cell differentiation(GO:0072069) metanephric distal convoluted tubule development(GO:0072221) metanephric distal tubule development(GO:0072235) metanephric DCT cell differentiation(GO:0072240) |
6.9 | 27.5 | GO:0098735 | positive regulation of the force of heart contraction(GO:0098735) |
6.5 | 32.7 | GO:2000807 | regulation of synaptic vesicle clustering(GO:2000807) |
6.5 | 25.9 | GO:0071205 | protein localization to juxtaparanode region of axon(GO:0071205) |
6.1 | 30.3 | GO:0060316 | positive regulation of ryanodine-sensitive calcium-release channel activity(GO:0060316) |
6.0 | 17.9 | GO:0099558 | maintenance of synapse structure(GO:0099558) |
5.9 | 5.9 | GO:1902474 | positive regulation of protein localization to synapse(GO:1902474) |
5.8 | 46.7 | GO:0021830 | interneuron migration from the subpallium to the cortex(GO:0021830) |
5.8 | 11.6 | GO:1903279 | regulation of calcium:sodium antiporter activity(GO:1903279) |
5.7 | 22.9 | GO:0003195 | tricuspid valve morphogenesis(GO:0003186) tricuspid valve formation(GO:0003195) |
5.7 | 17.1 | GO:0033602 | negative regulation of dopamine secretion(GO:0033602) |
5.7 | 17.1 | GO:1903690 | negative regulation of wound healing, spreading of epidermal cells(GO:1903690) |
5.6 | 16.9 | GO:0097105 | presynaptic membrane assembly(GO:0097105) |
5.6 | 16.8 | GO:0046684 | response to pyrethroid(GO:0046684) |
5.6 | 5.6 | GO:0070460 | thyroid-stimulating hormone secretion(GO:0070460) |
5.5 | 16.4 | GO:0090259 | regulation of retinal ganglion cell axon guidance(GO:0090259) |
5.4 | 16.3 | GO:0001661 | conditioned taste aversion(GO:0001661) |
5.4 | 16.1 | GO:1904742 | regulation of telomeric DNA binding(GO:1904742) |
5.3 | 21.4 | GO:0007258 | JUN phosphorylation(GO:0007258) |
5.2 | 20.8 | GO:0035995 | detection of muscle stretch(GO:0035995) |
5.2 | 46.7 | GO:0071625 | vocalization behavior(GO:0071625) |
5.2 | 51.6 | GO:0097120 | receptor localization to synapse(GO:0097120) |
5.1 | 15.4 | GO:0021773 | striatal medium spiny neuron differentiation(GO:0021773) |
5.1 | 20.3 | GO:0031117 | positive regulation of microtubule depolymerization(GO:0031117) |
5.0 | 5.0 | GO:0006533 | aspartate catabolic process(GO:0006533) |
5.0 | 15.0 | GO:0032097 | positive regulation of response to food(GO:0032097) positive regulation of appetite(GO:0032100) |
5.0 | 5.0 | GO:0050923 | regulation of negative chemotaxis(GO:0050923) |
4.9 | 14.8 | GO:0060159 | regulation of dopamine receptor signaling pathway(GO:0060159) |
4.9 | 24.6 | GO:1900227 | positive regulation of NLRP3 inflammasome complex assembly(GO:1900227) |
4.9 | 68.4 | GO:0035235 | ionotropic glutamate receptor signaling pathway(GO:0035235) |
4.7 | 23.7 | GO:0031339 | negative regulation of vesicle fusion(GO:0031339) |
4.7 | 14.2 | GO:0075509 | receptor-mediated endocytosis of virus by host cell(GO:0019065) endocytosis involved in viral entry into host cell(GO:0075509) |
4.7 | 33.0 | GO:0042118 | endothelial cell activation(GO:0042118) |
4.7 | 23.4 | GO:0097151 | positive regulation of inhibitory postsynaptic potential(GO:0097151) |
4.7 | 83.7 | GO:0060074 | synapse maturation(GO:0060074) |
4.6 | 18.2 | GO:2001286 | regulation of caveolin-mediated endocytosis(GO:2001286) |
4.5 | 9.1 | GO:0043267 | negative regulation of potassium ion transport(GO:0043267) |
4.4 | 13.3 | GO:0048677 | axon extension involved in regeneration(GO:0048677) sprouting of injured axon(GO:0048682) |
4.4 | 26.1 | GO:0090527 | actin filament reorganization(GO:0090527) |
4.3 | 8.5 | GO:0097477 | lateral motor column neuron migration(GO:0097477) |
4.3 | 8.5 | GO:1901629 | regulation of presynaptic membrane organization(GO:1901629) |
4.2 | 21.1 | GO:1902993 | positive regulation of beta-amyloid formation(GO:1902004) positive regulation of amyloid precursor protein catabolic process(GO:1902993) |
4.2 | 20.8 | GO:0090394 | negative regulation of excitatory postsynaptic potential(GO:0090394) |
4.1 | 12.3 | GO:0044337 | canonical Wnt signaling pathway involved in positive regulation of apoptotic process(GO:0044337) |
4.1 | 16.3 | GO:0006538 | glutamate catabolic process(GO:0006538) |
4.0 | 28.2 | GO:0021540 | corpus callosum morphogenesis(GO:0021540) |
3.9 | 11.7 | GO:2000143 | negative regulation of transcription initiation from RNA polymerase II promoter(GO:0060633) negative regulation of DNA-templated transcription, initiation(GO:2000143) |
3.9 | 7.8 | GO:0098903 | regulation of membrane repolarization during action potential(GO:0098903) |
3.9 | 23.2 | GO:0090273 | regulation of somatostatin secretion(GO:0090273) |
3.8 | 7.7 | GO:1901509 | regulation of endothelial tube morphogenesis(GO:1901509) |
3.8 | 15.3 | GO:0030091 | protein repair(GO:0030091) |
3.8 | 30.4 | GO:0046069 | cGMP catabolic process(GO:0046069) |
3.7 | 11.2 | GO:1902630 | regulation of membrane hyperpolarization(GO:1902630) |
3.7 | 26.0 | GO:0051967 | negative regulation of synaptic transmission, glutamatergic(GO:0051967) |
3.7 | 3.7 | GO:0003175 | tricuspid valve development(GO:0003175) |
3.5 | 21.3 | GO:0021796 | cerebral cortex regionalization(GO:0021796) |
3.5 | 3.5 | GO:0003011 | involuntary skeletal muscle contraction(GO:0003011) |
3.5 | 10.6 | GO:1903261 | regulation of serine phosphorylation of STAT3 protein(GO:1903261) |
3.5 | 28.1 | GO:0021707 | cerebellar granular layer formation(GO:0021684) cerebellar granule cell differentiation(GO:0021707) |
3.4 | 3.4 | GO:0098828 | modulation of inhibitory postsynaptic potential(GO:0098828) |
3.4 | 30.9 | GO:0060012 | synaptic transmission, glycinergic(GO:0060012) |
3.4 | 10.3 | GO:0086023 | adrenergic receptor signaling pathway involved in heart process(GO:0086023) |
3.4 | 13.6 | GO:0043402 | glucocorticoid mediated signaling pathway(GO:0043402) |
3.4 | 6.8 | GO:0055005 | ventricular cardiac myofibril assembly(GO:0055005) |
3.4 | 40.7 | GO:0014051 | gamma-aminobutyric acid secretion(GO:0014051) |
3.3 | 13.4 | GO:0030035 | microspike assembly(GO:0030035) |
3.3 | 9.9 | GO:1903223 | positive regulation of oxidative stress-induced neuron death(GO:1903223) |
3.3 | 9.9 | GO:0035021 | negative regulation of Rac protein signal transduction(GO:0035021) |
3.3 | 22.9 | GO:0097264 | self proteolysis(GO:0097264) |
3.3 | 3.3 | GO:0021586 | pons maturation(GO:0021586) |
3.2 | 9.7 | GO:0034773 | histone H4-K20 trimethylation(GO:0034773) |
3.2 | 16.1 | GO:0010891 | negative regulation of sequestering of triglyceride(GO:0010891) |
3.1 | 25.1 | GO:0035641 | locomotory exploration behavior(GO:0035641) |
3.1 | 3.1 | GO:1901187 | regulation of ephrin receptor signaling pathway(GO:1901187) |
3.1 | 61.1 | GO:0060292 | long term synaptic depression(GO:0060292) |
3.0 | 18.2 | GO:0021942 | radial glia guided migration of Purkinje cell(GO:0021942) |
3.0 | 9.0 | GO:0060454 | positive regulation of gastric acid secretion(GO:0060454) |
3.0 | 27.0 | GO:0007216 | G-protein coupled glutamate receptor signaling pathway(GO:0007216) |
2.9 | 8.8 | GO:0051385 | response to mineralocorticoid(GO:0051385) |
2.9 | 2.9 | GO:0050847 | progesterone receptor signaling pathway(GO:0050847) |
2.9 | 23.4 | GO:0071420 | cellular response to histamine(GO:0071420) |
2.9 | 17.4 | GO:0002091 | negative regulation of receptor internalization(GO:0002091) |
2.9 | 8.7 | GO:0035887 | aortic smooth muscle cell differentiation(GO:0035887) |
2.8 | 8.5 | GO:0045196 | establishment or maintenance of neuroblast polarity(GO:0045196) establishment of neuroblast polarity(GO:0045200) |
2.8 | 11.3 | GO:1900084 | regulation of peptidyl-tyrosine autophosphorylation(GO:1900084) positive regulation of peptidyl-tyrosine autophosphorylation(GO:1900086) |
2.8 | 19.7 | GO:1904321 | response to forskolin(GO:1904321) cellular response to forskolin(GO:1904322) |
2.8 | 5.6 | GO:0097119 | postsynaptic density protein 95 clustering(GO:0097119) |
2.8 | 5.6 | GO:0035907 | dorsal aorta development(GO:0035907) dorsal aorta morphogenesis(GO:0035912) |
2.8 | 8.4 | GO:1900245 | positive regulation of MDA-5 signaling pathway(GO:1900245) |
2.8 | 5.6 | GO:1900222 | negative regulation of beta-amyloid clearance(GO:1900222) |
2.8 | 16.6 | GO:0005513 | detection of calcium ion(GO:0005513) |
2.7 | 24.5 | GO:0031987 | locomotion involved in locomotory behavior(GO:0031987) |
2.7 | 16.3 | GO:0019934 | cGMP-mediated signaling(GO:0019934) |
2.7 | 16.2 | GO:0016198 | axon choice point recognition(GO:0016198) |
2.7 | 5.4 | GO:0003289 | atrial septum primum morphogenesis(GO:0003289) |
2.7 | 5.4 | GO:0070779 | D-aspartate transport(GO:0070777) D-aspartate import(GO:0070779) |
2.7 | 8.0 | GO:0034184 | positive regulation of maintenance of sister chromatid cohesion(GO:0034093) positive regulation of maintenance of mitotic sister chromatid cohesion(GO:0034184) |
2.7 | 2.7 | GO:0060315 | negative regulation of ryanodine-sensitive calcium-release channel activity(GO:0060315) |
2.6 | 7.9 | GO:0000160 | phosphorelay signal transduction system(GO:0000160) |
2.6 | 2.6 | GO:2000173 | negative regulation of branching morphogenesis of a nerve(GO:2000173) |
2.6 | 10.5 | GO:0021698 | cerebellar cortex structural organization(GO:0021698) |
2.6 | 15.7 | GO:0086036 | regulation of cardiac muscle cell membrane potential(GO:0086036) |
2.6 | 20.8 | GO:0050957 | equilibrioception(GO:0050957) |
2.6 | 20.6 | GO:0042090 | interleukin-12 biosynthetic process(GO:0042090) regulation of interleukin-12 biosynthetic process(GO:0045075) |
2.6 | 5.1 | GO:0001698 | gastrin-induced gastric acid secretion(GO:0001698) |
2.6 | 2.6 | GO:0007412 | axon target recognition(GO:0007412) |
2.6 | 7.7 | GO:0007638 | mechanosensory behavior(GO:0007638) |
2.5 | 7.6 | GO:0001994 | norepinephrine-epinephrine vasoconstriction involved in regulation of systemic arterial blood pressure(GO:0001994) |
2.5 | 15.1 | GO:0015816 | glycine transport(GO:0015816) |
2.5 | 7.5 | GO:1903898 | negative regulation of PERK-mediated unfolded protein response(GO:1903898) |
2.5 | 5.0 | GO:0071877 | regulation of adrenergic receptor signaling pathway(GO:0071877) |
2.5 | 64.4 | GO:0032728 | positive regulation of interferon-beta production(GO:0032728) |
2.5 | 2.5 | GO:0010735 | positive regulation of transcription via serum response element binding(GO:0010735) |
2.5 | 2.5 | GO:1903596 | regulation of gap junction assembly(GO:1903596) positive regulation of gap junction assembly(GO:1903598) |
2.5 | 7.4 | GO:0030382 | sperm mitochondrion organization(GO:0030382) |
2.5 | 54.2 | GO:0006376 | mRNA splice site selection(GO:0006376) |
2.4 | 2.4 | GO:0060842 | arterial endothelial cell differentiation(GO:0060842) |
2.4 | 2.4 | GO:0060137 | maternal process involved in parturition(GO:0060137) |
2.4 | 2.4 | GO:0001765 | membrane raft assembly(GO:0001765) |
2.4 | 4.8 | GO:0022009 | central nervous system vasculogenesis(GO:0022009) |
2.4 | 4.8 | GO:2000821 | regulation of grooming behavior(GO:2000821) |
2.4 | 7.2 | GO:1902564 | negative regulation of neutrophil activation(GO:1902564) |
2.4 | 2.4 | GO:0003051 | angiotensin-mediated drinking behavior(GO:0003051) |
2.4 | 9.5 | GO:0070842 | aggresome assembly(GO:0070842) |
2.4 | 16.7 | GO:0086066 | atrial cardiac muscle cell action potential(GO:0086014) atrial cardiac muscle cell to AV node cell signaling(GO:0086026) atrial cardiac muscle cell to AV node cell communication(GO:0086066) |
2.4 | 4.8 | GO:1903818 | positive regulation of delayed rectifier potassium channel activity(GO:1902261) positive regulation of voltage-gated potassium channel activity(GO:1903818) |
2.4 | 21.4 | GO:0021542 | dentate gyrus development(GO:0021542) |
2.4 | 4.7 | GO:0043490 | malate-aspartate shuttle(GO:0043490) |
2.4 | 4.7 | GO:1903977 | positive regulation of glial cell migration(GO:1903977) |
2.4 | 7.1 | GO:2000474 | regulation of opioid receptor signaling pathway(GO:2000474) |
2.4 | 2.4 | GO:1902514 | regulation of calcium ion transmembrane transport via high voltage-gated calcium channel(GO:1902514) |
2.3 | 2.3 | GO:0035646 | endosome to melanosome transport(GO:0035646) cellular pigment accumulation(GO:0043482) endosome to pigment granule transport(GO:0043485) pigment granule maturation(GO:0048757) |
2.3 | 16.4 | GO:2000480 | negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
2.3 | 2.3 | GO:0035284 | central nervous system segmentation(GO:0035283) brain segmentation(GO:0035284) |
2.3 | 11.6 | GO:1900028 | negative regulation of ruffle assembly(GO:1900028) |
2.3 | 30.1 | GO:0046549 | retinal cone cell development(GO:0046549) |
2.3 | 11.6 | GO:0034047 | regulation of protein phosphatase type 2A activity(GO:0034047) |
2.3 | 2.3 | GO:0045117 | azole transport(GO:0045117) |
2.3 | 6.8 | GO:0007525 | somatic muscle development(GO:0007525) |
2.3 | 9.1 | GO:0030432 | peristalsis(GO:0030432) |
2.3 | 6.8 | GO:0001831 | trophectodermal cellular morphogenesis(GO:0001831) |
2.2 | 6.7 | GO:0033693 | neurofilament bundle assembly(GO:0033693) |
2.2 | 38.0 | GO:0071475 | cellular hyperosmotic salinity response(GO:0071475) |
2.2 | 4.5 | GO:1902498 | regulation of protein autoubiquitination(GO:1902498) |
2.2 | 2.2 | GO:0071372 | cellular response to follicle-stimulating hormone stimulus(GO:0071372) |
2.2 | 11.1 | GO:0045113 | regulation of integrin biosynthetic process(GO:0045113) |
2.2 | 4.4 | GO:0031585 | regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0031585) |
2.2 | 2.2 | GO:0098904 | regulation of AV node cell action potential(GO:0098904) |
2.2 | 4.4 | GO:0030240 | skeletal muscle thin filament assembly(GO:0030240) |
2.2 | 6.6 | GO:0090038 | negative regulation of protein kinase C signaling(GO:0090038) |
2.2 | 33.0 | GO:0031114 | regulation of microtubule depolymerization(GO:0031114) |
2.2 | 6.6 | GO:0035701 | hematopoietic stem cell migration(GO:0035701) |
2.2 | 43.8 | GO:0051491 | positive regulation of filopodium assembly(GO:0051491) |
2.2 | 8.8 | GO:0006651 | diacylglycerol biosynthetic process(GO:0006651) |
2.2 | 13.1 | GO:0010739 | positive regulation of protein kinase A signaling(GO:0010739) |
2.2 | 21.8 | GO:0042759 | long-chain fatty acid biosynthetic process(GO:0042759) |
2.2 | 10.9 | GO:0007256 | activation of JNKK activity(GO:0007256) |
2.2 | 21.7 | GO:0035726 | common myeloid progenitor cell proliferation(GO:0035726) |
2.2 | 4.3 | GO:1990123 | L-glutamate(1-) import into cell(GO:1903802) L-glutamate import into cell(GO:1990123) |
2.2 | 4.3 | GO:0007621 | negative regulation of female receptivity(GO:0007621) |
2.1 | 4.3 | GO:1903215 | negative regulation of protein targeting to mitochondrion(GO:1903215) |
2.1 | 17.1 | GO:0021702 | cerebellar Purkinje cell differentiation(GO:0021702) |
2.1 | 4.3 | GO:0007158 | neuron cell-cell adhesion(GO:0007158) |
2.1 | 8.5 | GO:0060278 | regulation of ovulation(GO:0060278) |
2.1 | 2.1 | GO:2000980 | regulation of auditory receptor cell differentiation(GO:0045607) regulation of mechanoreceptor differentiation(GO:0045631) regulation of inner ear receptor cell differentiation(GO:2000980) |
2.1 | 6.3 | GO:0033563 | dorsal/ventral axon guidance(GO:0033563) |
2.1 | 6.3 | GO:1903779 | regulation of cardiac conduction(GO:1903779) |
2.1 | 6.3 | GO:0055099 | response to high density lipoprotein particle(GO:0055099) |
2.1 | 2.1 | GO:0042271 | susceptibility to natural killer cell mediated cytotoxicity(GO:0042271) |
2.1 | 6.2 | GO:0051684 | maintenance of Golgi location(GO:0051684) |
2.1 | 4.1 | GO:0014858 | positive regulation of skeletal muscle cell proliferation(GO:0014858) |
2.0 | 4.1 | GO:0031915 | positive regulation of synaptic plasticity(GO:0031915) |
2.0 | 2.0 | GO:0021683 | cerebellar granular layer morphogenesis(GO:0021683) |
2.0 | 2.0 | GO:0072300 | positive regulation of metanephric glomerulus development(GO:0072300) |
2.0 | 8.1 | GO:0048014 | Tie signaling pathway(GO:0048014) |
2.0 | 2.0 | GO:1902988 | neurofibrillary tangle assembly(GO:1902988) regulation of neurofibrillary tangle assembly(GO:1902996) |
2.0 | 65.7 | GO:0050885 | neuromuscular process controlling balance(GO:0050885) |
2.0 | 9.9 | GO:0021535 | cell migration in hindbrain(GO:0021535) |
2.0 | 3.9 | GO:0099624 | regulation of atrial cardiac muscle cell membrane repolarization(GO:0060372) atrial cardiac muscle cell membrane repolarization(GO:0099624) |
2.0 | 25.7 | GO:2000114 | regulation of establishment of cell polarity(GO:2000114) |
2.0 | 19.7 | GO:2000369 | regulation of clathrin-mediated endocytosis(GO:2000369) |
2.0 | 13.8 | GO:0042428 | serotonin metabolic process(GO:0042428) |
2.0 | 5.9 | GO:0032971 | regulation of muscle filament sliding(GO:0032971) |
2.0 | 21.5 | GO:0001964 | startle response(GO:0001964) |
1.9 | 93.5 | GO:0051965 | positive regulation of synapse assembly(GO:0051965) |
1.9 | 1.9 | GO:0035815 | positive regulation of renal sodium excretion(GO:0035815) |
1.9 | 3.9 | GO:0090154 | positive regulation of sphingolipid biosynthetic process(GO:0090154) positive regulation of ceramide biosynthetic process(GO:2000304) |
1.9 | 5.8 | GO:0043321 | regulation of natural killer cell degranulation(GO:0043321) |
1.9 | 1.9 | GO:0051462 | cortisol secretion(GO:0043400) regulation of cortisol secretion(GO:0051462) positive regulation of cortisol secretion(GO:0051464) |
1.9 | 3.9 | GO:0032513 | negative regulation of protein phosphatase type 2B activity(GO:0032513) |
1.9 | 9.6 | GO:2001275 | positive regulation of glucose import in response to insulin stimulus(GO:2001275) |
1.9 | 5.7 | GO:0002315 | marginal zone B cell differentiation(GO:0002315) |
1.9 | 9.5 | GO:0070236 | negative regulation of activation-induced cell death of T cells(GO:0070236) |
1.9 | 5.7 | GO:2000850 | negative regulation of steroid hormone secretion(GO:2000832) negative regulation of corticosteroid hormone secretion(GO:2000847) negative regulation of glucocorticoid secretion(GO:2000850) |
1.9 | 1.9 | GO:1905065 | positive regulation of vascular smooth muscle cell differentiation(GO:1905065) |
1.9 | 13.2 | GO:0051152 | positive regulation of smooth muscle cell differentiation(GO:0051152) |
1.9 | 15.0 | GO:0061003 | positive regulation of dendritic spine morphogenesis(GO:0061003) |
1.9 | 7.5 | GO:0008228 | opsonization(GO:0008228) |
1.8 | 7.4 | GO:1903352 | ornithine transport(GO:0015822) L-ornithine transmembrane transport(GO:1903352) |
1.8 | 14.7 | GO:0001504 | neurotransmitter uptake(GO:0001504) |
1.8 | 7.3 | GO:0045636 | positive regulation of melanocyte differentiation(GO:0045636) |
1.8 | 1.8 | GO:1905063 | regulation of vascular smooth muscle cell differentiation(GO:1905063) |
1.8 | 12.7 | GO:0051968 | positive regulation of synaptic transmission, glutamatergic(GO:0051968) |
1.8 | 10.9 | GO:0086042 | cardiac muscle cell-cardiac muscle cell adhesion(GO:0086042) bundle of His cell-Purkinje myocyte adhesion involved in cell communication(GO:0086073) |
1.8 | 14.5 | GO:0048268 | clathrin coat assembly(GO:0048268) |
1.8 | 3.6 | GO:1904124 | microglial cell migration(GO:1904124) regulation of microglial cell migration(GO:1904139) |
1.8 | 7.2 | GO:1900042 | positive regulation of interleukin-2 secretion(GO:1900042) |
1.8 | 5.4 | GO:0030242 | pexophagy(GO:0030242) |
1.8 | 1.8 | GO:0098902 | regulation of membrane depolarization during action potential(GO:0098902) |
1.8 | 10.7 | GO:0051966 | regulation of synaptic transmission, glutamatergic(GO:0051966) |
1.8 | 3.5 | GO:2001171 | positive regulation of ATP biosynthetic process(GO:2001171) |
1.8 | 12.3 | GO:0021979 | hypothalamus cell differentiation(GO:0021979) |
1.8 | 19.3 | GO:0002026 | regulation of the force of heart contraction(GO:0002026) |
1.7 | 5.2 | GO:0016264 | gap junction assembly(GO:0016264) |
1.7 | 7.0 | GO:0044336 | canonical Wnt signaling pathway involved in negative regulation of apoptotic process(GO:0044336) |
1.7 | 8.7 | GO:0019227 | neuronal action potential propagation(GO:0019227) action potential propagation(GO:0098870) |
1.7 | 12.1 | GO:0070995 | NADPH oxidation(GO:0070995) |
1.7 | 10.4 | GO:0043031 | negative regulation of macrophage activation(GO:0043031) |
1.7 | 15.6 | GO:0034331 | cell junction maintenance(GO:0034331) |
1.7 | 3.4 | GO:0042435 | indole-containing compound biosynthetic process(GO:0042435) |
1.7 | 3.4 | GO:1903242 | regulation of cardiac muscle adaptation(GO:0010612) regulation of cardiac muscle hypertrophy in response to stress(GO:1903242) |
1.7 | 39.1 | GO:0010107 | potassium ion import(GO:0010107) |
1.7 | 11.9 | GO:0030388 | fructose 1,6-bisphosphate metabolic process(GO:0030388) |
1.7 | 3.4 | GO:0071374 | cellular response to parathyroid hormone stimulus(GO:0071374) |
1.7 | 8.4 | GO:0070072 | vacuolar proton-transporting V-type ATPase complex assembly(GO:0070072) |
1.7 | 5.0 | GO:1902071 | regulation of hypoxia-inducible factor-1alpha signaling pathway(GO:1902071) |
1.7 | 9.9 | GO:1901621 | negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:1901621) |
1.6 | 29.7 | GO:0043268 | positive regulation of potassium ion transport(GO:0043268) |
1.6 | 6.5 | GO:0070427 | nucleotide-binding oligomerization domain containing 1 signaling pathway(GO:0070427) |
1.6 | 8.2 | GO:0060158 | phospholipase C-activating dopamine receptor signaling pathway(GO:0060158) |
1.6 | 6.5 | GO:0010510 | regulation of acetyl-CoA biosynthetic process from pyruvate(GO:0010510) |
1.6 | 3.3 | GO:0097411 | hypoxia-inducible factor-1alpha signaling pathway(GO:0097411) |
1.6 | 1.6 | GO:2000823 | regulation of androgen receptor activity(GO:2000823) |
1.6 | 4.9 | GO:0042091 | interleukin-10 biosynthetic process(GO:0042091) regulation of interleukin-10 biosynthetic process(GO:0045074) |
1.6 | 4.8 | GO:2000587 | regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000586) negative regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000587) |
1.6 | 3.2 | GO:0060907 | positive regulation of macrophage cytokine production(GO:0060907) |
1.6 | 6.4 | GO:0002087 | regulation of respiratory gaseous exchange by neurological system process(GO:0002087) |
1.6 | 11.3 | GO:1902855 | regulation of nonmotile primary cilium assembly(GO:1902855) |
1.6 | 4.8 | GO:0042891 | antibiotic transport(GO:0042891) |
1.6 | 116.6 | GO:0007156 | homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
1.6 | 4.8 | GO:0038128 | ERBB2 signaling pathway(GO:0038128) |
1.6 | 6.4 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
1.6 | 1.6 | GO:0023041 | neuronal signal transduction(GO:0023041) |
1.6 | 6.3 | GO:0043415 | positive regulation of skeletal muscle tissue regeneration(GO:0043415) |
1.6 | 15.7 | GO:0033523 | histone H2B ubiquitination(GO:0033523) |
1.6 | 17.3 | GO:2000311 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000311) |
1.6 | 3.1 | GO:2000211 | regulation of glutamate metabolic process(GO:2000211) |
1.6 | 4.7 | GO:0060666 | dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
1.6 | 3.1 | GO:1903587 | regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:1903587) |
1.5 | 6.2 | GO:0031999 | negative regulation of fatty acid beta-oxidation(GO:0031999) |
1.5 | 3.1 | GO:0045199 | maintenance of epithelial cell apical/basal polarity(GO:0045199) |
1.5 | 1.5 | GO:1904378 | maintenance of unfolded protein(GO:0036506) maintenance of unfolded protein involved in ERAD pathway(GO:1904378) |
1.5 | 1.5 | GO:0060837 | blood vessel endothelial cell differentiation(GO:0060837) |
1.5 | 24.2 | GO:0007214 | gamma-aminobutyric acid signaling pathway(GO:0007214) |
1.5 | 3.0 | GO:0034395 | regulation of transcription from RNA polymerase II promoter in response to iron(GO:0034395) |
1.5 | 3.0 | GO:0010871 | negative regulation of receptor biosynthetic process(GO:0010871) |
1.5 | 6.0 | GO:1903887 | motile primary cilium assembly(GO:1903887) |
1.5 | 4.5 | GO:0060178 | regulation of exocyst localization(GO:0060178) |
1.5 | 3.0 | GO:0032430 | positive regulation of phospholipase A2 activity(GO:0032430) |
1.5 | 19.3 | GO:0010758 | regulation of macrophage chemotaxis(GO:0010758) |
1.5 | 3.0 | GO:0035609 | C-terminal protein deglutamylation(GO:0035609) |
1.5 | 5.9 | GO:0014874 | response to stimulus involved in regulation of muscle adaptation(GO:0014874) |
1.5 | 4.4 | GO:1901529 | positive regulation of anion channel activity(GO:1901529) |
1.5 | 14.7 | GO:0003301 | physiological muscle hypertrophy(GO:0003298) physiological cardiac muscle hypertrophy(GO:0003301) cell growth involved in cardiac muscle cell development(GO:0061049) |
1.5 | 10.3 | GO:0016322 | neuron remodeling(GO:0016322) |
1.5 | 4.4 | GO:0070973 | protein localization to endoplasmic reticulum exit site(GO:0070973) |
1.4 | 7.2 | GO:0034983 | peptidyl-lysine deacetylation(GO:0034983) |
1.4 | 13.0 | GO:0007215 | glutamate receptor signaling pathway(GO:0007215) |
1.4 | 1.4 | GO:0006940 | regulation of smooth muscle contraction(GO:0006940) |
1.4 | 4.3 | GO:0060060 | post-embryonic retina morphogenesis in camera-type eye(GO:0060060) |
1.4 | 8.6 | GO:0003376 | sphingosine-1-phosphate signaling pathway(GO:0003376) |
1.4 | 2.8 | GO:1901889 | negative regulation of cell junction assembly(GO:1901889) |
1.4 | 11.4 | GO:0090051 | negative regulation of cell migration involved in sprouting angiogenesis(GO:0090051) |
1.4 | 4.3 | GO:0015888 | thiamine transport(GO:0015888) |
1.4 | 1.4 | GO:0051541 | elastin metabolic process(GO:0051541) |
1.4 | 4.2 | GO:2000659 | regulation of interleukin-1-mediated signaling pathway(GO:2000659) |
1.4 | 4.2 | GO:0015812 | gamma-aminobutyric acid transport(GO:0015812) |
1.4 | 4.2 | GO:0060618 | nipple development(GO:0060618) |
1.4 | 4.2 | GO:0071280 | cellular response to copper ion(GO:0071280) |
1.4 | 2.8 | GO:0061153 | trachea submucosa development(GO:0061152) trachea gland development(GO:0061153) |
1.4 | 2.8 | GO:0010728 | regulation of hydrogen peroxide biosynthetic process(GO:0010728) |
1.4 | 1.4 | GO:0001998 | angiotensin mediated vasoconstriction involved in regulation of systemic arterial blood pressure(GO:0001998) |
1.4 | 1.4 | GO:0070445 | oligodendrocyte progenitor proliferation(GO:0070444) regulation of oligodendrocyte progenitor proliferation(GO:0070445) |
1.4 | 5.5 | GO:0072393 | microtubule anchoring at microtubule organizing center(GO:0072393) |
1.4 | 5.5 | GO:0051823 | regulation of synapse structural plasticity(GO:0051823) |
1.4 | 2.7 | GO:0019478 | D-amino acid catabolic process(GO:0019478) |
1.4 | 10.9 | GO:0010614 | negative regulation of cardiac muscle hypertrophy(GO:0010614) |
1.4 | 2.7 | GO:0016344 | meiotic chromosome movement towards spindle pole(GO:0016344) |
1.4 | 4.1 | GO:0032056 | positive regulation of translation in response to stress(GO:0032056) |
1.4 | 5.4 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
1.4 | 12.2 | GO:0014047 | glutamate secretion(GO:0014047) |
1.3 | 2.7 | GO:0035482 | gastric motility(GO:0035482) |
1.3 | 4.0 | GO:0097503 | sialylation(GO:0097503) |
1.3 | 2.7 | GO:2000324 | positive regulation of glucocorticoid receptor signaling pathway(GO:2000324) |
1.3 | 5.3 | GO:0038165 | oncostatin-M-mediated signaling pathway(GO:0038165) |
1.3 | 2.6 | GO:0006701 | progesterone biosynthetic process(GO:0006701) |
1.3 | 4.0 | GO:0007084 | mitotic nuclear envelope reassembly(GO:0007084) |
1.3 | 3.9 | GO:0070634 | transepithelial ammonium transport(GO:0070634) |
1.3 | 9.1 | GO:0007021 | tubulin complex assembly(GO:0007021) |
1.3 | 13.0 | GO:0051292 | nuclear pore complex assembly(GO:0051292) |
1.3 | 1.3 | GO:0030157 | pancreatic juice secretion(GO:0030157) |
1.3 | 1.3 | GO:0002860 | positive regulation of natural killer cell mediated immune response to tumor cell(GO:0002857) positive regulation of natural killer cell mediated cytotoxicity directed against tumor cell target(GO:0002860) |
1.3 | 1.3 | GO:1900122 | positive regulation of receptor binding(GO:1900122) |
1.3 | 1.3 | GO:0051665 | membrane raft localization(GO:0051665) |
1.3 | 5.1 | GO:0006382 | adenosine to inosine editing(GO:0006382) |
1.3 | 6.3 | GO:0010459 | negative regulation of heart rate(GO:0010459) |
1.3 | 2.5 | GO:0051088 | PMA-inducible membrane protein ectodomain proteolysis(GO:0051088) |
1.3 | 39.2 | GO:0046580 | negative regulation of Ras protein signal transduction(GO:0046580) |
1.3 | 2.5 | GO:0002282 | microglial cell activation involved in immune response(GO:0002282) |
1.3 | 3.8 | GO:0031086 | nuclear-transcribed mRNA catabolic process, deadenylation-independent decay(GO:0031086) deadenylation-independent decapping of nuclear-transcribed mRNA(GO:0031087) |
1.3 | 10.1 | GO:0006086 | acetyl-CoA biosynthetic process from pyruvate(GO:0006086) mitochondrial acetyl-CoA biosynthetic process from pyruvate(GO:0061732) |
1.3 | 10.1 | GO:0051971 | positive regulation of transmission of nerve impulse(GO:0051971) |
1.3 | 1.3 | GO:0070358 | actin polymerization-dependent cell motility(GO:0070358) |
1.3 | 8.8 | GO:0031111 | negative regulation of microtubule polymerization or depolymerization(GO:0031111) |
1.2 | 1.2 | GO:0044849 | estrous cycle(GO:0044849) |
1.2 | 8.7 | GO:0070257 | positive regulation of mucus secretion(GO:0070257) |
1.2 | 5.0 | GO:0060830 | ciliary receptor clustering involved in smoothened signaling pathway(GO:0060830) |
1.2 | 7.4 | GO:0048245 | eosinophil chemotaxis(GO:0048245) |
1.2 | 1.2 | GO:0045626 | negative regulation of T-helper 1 cell differentiation(GO:0045626) |
1.2 | 1.2 | GO:0070346 | positive regulation of fat cell proliferation(GO:0070346) |
1.2 | 9.8 | GO:0007616 | long-term memory(GO:0007616) |
1.2 | 8.6 | GO:0035994 | response to muscle stretch(GO:0035994) |
1.2 | 3.7 | GO:0001696 | gastric acid secretion(GO:0001696) |
1.2 | 90.9 | GO:0071805 | potassium ion transmembrane transport(GO:0071805) |
1.2 | 4.8 | GO:1902307 | positive regulation of sodium ion transmembrane transport(GO:1902307) |
1.2 | 4.8 | GO:0061588 | calcium activated phospholipid scrambling(GO:0061588) calcium activated phosphatidylcholine scrambling(GO:0061590) calcium activated galactosylceramide scrambling(GO:0061591) |
1.2 | 3.6 | GO:0036092 | phosphatidylinositol-3-phosphate biosynthetic process(GO:0036092) |
1.2 | 4.8 | GO:2000662 | interleukin-5 secretion(GO:0072603) interleukin-13 secretion(GO:0072611) regulation of interleukin-5 secretion(GO:2000662) regulation of interleukin-13 secretion(GO:2000665) |
1.2 | 3.6 | GO:0000189 | MAPK import into nucleus(GO:0000189) |
1.2 | 8.4 | GO:2001258 | negative regulation of cation channel activity(GO:2001258) |
1.2 | 2.4 | GO:0019230 | proprioception(GO:0019230) |
1.2 | 3.6 | GO:1900127 | positive regulation of hyaluronan biosynthetic process(GO:1900127) |
1.2 | 1.2 | GO:0044068 | modulation by symbiont of host cellular process(GO:0044068) |
1.2 | 4.7 | GO:0031666 | positive regulation of lipopolysaccharide-mediated signaling pathway(GO:0031666) |
1.2 | 7.1 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
1.2 | 73.3 | GO:0007612 | learning(GO:0007612) |
1.2 | 7.0 | GO:0043368 | positive T cell selection(GO:0043368) |
1.2 | 1.2 | GO:0070093 | negative regulation of glucagon secretion(GO:0070093) |
1.2 | 8.1 | GO:0043374 | CD8-positive, alpha-beta T cell differentiation(GO:0043374) |
1.2 | 11.5 | GO:0070884 | regulation of calcineurin-NFAT signaling cascade(GO:0070884) |
1.2 | 1.2 | GO:0050859 | negative regulation of B cell receptor signaling pathway(GO:0050859) |
1.2 | 3.5 | GO:0019859 | pyrimidine nucleobase catabolic process(GO:0006208) thymine catabolic process(GO:0006210) thymine metabolic process(GO:0019859) |
1.1 | 3.4 | GO:0046391 | 5-phosphoribose 1-diphosphate biosynthetic process(GO:0006015) 5-phosphoribose 1-diphosphate metabolic process(GO:0046391) |
1.1 | 4.6 | GO:1904659 | glucose transmembrane transport(GO:1904659) |
1.1 | 1.1 | GO:0045602 | negative regulation of endothelial cell differentiation(GO:0045602) |
1.1 | 5.7 | GO:0007197 | adenylate cyclase-inhibiting G-protein coupled acetylcholine receptor signaling pathway(GO:0007197) phospholipase C-activating G-protein coupled acetylcholine receptor signaling pathway(GO:0007207) |
1.1 | 4.5 | GO:0008090 | retrograde axonal transport(GO:0008090) |
1.1 | 4.5 | GO:0019732 | antifungal humoral response(GO:0019732) |
1.1 | 2.3 | GO:0035434 | copper ion transmembrane transport(GO:0035434) |
1.1 | 1.1 | GO:0070294 | renal sodium ion transport(GO:0003096) renal sodium ion absorption(GO:0070294) |
1.1 | 3.4 | GO:0003105 | negative regulation of glomerular filtration(GO:0003105) |
1.1 | 1.1 | GO:0070070 | proton-transporting V-type ATPase complex assembly(GO:0070070) |
1.1 | 2.2 | GO:0090148 | membrane fission(GO:0090148) |
1.1 | 3.3 | GO:0021530 | spinal cord oligodendrocyte cell differentiation(GO:0021529) spinal cord oligodendrocyte cell fate specification(GO:0021530) |
1.1 | 3.3 | GO:2000327 | regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000325) positive regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000327) |
1.1 | 4.4 | GO:0061302 | smooth muscle cell-matrix adhesion(GO:0061302) |
1.1 | 1.1 | GO:0044333 | Wnt signaling pathway involved in digestive tract morphogenesis(GO:0044333) |
1.1 | 1.1 | GO:0002434 | immune complex clearance(GO:0002434) |
1.1 | 6.5 | GO:0043651 | linoleic acid metabolic process(GO:0043651) |
1.1 | 6.5 | GO:0014046 | dopamine secretion(GO:0014046) regulation of dopamine secretion(GO:0014059) |
1.1 | 1.1 | GO:2000676 | positive regulation of type B pancreatic cell apoptotic process(GO:2000676) |
1.1 | 6.4 | GO:0015074 | DNA integration(GO:0015074) |
1.1 | 1.1 | GO:2000727 | positive regulation of cardiac muscle cell differentiation(GO:2000727) |
1.1 | 5.4 | GO:0051639 | actin filament network formation(GO:0051639) |
1.1 | 14.9 | GO:0016486 | peptide hormone processing(GO:0016486) |
1.1 | 10.7 | GO:0009312 | oligosaccharide biosynthetic process(GO:0009312) |
1.1 | 1.1 | GO:1901841 | regulation of high voltage-gated calcium channel activity(GO:1901841) |
1.1 | 3.2 | GO:0090310 | negative regulation of methylation-dependent chromatin silencing(GO:0090310) |
1.1 | 2.1 | GO:0002036 | regulation of L-glutamate transport(GO:0002036) |
1.0 | 2.1 | GO:0060355 | positive regulation of cell adhesion molecule production(GO:0060355) |
1.0 | 3.1 | GO:0090331 | negative regulation of platelet aggregation(GO:0090331) |
1.0 | 15.7 | GO:0090659 | adult walking behavior(GO:0007628) walking behavior(GO:0090659) |
1.0 | 2.1 | GO:0060748 | tertiary branching involved in mammary gland duct morphogenesis(GO:0060748) |
1.0 | 2.1 | GO:0042414 | epinephrine metabolic process(GO:0042414) |
1.0 | 6.2 | GO:0032534 | regulation of microvillus assembly(GO:0032534) |
1.0 | 13.4 | GO:0032011 | ARF protein signal transduction(GO:0032011) regulation of ARF protein signal transduction(GO:0032012) |
1.0 | 4.1 | GO:0071440 | regulation of histone H3-K14 acetylation(GO:0071440) positive regulation of histone H3-K14 acetylation(GO:0071442) |
1.0 | 31.9 | GO:1904893 | negative regulation of JAK-STAT cascade(GO:0046426) negative regulation of STAT cascade(GO:1904893) |
1.0 | 1.0 | GO:0038026 | reelin-mediated signaling pathway(GO:0038026) |
1.0 | 2.0 | GO:0060971 | embryonic heart tube left/right pattern formation(GO:0060971) |
1.0 | 1.0 | GO:0060414 | aorta smooth muscle tissue morphogenesis(GO:0060414) |
1.0 | 1.0 | GO:0097501 | stress response to metal ion(GO:0097501) |
1.0 | 1.0 | GO:0014045 | establishment of endothelial blood-brain barrier(GO:0014045) |
1.0 | 2.0 | GO:0090271 | positive regulation of fibroblast growth factor production(GO:0090271) |
1.0 | 4.0 | GO:0071847 | TNFSF11-mediated signaling pathway(GO:0071847) |
1.0 | 26.2 | GO:0034605 | cellular response to heat(GO:0034605) |
1.0 | 1.0 | GO:0033122 | negative regulation of purine nucleotide catabolic process(GO:0033122) |
1.0 | 3.0 | GO:0002576 | platelet degranulation(GO:0002576) |
1.0 | 2.0 | GO:0043553 | negative regulation of phosphatidylinositol 3-kinase activity(GO:0043553) |
1.0 | 3.0 | GO:0015808 | L-alanine transport(GO:0015808) |
1.0 | 9.0 | GO:2001222 | regulation of neuron migration(GO:2001222) |
1.0 | 4.0 | GO:1901026 | ripoptosome assembly(GO:0097343) ripoptosome assembly involved in necroptotic process(GO:1901026) |
1.0 | 3.0 | GO:0090315 | negative regulation of protein targeting to membrane(GO:0090315) |
1.0 | 2.0 | GO:0060353 | regulation of cell adhesion molecule production(GO:0060353) |
1.0 | 2.0 | GO:0090241 | negative regulation of histone H4 acetylation(GO:0090241) |
1.0 | 1.9 | GO:0021914 | negative regulation of smoothened signaling pathway involved in ventral spinal cord patterning(GO:0021914) |
1.0 | 2.9 | GO:0000733 | DNA strand renaturation(GO:0000733) |
1.0 | 1.0 | GO:0032957 | inositol trisphosphate metabolic process(GO:0032957) |
1.0 | 1.0 | GO:2000169 | regulation of peptidyl-cysteine S-nitrosylation(GO:2000169) |
1.0 | 3.9 | GO:0035428 | hexose transmembrane transport(GO:0035428) |
1.0 | 2.9 | GO:1902308 | regulation of peptidyl-serine dephosphorylation(GO:1902308) |
1.0 | 3.9 | GO:0021785 | branchiomotor neuron axon guidance(GO:0021785) |
1.0 | 10.6 | GO:0046847 | filopodium assembly(GO:0046847) |
1.0 | 1.9 | GO:0019482 | beta-alanine metabolic process(GO:0019482) |
1.0 | 21.0 | GO:0006491 | N-glycan processing(GO:0006491) |
1.0 | 4.8 | GO:0035507 | regulation of myosin-light-chain-phosphatase activity(GO:0035507) |
1.0 | 1.9 | GO:1902774 | late endosome to lysosome transport(GO:1902774) |
0.9 | 2.8 | GO:2000009 | negative regulation of protein localization to cell surface(GO:2000009) |
0.9 | 0.9 | GO:0001787 | natural killer cell proliferation(GO:0001787) |
0.9 | 2.8 | GO:0046103 | inosine biosynthetic process(GO:0046103) |
0.9 | 2.8 | GO:0051791 | medium-chain fatty acid metabolic process(GO:0051791) |
0.9 | 0.9 | GO:0048769 | sarcomerogenesis(GO:0048769) |
0.9 | 0.9 | GO:0072584 | caveolin-mediated endocytosis(GO:0072584) |
0.9 | 0.9 | GO:0090403 | oxidative stress-induced premature senescence(GO:0090403) |
0.9 | 0.9 | GO:0060125 | negative regulation of growth hormone secretion(GO:0060125) |
0.9 | 5.6 | GO:0051574 | positive regulation of histone H3-K9 methylation(GO:0051574) |
0.9 | 2.8 | GO:0042097 | interleukin-4 biosynthetic process(GO:0042097) regulation of interleukin-4 biosynthetic process(GO:0045402) positive regulation of interleukin-4 biosynthetic process(GO:0045404) |
0.9 | 2.8 | GO:0050862 | positive regulation of T cell receptor signaling pathway(GO:0050862) |
0.9 | 0.9 | GO:1902202 | regulation of hepatocyte growth factor receptor signaling pathway(GO:1902202) |
0.9 | 0.9 | GO:0007632 | visual behavior(GO:0007632) |
0.9 | 1.8 | GO:0071787 | endoplasmic reticulum tubular network assembly(GO:0071787) |
0.9 | 0.9 | GO:0035811 | negative regulation of urine volume(GO:0035811) |
0.9 | 1.8 | GO:0035963 | response to interleukin-13(GO:0035962) cellular response to interleukin-13(GO:0035963) |
0.9 | 6.4 | GO:0032095 | regulation of response to food(GO:0032095) |
0.9 | 0.9 | GO:1902109 | negative regulation of mitochondrial membrane permeability involved in apoptotic process(GO:1902109) |
0.9 | 2.7 | GO:0044339 | canonical Wnt signaling pathway involved in osteoblast differentiation(GO:0044339) |
0.9 | 2.7 | GO:0014824 | artery smooth muscle contraction(GO:0014824) |
0.9 | 10.9 | GO:0002021 | response to dietary excess(GO:0002021) |
0.9 | 2.7 | GO:0007220 | Notch receptor processing(GO:0007220) |
0.9 | 4.5 | GO:0060052 | neurofilament cytoskeleton organization(GO:0060052) |
0.9 | 0.9 | GO:1901535 | regulation of DNA demethylation(GO:1901535) negative regulation of DNA demethylation(GO:1901536) |
0.9 | 2.7 | GO:0010499 | proteasomal ubiquitin-independent protein catabolic process(GO:0010499) |
0.9 | 1.8 | GO:0032829 | regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation(GO:0032829) positive regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation(GO:0032831) |
0.9 | 2.7 | GO:0003222 | ventricular trabecula myocardium morphogenesis(GO:0003222) |
0.9 | 1.8 | GO:1901660 | calcium ion export(GO:1901660) |
0.9 | 0.9 | GO:0031529 | ruffle organization(GO:0031529) |
0.9 | 1.8 | GO:1903774 | positive regulation of viral budding via host ESCRT complex(GO:1903774) |
0.9 | 4.4 | GO:0030949 | positive regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030949) |
0.9 | 7.0 | GO:0007205 | protein kinase C-activating G-protein coupled receptor signaling pathway(GO:0007205) |
0.9 | 1.7 | GO:0021523 | somatic motor neuron differentiation(GO:0021523) |
0.9 | 8.7 | GO:0019228 | neuronal action potential(GO:0019228) |
0.9 | 1.7 | GO:0070102 | interleukin-6-mediated signaling pathway(GO:0070102) |
0.9 | 13.1 | GO:0051205 | protein insertion into membrane(GO:0051205) |
0.9 | 6.1 | GO:0032790 | ribosome disassembly(GO:0032790) |
0.9 | 4.3 | GO:0044539 | long-chain fatty acid import(GO:0044539) |
0.9 | 7.8 | GO:0014912 | negative regulation of smooth muscle cell migration(GO:0014912) |
0.9 | 4.3 | GO:0014883 | transition between fast and slow fiber(GO:0014883) |
0.9 | 1.7 | GO:0050849 | negative regulation of calcium-mediated signaling(GO:0050849) |
0.9 | 1.7 | GO:0036295 | cellular response to increased oxygen levels(GO:0036295) cellular response to hyperoxia(GO:0071455) |
0.9 | 5.2 | GO:1904262 | negative regulation of TORC1 signaling(GO:1904262) |
0.9 | 0.9 | GO:0060300 | regulation of cytokine activity(GO:0060300) |
0.9 | 0.9 | GO:0046541 | saliva secretion(GO:0046541) |
0.9 | 0.9 | GO:0045590 | negative regulation of regulatory T cell differentiation(GO:0045590) |
0.9 | 5.1 | GO:0051694 | pointed-end actin filament capping(GO:0051694) |
0.9 | 5.1 | GO:0042523 | positive regulation of tyrosine phosphorylation of Stat5 protein(GO:0042523) |
0.8 | 2.5 | GO:0050853 | B cell receptor signaling pathway(GO:0050853) |
0.8 | 1.7 | GO:0090136 | epithelial cell-cell adhesion(GO:0090136) |
0.8 | 1.7 | GO:1901077 | regulation of relaxation of muscle(GO:1901077) |
0.8 | 1.7 | GO:0007413 | axonal fasciculation(GO:0007413) |
0.8 | 5.0 | GO:0045046 | peroxisomal membrane transport(GO:0015919) protein import into peroxisome membrane(GO:0045046) |
0.8 | 2.5 | GO:0002331 | pre-B cell allelic exclusion(GO:0002331) |
0.8 | 0.8 | GO:1903599 | positive regulation of mitophagy(GO:1903599) |
0.8 | 5.0 | GO:0060287 | epithelial cilium movement involved in determination of left/right asymmetry(GO:0060287) |
0.8 | 1.7 | GO:0007039 | protein catabolic process in the vacuole(GO:0007039) |
0.8 | 0.8 | GO:0097112 | gamma-aminobutyric acid receptor clustering(GO:0097112) |
0.8 | 2.5 | GO:0060447 | bud outgrowth involved in lung branching(GO:0060447) |
0.8 | 3.3 | GO:0006432 | phenylalanyl-tRNA aminoacylation(GO:0006432) |
0.8 | 1.6 | GO:0010511 | regulation of phosphatidylinositol biosynthetic process(GO:0010511) |
0.8 | 0.8 | GO:0002513 | tolerance induction to self antigen(GO:0002513) |
0.8 | 4.9 | GO:0071985 | multivesicular body sorting pathway(GO:0071985) |
0.8 | 5.7 | GO:0032291 | central nervous system myelination(GO:0022010) axon ensheathment in central nervous system(GO:0032291) |
0.8 | 2.4 | GO:0042723 | thiamine metabolic process(GO:0006772) thiamine-containing compound metabolic process(GO:0042723) |
0.8 | 0.8 | GO:0033159 | negative regulation of protein import into nucleus, translocation(GO:0033159) |
0.8 | 5.6 | GO:0035249 | synaptic transmission, glutamatergic(GO:0035249) |
0.8 | 1.6 | GO:0035372 | protein localization to microtubule(GO:0035372) |
0.8 | 0.8 | GO:1904193 | cholangiocyte apoptotic process(GO:1902488) regulation of cholangiocyte apoptotic process(GO:1904192) negative regulation of cholangiocyte apoptotic process(GO:1904193) |
0.8 | 6.4 | GO:0006622 | protein targeting to lysosome(GO:0006622) |
0.8 | 4.0 | GO:0001778 | plasma membrane repair(GO:0001778) |
0.8 | 0.8 | GO:0043092 | L-amino acid import(GO:0043092) |
0.8 | 0.8 | GO:0090022 | regulation of neutrophil chemotaxis(GO:0090022) |
0.8 | 11.0 | GO:0007617 | mating behavior(GO:0007617) multi-organism reproductive behavior(GO:0044705) |
0.8 | 1.6 | GO:0045226 | extracellular polysaccharide biosynthetic process(GO:0045226) extracellular polysaccharide metabolic process(GO:0046379) |
0.8 | 0.8 | GO:0032959 | inositol trisphosphate biosynthetic process(GO:0032959) |
0.8 | 0.8 | GO:0045792 | negative regulation of cell size(GO:0045792) |
0.8 | 1.6 | GO:1901492 | positive regulation of lymphangiogenesis(GO:1901492) |
0.8 | 3.9 | GO:0070050 | neuron cellular homeostasis(GO:0070050) |
0.8 | 1.6 | GO:0008594 | photoreceptor cell morphogenesis(GO:0008594) |
0.8 | 3.1 | GO:0032482 | Rab protein signal transduction(GO:0032482) |
0.8 | 3.1 | GO:0071786 | endoplasmic reticulum tubular network organization(GO:0071786) |
0.8 | 1.6 | GO:1902065 | response to L-glutamate(GO:1902065) |
0.8 | 1.6 | GO:0018125 | peptidyl-cysteine methylation(GO:0018125) |
0.8 | 3.1 | GO:0033564 | anterior/posterior axon guidance(GO:0033564) |
0.8 | 3.1 | GO:0043456 | regulation of pentose-phosphate shunt(GO:0043456) |
0.8 | 1.6 | GO:0070948 | regulation of neutrophil mediated cytotoxicity(GO:0070948) regulation of neutrophil mediated killing of symbiont cell(GO:0070949) |
0.8 | 2.3 | GO:0002901 | mature B cell apoptotic process(GO:0002901) regulation of mature B cell apoptotic process(GO:0002905) negative regulation of mature B cell apoptotic process(GO:0002906) |
0.8 | 1.5 | GO:2001184 | positive regulation of interleukin-12 secretion(GO:2001184) |
0.8 | 1.5 | GO:0010986 | positive regulation of lipoprotein particle clearance(GO:0010986) |
0.8 | 1.5 | GO:0090361 | platelet-derived growth factor production(GO:0090360) regulation of platelet-derived growth factor production(GO:0090361) |
0.8 | 4.6 | GO:0042985 | negative regulation of amyloid precursor protein biosynthetic process(GO:0042985) |
0.8 | 3.1 | GO:0045954 | positive regulation of natural killer cell mediated cytotoxicity(GO:0045954) |
0.8 | 2.3 | GO:1901029 | negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901029) |
0.8 | 1.5 | GO:0071360 | cellular response to exogenous dsRNA(GO:0071360) |
0.8 | 1.5 | GO:1904995 | negative regulation of leukocyte tethering or rolling(GO:1903237) negative regulation of leukocyte adhesion to vascular endothelial cell(GO:1904995) |
0.8 | 0.8 | GO:0032225 | regulation of synaptic transmission, dopaminergic(GO:0032225) |
0.8 | 3.0 | GO:0097039 | protein linear polyubiquitination(GO:0097039) |
0.8 | 6.1 | GO:0051044 | positive regulation of membrane protein ectodomain proteolysis(GO:0051044) |
0.8 | 6.8 | GO:0072538 | T-helper 17 type immune response(GO:0072538) |
0.8 | 3.0 | GO:0046548 | retinal rod cell development(GO:0046548) |
0.8 | 3.8 | GO:0045906 | negative regulation of vasoconstriction(GO:0045906) |
0.8 | 0.8 | GO:0050434 | positive regulation of viral transcription(GO:0050434) |
0.7 | 1.5 | GO:0023058 | adaptation of signaling pathway(GO:0023058) |
0.7 | 1.5 | GO:1903862 | positive regulation of oxidative phosphorylation(GO:1903862) |
0.7 | 11.9 | GO:0048168 | regulation of neuronal synaptic plasticity(GO:0048168) |
0.7 | 2.2 | GO:0002431 | Fc receptor mediated stimulatory signaling pathway(GO:0002431) |
0.7 | 15.6 | GO:0042832 | defense response to protozoan(GO:0042832) |
0.7 | 1.5 | GO:0061356 | Wnt protein secretion(GO:0061355) regulation of Wnt protein secretion(GO:0061356) |
0.7 | 0.7 | GO:0097476 | motor neuron migration(GO:0097475) spinal cord motor neuron migration(GO:0097476) |
0.7 | 4.4 | GO:0034625 | fatty acid elongation, saturated fatty acid(GO:0019367) fatty acid elongation, unsaturated fatty acid(GO:0019368) fatty acid elongation, monounsaturated fatty acid(GO:0034625) fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
0.7 | 1.5 | GO:1900226 | negative regulation of NLRP3 inflammasome complex assembly(GO:1900226) |
0.7 | 1.5 | GO:2001224 | positive regulation of neuron migration(GO:2001224) |
0.7 | 0.7 | GO:0070375 | ERK5 cascade(GO:0070375) |
0.7 | 4.4 | GO:0008063 | Toll signaling pathway(GO:0008063) |
0.7 | 1.5 | GO:0042737 | drug catabolic process(GO:0042737) |
0.7 | 0.7 | GO:1901252 | regulation of intracellular transport of viral material(GO:1901252) |
0.7 | 0.7 | GO:1901387 | positive regulation of voltage-gated calcium channel activity(GO:1901387) |
0.7 | 1.5 | GO:0051454 | pH elevation(GO:0045852) intracellular pH elevation(GO:0051454) |
0.7 | 2.2 | GO:0070164 | negative regulation of adiponectin secretion(GO:0070164) |
0.7 | 3.6 | GO:0001845 | phagolysosome assembly(GO:0001845) |
0.7 | 2.2 | GO:0061038 | uterus morphogenesis(GO:0061038) |
0.7 | 2.2 | GO:0031642 | negative regulation of myelination(GO:0031642) |
0.7 | 0.7 | GO:0016080 | synaptic vesicle targeting(GO:0016080) |
0.7 | 2.2 | GO:0006883 | cellular sodium ion homeostasis(GO:0006883) |
0.7 | 10.1 | GO:0008045 | motor neuron axon guidance(GO:0008045) |
0.7 | 0.7 | GO:0072610 | interleukin-12 secretion(GO:0072610) regulation of interleukin-12 secretion(GO:2001182) |
0.7 | 3.6 | GO:0046485 | ether lipid metabolic process(GO:0046485) |
0.7 | 5.0 | GO:0032780 | negative regulation of ATPase activity(GO:0032780) |
0.7 | 2.2 | GO:0052041 | negative regulation by symbiont of host apoptotic process(GO:0033668) negative regulation by symbiont of host programmed cell death(GO:0052041) negative regulation by organism of programmed cell death in other organism involved in symbiotic interaction(GO:0052490) |
0.7 | 0.7 | GO:0048850 | hypophysis morphogenesis(GO:0048850) |
0.7 | 2.1 | GO:0032026 | response to magnesium ion(GO:0032026) |
0.7 | 2.9 | GO:0018230 | peptidyl-L-cysteine S-palmitoylation(GO:0018230) peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine(GO:0018231) |
0.7 | 1.4 | GO:0010360 | negative regulation of anion channel activity(GO:0010360) |
0.7 | 0.7 | GO:0071351 | cellular response to interleukin-18(GO:0071351) |
0.7 | 2.1 | GO:0015755 | fructose transport(GO:0015755) |
0.7 | 7.1 | GO:0006828 | manganese ion transport(GO:0006828) |
0.7 | 2.8 | GO:0030517 | negative regulation of axon extension(GO:0030517) |
0.7 | 2.8 | GO:0033227 | dsRNA transport(GO:0033227) |
0.7 | 1.4 | GO:0002726 | positive regulation of T cell cytokine production(GO:0002726) |
0.7 | 0.7 | GO:0048069 | eye pigmentation(GO:0048069) |
0.7 | 2.8 | GO:0034643 | establishment of mitochondrion localization, microtubule-mediated(GO:0034643) mitochondrion transport along microtubule(GO:0047497) |
0.7 | 2.8 | GO:0080009 | mRNA methylation(GO:0080009) |
0.7 | 3.5 | GO:0006685 | sphingomyelin catabolic process(GO:0006685) |
0.7 | 1.4 | GO:0072321 | chaperone-mediated protein transport(GO:0072321) |
0.7 | 2.1 | GO:0090240 | positive regulation of histone H4 acetylation(GO:0090240) |
0.7 | 9.8 | GO:0009648 | photoperiodism(GO:0009648) |
0.7 | 4.9 | GO:0006620 | posttranslational protein targeting to membrane(GO:0006620) |
0.7 | 1.4 | GO:0060020 | Bergmann glial cell differentiation(GO:0060020) |
0.7 | 10.3 | GO:0051196 | regulation of coenzyme metabolic process(GO:0051196) |
0.7 | 10.9 | GO:0046839 | phospholipid dephosphorylation(GO:0046839) |
0.7 | 10.8 | GO:0045214 | sarcomere organization(GO:0045214) |
0.7 | 29.1 | GO:0008277 | regulation of G-protein coupled receptor protein signaling pathway(GO:0008277) |
0.7 | 0.7 | GO:2001044 | regulation of integrin-mediated signaling pathway(GO:2001044) |
0.7 | 2.0 | GO:0090168 | Golgi reassembly(GO:0090168) |
0.7 | 1.4 | GO:0060126 | somatotropin secreting cell differentiation(GO:0060126) |
0.7 | 0.7 | GO:2000049 | positive regulation of cell-cell adhesion mediated by cadherin(GO:2000049) |
0.7 | 2.0 | GO:0043578 | nuclear matrix organization(GO:0043578) nuclear matrix anchoring at nuclear membrane(GO:0090292) |
0.7 | 0.7 | GO:0017085 | response to insecticide(GO:0017085) |
0.7 | 1.3 | GO:0006499 | N-terminal protein myristoylation(GO:0006499) |
0.7 | 0.7 | GO:1904587 | glycoprotein ERAD pathway(GO:0097466) response to glycoprotein(GO:1904587) |
0.7 | 1.3 | GO:0048388 | endosomal lumen acidification(GO:0048388) |
0.7 | 15.9 | GO:0007040 | lysosome organization(GO:0007040) lytic vacuole organization(GO:0080171) |
0.7 | 1.3 | GO:0090188 | negative regulation of pancreatic juice secretion(GO:0090188) |
0.7 | 8.6 | GO:0001919 | regulation of receptor recycling(GO:0001919) |
0.7 | 1.3 | GO:0002767 | immune response-inhibiting cell surface receptor signaling pathway(GO:0002767) |
0.7 | 1.3 | GO:0014719 | skeletal muscle satellite cell activation(GO:0014719) |
0.7 | 1.3 | GO:0051562 | negative regulation of mitochondrial calcium ion concentration(GO:0051562) |
0.7 | 2.6 | GO:0035735 | intraciliary transport involved in cilium morphogenesis(GO:0035735) |
0.6 | 4.5 | GO:0016048 | detection of temperature stimulus(GO:0016048) |
0.6 | 17.5 | GO:0043252 | sodium-independent organic anion transport(GO:0043252) |
0.6 | 1.9 | GO:0006391 | transcription initiation from mitochondrial promoter(GO:0006391) |
0.6 | 1.3 | GO:0061470 | T follicular helper cell differentiation(GO:0061470) |
0.6 | 1.3 | GO:1901552 | positive regulation of endothelial cell development(GO:1901552) positive regulation of establishment of endothelial barrier(GO:1903142) |
0.6 | 1.3 | GO:2000505 | regulation of energy homeostasis(GO:2000505) |
0.6 | 10.8 | GO:0048791 | calcium ion-regulated exocytosis of neurotransmitter(GO:0048791) |
0.6 | 3.2 | GO:1901317 | regulation of sperm motility(GO:1901317) |
0.6 | 12.1 | GO:0008333 | endosome to lysosome transport(GO:0008333) |
0.6 | 4.4 | GO:0006108 | malate metabolic process(GO:0006108) |
0.6 | 0.6 | GO:0035090 | maintenance of apical/basal cell polarity(GO:0035090) |
0.6 | 8.8 | GO:1902667 | regulation of axon guidance(GO:1902667) |
0.6 | 1.9 | GO:0044828 | negative regulation by host of viral genome replication(GO:0044828) |
0.6 | 0.6 | GO:0002363 | alpha-beta T cell lineage commitment(GO:0002363) |
0.6 | 6.9 | GO:0007019 | microtubule depolymerization(GO:0007019) |
0.6 | 1.9 | GO:0006546 | glycine catabolic process(GO:0006546) glycine decarboxylation via glycine cleavage system(GO:0019464) |
0.6 | 2.5 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
0.6 | 1.3 | GO:0010025 | wax biosynthetic process(GO:0010025) wax metabolic process(GO:0010166) |
0.6 | 1.9 | GO:0006663 | platelet activating factor biosynthetic process(GO:0006663) platelet activating factor metabolic process(GO:0046469) |
0.6 | 0.6 | GO:2000343 | positive regulation of chemokine (C-X-C motif) ligand 2 production(GO:2000343) |
0.6 | 1.9 | GO:0070126 | mitochondrial translational termination(GO:0070126) |
0.6 | 3.1 | GO:2001046 | positive regulation of integrin-mediated signaling pathway(GO:2001046) |
0.6 | 0.6 | GO:1903115 | regulation of actin filament-based movement(GO:1903115) |
0.6 | 19.1 | GO:0030032 | lamellipodium assembly(GO:0030032) |
0.6 | 4.9 | GO:2000649 | regulation of sodium ion transmembrane transporter activity(GO:2000649) |
0.6 | 2.5 | GO:0021794 | thalamus development(GO:0021794) |
0.6 | 5.5 | GO:0006509 | membrane protein ectodomain proteolysis(GO:0006509) |
0.6 | 0.6 | GO:1902956 | regulation of mitochondrial electron transport, NADH to ubiquinone(GO:1902956) |
0.6 | 1.2 | GO:1901421 | positive regulation of response to alcohol(GO:1901421) |
0.6 | 1.8 | GO:0006681 | galactosylceramide metabolic process(GO:0006681) |
0.6 | 1.2 | GO:1901524 | regulation of macromitophagy(GO:1901524) negative regulation of macromitophagy(GO:1901525) |
0.6 | 2.4 | GO:0018095 | protein polyglutamylation(GO:0018095) |
0.6 | 1.2 | GO:0090160 | Golgi to lysosome transport(GO:0090160) |
0.6 | 8.4 | GO:0043113 | receptor clustering(GO:0043113) |
0.6 | 3.6 | GO:0050716 | positive regulation of interleukin-1 secretion(GO:0050716) positive regulation of interleukin-1 beta secretion(GO:0050718) |
0.6 | 0.6 | GO:0034351 | negative regulation of glial cell apoptotic process(GO:0034351) |
0.6 | 4.2 | GO:0030730 | sequestering of triglyceride(GO:0030730) |
0.6 | 1.2 | GO:2000553 | positive regulation of T-helper 2 cell cytokine production(GO:2000553) |
0.6 | 1.2 | GO:0035426 | extracellular matrix-cell signaling(GO:0035426) |
0.6 | 1.2 | GO:2001206 | positive regulation of osteoclast development(GO:2001206) |
0.6 | 5.3 | GO:0045056 | transcytosis(GO:0045056) |
0.6 | 0.6 | GO:0035930 | corticosteroid hormone secretion(GO:0035930) regulation of corticosteroid hormone secretion(GO:2000846) |
0.6 | 2.4 | GO:0046826 | negative regulation of protein export from nucleus(GO:0046826) |
0.6 | 1.8 | GO:0060011 | Sertoli cell proliferation(GO:0060011) |
0.6 | 1.2 | GO:0071257 | cellular response to electrical stimulus(GO:0071257) |
0.6 | 2.3 | GO:0031293 | membrane protein intracellular domain proteolysis(GO:0031293) |
0.6 | 1.2 | GO:0045779 | negative regulation of bone resorption(GO:0045779) |
0.6 | 1.7 | GO:0019355 | nicotinamide nucleotide biosynthetic process from aspartate(GO:0019355) 'de novo' NAD biosynthetic process from aspartate(GO:0034628) |
0.6 | 1.7 | GO:0001771 | immunological synapse formation(GO:0001771) |
0.6 | 0.6 | GO:0006498 | N-terminal protein lipidation(GO:0006498) |
0.6 | 1.2 | GO:0002347 | response to tumor cell(GO:0002347) |
0.6 | 1.7 | GO:0061462 | protein localization to lysosome(GO:0061462) |
0.6 | 4.1 | GO:0046085 | adenosine metabolic process(GO:0046085) |
0.6 | 0.6 | GO:0034091 | regulation of maintenance of sister chromatid cohesion(GO:0034091) regulation of maintenance of mitotic sister chromatid cohesion(GO:0034182) |
0.6 | 1.7 | GO:0050703 | interleukin-1 alpha secretion(GO:0050703) |
0.6 | 0.6 | GO:0010520 | regulation of reciprocal meiotic recombination(GO:0010520) |
0.6 | 3.4 | GO:0034453 | microtubule anchoring(GO:0034453) |
0.6 | 1.1 | GO:0000350 | generation of catalytic spliceosome for second transesterification step(GO:0000350) |
0.6 | 2.8 | GO:0009256 | 10-formyltetrahydrofolate metabolic process(GO:0009256) |
0.6 | 1.1 | GO:0051386 | regulation of neurotrophin TRK receptor signaling pathway(GO:0051386) |
0.6 | 5.7 | GO:0006103 | 2-oxoglutarate metabolic process(GO:0006103) |
0.6 | 1.7 | GO:2000643 | positive regulation of early endosome to late endosome transport(GO:2000643) |
0.6 | 1.7 | GO:0017121 | phospholipid scrambling(GO:0017121) |
0.6 | 1.1 | GO:0032383 | regulation of intracellular lipid transport(GO:0032377) regulation of intracellular sterol transport(GO:0032380) regulation of intracellular cholesterol transport(GO:0032383) |
0.6 | 1.7 | GO:0035590 | G-protein coupled purinergic nucleotide receptor signaling pathway(GO:0035589) purinergic nucleotide receptor signaling pathway(GO:0035590) |
0.6 | 1.1 | GO:0031547 | brain-derived neurotrophic factor receptor signaling pathway(GO:0031547) |
0.6 | 0.6 | GO:0072061 | inner medullary collecting duct development(GO:0072061) |
0.5 | 1.1 | GO:0032304 | negative regulation of icosanoid secretion(GO:0032304) |
0.5 | 4.9 | GO:0045956 | positive regulation of calcium ion-dependent exocytosis(GO:0045956) |
0.5 | 6.0 | GO:0005980 | glycogen catabolic process(GO:0005980) glucan catabolic process(GO:0009251) cellular polysaccharide catabolic process(GO:0044247) |
0.5 | 5.5 | GO:0034314 | Arp2/3 complex-mediated actin nucleation(GO:0034314) |
0.5 | 0.5 | GO:0010642 | negative regulation of platelet-derived growth factor receptor signaling pathway(GO:0010642) |
0.5 | 24.0 | GO:0048813 | dendrite morphogenesis(GO:0048813) |
0.5 | 8.7 | GO:0010257 | NADH dehydrogenase complex assembly(GO:0010257) mitochondrial respiratory chain complex I assembly(GO:0032981) mitochondrial respiratory chain complex I biogenesis(GO:0097031) |
0.5 | 1.1 | GO:0030210 | heparin biosynthetic process(GO:0030210) |
0.5 | 5.4 | GO:0006750 | glutathione biosynthetic process(GO:0006750) |
0.5 | 1.1 | GO:0001975 | response to amphetamine(GO:0001975) |
0.5 | 0.5 | GO:0048382 | mesendoderm development(GO:0048382) |
0.5 | 2.7 | GO:0010919 | regulation of inositol phosphate biosynthetic process(GO:0010919) |
0.5 | 2.7 | GO:0051014 | actin filament severing(GO:0051014) |
0.5 | 1.1 | GO:0051295 | parallel actin filament bundle assembly(GO:0030046) establishment of meiotic spindle localization(GO:0051295) formin-nucleated actin cable assembly(GO:0070649) |
0.5 | 1.1 | GO:0042983 | amyloid precursor protein biosynthetic process(GO:0042983) regulation of amyloid precursor protein biosynthetic process(GO:0042984) |
0.5 | 3.7 | GO:0070914 | UV-damage excision repair(GO:0070914) |
0.5 | 1.6 | GO:0033566 | gamma-tubulin complex localization(GO:0033566) |
0.5 | 0.5 | GO:2001180 | negative regulation of interleukin-10 secretion(GO:2001180) |
0.5 | 1.1 | GO:0009996 | negative regulation of cell fate specification(GO:0009996) |
0.5 | 5.3 | GO:0009083 | branched-chain amino acid catabolic process(GO:0009083) |
0.5 | 3.2 | GO:1901186 | positive regulation of epidermal growth factor receptor signaling pathway(GO:0045742) positive regulation of ERBB signaling pathway(GO:1901186) |
0.5 | 0.5 | GO:1903998 | regulation of eating behavior(GO:1903998) |
0.5 | 0.5 | GO:0035739 | CD4-positive, alpha-beta T cell proliferation(GO:0035739) |
0.5 | 1.1 | GO:0015817 | histidine transport(GO:0015817) |
0.5 | 0.5 | GO:0045176 | apical protein localization(GO:0045176) |
0.5 | 4.2 | GO:0046339 | diacylglycerol metabolic process(GO:0046339) |
0.5 | 0.5 | GO:0090258 | negative regulation of mitochondrial fission(GO:0090258) |
0.5 | 2.1 | GO:0050884 | neuromuscular process controlling posture(GO:0050884) |
0.5 | 0.5 | GO:0061502 | early endosome to recycling endosome transport(GO:0061502) |
0.5 | 0.5 | GO:0034205 | beta-amyloid formation(GO:0034205) |
0.5 | 4.2 | GO:1902187 | negative regulation of viral release from host cell(GO:1902187) |
0.5 | 1.6 | GO:0003383 | apical constriction(GO:0003383) |
0.5 | 1.0 | GO:2000774 | positive regulation of cellular senescence(GO:2000774) |
0.5 | 1.0 | GO:2000609 | regulation of thyroid hormone generation(GO:2000609) |
0.5 | 1.0 | GO:0042494 | detection of bacterial lipoprotein(GO:0042494) |
0.5 | 1.6 | GO:0030327 | prenylated protein catabolic process(GO:0030327) |
0.5 | 1.6 | GO:2000255 | negative regulation of male germ cell proliferation(GO:2000255) |
0.5 | 2.1 | GO:0015871 | choline transport(GO:0015871) |
0.5 | 1.5 | GO:0002291 | T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell(GO:0002291) |
0.5 | 3.1 | GO:0030497 | fatty acid elongation(GO:0030497) |
0.5 | 1.5 | GO:0019226 | transmission of nerve impulse(GO:0019226) |
0.5 | 2.0 | GO:0036035 | osteoclast development(GO:0036035) |
0.5 | 0.5 | GO:0090382 | phagosome maturation(GO:0090382) |
0.5 | 1.5 | GO:0009597 | detection of virus(GO:0009597) |
0.5 | 1.0 | GO:0060999 | positive regulation of dendritic spine development(GO:0060999) |
0.5 | 2.0 | GO:0042256 | mature ribosome assembly(GO:0042256) |
0.5 | 2.5 | GO:1905144 | acetylcholine receptor signaling pathway(GO:0095500) postsynaptic signal transduction(GO:0098926) signal transduction involved in cellular response to ammonium ion(GO:1903831) response to acetylcholine(GO:1905144) cellular response to acetylcholine(GO:1905145) |
0.5 | 2.5 | GO:0043117 | positive regulation of vascular permeability(GO:0043117) |
0.5 | 1.0 | GO:0071896 | protein localization to adherens junction(GO:0071896) |
0.5 | 1.0 | GO:0016560 | protein import into peroxisome matrix, docking(GO:0016560) |
0.5 | 1.0 | GO:0060468 | prevention of polyspermy(GO:0060468) |
0.5 | 0.5 | GO:0045869 | negative regulation of single stranded viral RNA replication via double stranded DNA intermediate(GO:0045869) |
0.5 | 1.5 | GO:0042758 | long-chain fatty acid catabolic process(GO:0042758) |
0.5 | 4.0 | GO:0046855 | inositol phosphate dephosphorylation(GO:0046855) |
0.5 | 2.0 | GO:1900016 | negative regulation of cytokine production involved in inflammatory response(GO:1900016) |
0.5 | 0.5 | GO:0043320 | natural killer cell degranulation(GO:0043320) |
0.5 | 2.5 | GO:0030252 | growth hormone secretion(GO:0030252) |
0.5 | 1.0 | GO:0010524 | positive regulation of calcium ion transport into cytosol(GO:0010524) |
0.5 | 3.9 | GO:0035970 | peptidyl-threonine dephosphorylation(GO:0035970) |
0.5 | 3.9 | GO:0042417 | dopamine metabolic process(GO:0042417) |
0.5 | 1.0 | GO:0050913 | sensory perception of bitter taste(GO:0050913) |
0.5 | 0.5 | GO:0001866 | NK T cell proliferation(GO:0001866) |
0.5 | 1.5 | GO:0044827 | modulation by host of viral genome replication(GO:0044827) |
0.5 | 1.5 | GO:0002016 | regulation of blood volume by renin-angiotensin(GO:0002016) brain renin-angiotensin system(GO:0002035) |
0.5 | 0.5 | GO:0045351 | type I interferon biosynthetic process(GO:0045351) |
0.5 | 0.5 | GO:0010918 | positive regulation of mitochondrial membrane potential(GO:0010918) |
0.5 | 2.9 | GO:0046325 | negative regulation of glucose import(GO:0046325) |
0.5 | 0.5 | GO:0055089 | fatty acid homeostasis(GO:0055089) |
0.5 | 0.9 | GO:0030800 | negative regulation of cyclic nucleotide metabolic process(GO:0030800) negative regulation of cAMP metabolic process(GO:0030815) |
0.5 | 2.4 | GO:1902715 | positive regulation of interferon-gamma secretion(GO:1902715) |
0.5 | 1.4 | GO:0002756 | MyD88-independent toll-like receptor signaling pathway(GO:0002756) |
0.5 | 0.5 | GO:0045085 | negative regulation of interleukin-2 biosynthetic process(GO:0045085) |
0.5 | 0.9 | GO:2000599 | regulation of cyclin catabolic process(GO:2000598) negative regulation of cyclin catabolic process(GO:2000599) |
0.5 | 0.5 | GO:0002175 | protein localization to paranode region of axon(GO:0002175) |
0.5 | 1.4 | GO:0006083 | acetate metabolic process(GO:0006083) |
0.5 | 3.2 | GO:0097320 | membrane tubulation(GO:0097320) |
0.5 | 1.4 | GO:1900095 | regulation of dosage compensation by inactivation of X chromosome(GO:1900095) |
0.5 | 1.9 | GO:0042119 | neutrophil activation(GO:0042119) |
0.5 | 1.4 | GO:0060347 | heart trabecula formation(GO:0060347) |
0.5 | 2.8 | GO:2000060 | positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:2000060) |
0.5 | 0.5 | GO:1903671 | negative regulation of sprouting angiogenesis(GO:1903671) |
0.5 | 0.5 | GO:0032911 | negative regulation of transforming growth factor beta1 production(GO:0032911) |
0.5 | 0.5 | GO:0051937 | catecholamine transport(GO:0051937) |
0.5 | 0.5 | GO:0045918 | negative regulation of cytolysis(GO:0045918) |
0.5 | 0.9 | GO:0018171 | peptidyl-cysteine oxidation(GO:0018171) |
0.5 | 0.5 | GO:0032596 | protein transport into membrane raft(GO:0032596) |
0.5 | 1.8 | GO:0097283 | keratinocyte apoptotic process(GO:0097283) regulation of keratinocyte apoptotic process(GO:1902172) |
0.5 | 0.9 | GO:0071494 | cellular response to UV-C(GO:0071494) |
0.5 | 0.9 | GO:0060509 | Type I pneumocyte differentiation(GO:0060509) |
0.5 | 0.5 | GO:0060166 | olfactory pit development(GO:0060166) |
0.5 | 0.5 | GO:0060717 | chorion development(GO:0060717) extraembryonic membrane development(GO:1903867) |
0.5 | 1.8 | GO:2000399 | negative regulation of T cell differentiation in thymus(GO:0033085) negative regulation of thymocyte aggregation(GO:2000399) |
0.5 | 1.4 | GO:1900108 | negative regulation of nodal signaling pathway(GO:1900108) |
0.4 | 1.3 | GO:0014028 | notochord formation(GO:0014028) |
0.4 | 3.1 | GO:0071801 | regulation of podosome assembly(GO:0071801) |
0.4 | 2.7 | GO:0006104 | succinyl-CoA metabolic process(GO:0006104) |
0.4 | 1.3 | GO:0035864 | response to potassium ion(GO:0035864) cellular response to potassium ion(GO:0035865) |
0.4 | 6.6 | GO:0043171 | peptide catabolic process(GO:0043171) |
0.4 | 1.3 | GO:0032713 | negative regulation of interleukin-4 production(GO:0032713) |
0.4 | 1.8 | GO:2000058 | regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:2000058) |
0.4 | 0.4 | GO:0002855 | natural killer cell mediated cytotoxicity directed against tumor cell target(GO:0002420) natural killer cell mediated immune response to tumor cell(GO:0002423) regulation of natural killer cell mediated immune response to tumor cell(GO:0002855) regulation of natural killer cell mediated cytotoxicity directed against tumor cell target(GO:0002858) |
0.4 | 2.6 | GO:0072502 | cellular phosphate ion homeostasis(GO:0030643) cellular trivalent inorganic anion homeostasis(GO:0072502) |
0.4 | 1.3 | GO:0045991 | carbon catabolite regulation of transcription from RNA polymerase II promoter(GO:0000429) regulation of transcription from RNA polymerase II promoter by glucose(GO:0000430) positive regulation of transcription from RNA polymerase II promoter by glucose(GO:0000432) carbon catabolite activation of transcription from RNA polymerase II promoter(GO:0000436) carbon catabolite activation of transcription(GO:0045991) positive regulation of transcription by glucose(GO:0046016) |
0.4 | 1.3 | GO:0034144 | negative regulation of toll-like receptor 4 signaling pathway(GO:0034144) |
0.4 | 1.3 | GO:0033278 | cell proliferation in midbrain(GO:0033278) |
0.4 | 0.9 | GO:0072015 | glomerular visceral epithelial cell development(GO:0072015) glomerular epithelial cell development(GO:0072310) |
0.4 | 1.7 | GO:0051725 | protein de-ADP-ribosylation(GO:0051725) |
0.4 | 1.7 | GO:2000008 | regulation of protein localization to cell surface(GO:2000008) |
0.4 | 0.4 | GO:0030579 | ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
0.4 | 1.3 | GO:0030814 | regulation of cAMP metabolic process(GO:0030814) |
0.4 | 1.3 | GO:0071616 | thioester biosynthetic process(GO:0035384) acyl-CoA biosynthetic process(GO:0071616) |
0.4 | 0.9 | GO:0071276 | cellular response to cadmium ion(GO:0071276) |
0.4 | 0.9 | GO:0007171 | activation of transmembrane receptor protein tyrosine kinase activity(GO:0007171) |
0.4 | 1.7 | GO:0006995 | cellular response to nitrogen starvation(GO:0006995) cellular response to nitrogen levels(GO:0043562) |
0.4 | 0.8 | GO:0045650 | negative regulation of macrophage differentiation(GO:0045650) |
0.4 | 0.4 | GO:1904526 | regulation of microtubule binding(GO:1904526) positive regulation of microtubule binding(GO:1904528) |
0.4 | 3.4 | GO:1990403 | embryonic brain development(GO:1990403) |
0.4 | 0.4 | GO:1900157 | regulation of bone mineralization involved in bone maturation(GO:1900157) |
0.4 | 1.7 | GO:0032528 | microvillus organization(GO:0032528) |
0.4 | 2.5 | GO:0010738 | regulation of protein kinase A signaling(GO:0010738) |
0.4 | 1.7 | GO:0010606 | positive regulation of cytoplasmic mRNA processing body assembly(GO:0010606) |
0.4 | 1.2 | GO:0002360 | T cell lineage commitment(GO:0002360) |
0.4 | 6.6 | GO:0008053 | mitochondrial fusion(GO:0008053) |
0.4 | 2.1 | GO:0097178 | ruffle assembly(GO:0097178) |
0.4 | 1.2 | GO:0042851 | alanine metabolic process(GO:0006522) pyruvate family amino acid metabolic process(GO:0009078) L-alanine metabolic process(GO:0042851) |
0.4 | 0.8 | GO:1900748 | positive regulation of vascular endothelial growth factor signaling pathway(GO:1900748) |
0.4 | 5.8 | GO:0006836 | neurotransmitter transport(GO:0006836) |
0.4 | 0.8 | GO:0046643 | regulation of gamma-delta T cell differentiation(GO:0045586) regulation of gamma-delta T cell activation(GO:0046643) |
0.4 | 0.8 | GO:1902285 | semaphorin-plexin signaling pathway involved in neuron projection guidance(GO:1902285) |
0.4 | 1.6 | GO:0048739 | cardiac muscle fiber development(GO:0048739) |
0.4 | 2.4 | GO:0001867 | complement activation, lectin pathway(GO:0001867) |
0.4 | 2.0 | GO:0033619 | membrane protein proteolysis(GO:0033619) |
0.4 | 1.6 | GO:0032801 | receptor catabolic process(GO:0032801) |
0.4 | 1.2 | GO:0010961 | cellular magnesium ion homeostasis(GO:0010961) |
0.4 | 2.8 | GO:0006120 | mitochondrial electron transport, NADH to ubiquinone(GO:0006120) |
0.4 | 1.2 | GO:0018242 | protein O-linked glycosylation via serine(GO:0018242) |
0.4 | 22.1 | GO:0001578 | microtubule bundle formation(GO:0001578) |
0.4 | 0.4 | GO:0021902 | commitment of neuronal cell to specific neuron type in forebrain(GO:0021902) |
0.4 | 1.2 | GO:0070317 | negative regulation of G0 to G1 transition(GO:0070317) |
0.4 | 4.0 | GO:0071880 | adenylate cyclase-activating adrenergic receptor signaling pathway(GO:0071880) |
0.4 | 0.8 | GO:0060398 | regulation of growth hormone receptor signaling pathway(GO:0060398) positive regulation of growth hormone receptor signaling pathway(GO:0060399) |
0.4 | 1.6 | GO:0010756 | positive regulation of plasminogen activation(GO:0010756) |
0.4 | 1.2 | GO:0033387 | putrescine biosynthetic process from ornithine(GO:0033387) |
0.4 | 0.8 | GO:0002370 | natural killer cell cytokine production(GO:0002370) regulation of natural killer cell cytokine production(GO:0002727) |
0.4 | 2.4 | GO:0045086 | positive regulation of interleukin-2 biosynthetic process(GO:0045086) |
0.4 | 9.4 | GO:0035456 | response to interferon-beta(GO:0035456) |
0.4 | 2.7 | GO:0030828 | positive regulation of cGMP biosynthetic process(GO:0030828) |
0.4 | 1.2 | GO:1902775 | mitochondrial large ribosomal subunit assembly(GO:1902775) |
0.4 | 0.4 | GO:0035542 | regulation of SNARE complex assembly(GO:0035542) |
0.4 | 0.4 | GO:0045583 | regulation of cytotoxic T cell differentiation(GO:0045583) positive regulation of cytotoxic T cell differentiation(GO:0045585) |
0.4 | 4.3 | GO:0030449 | regulation of complement activation(GO:0030449) |
0.4 | 0.8 | GO:1903336 | negative regulation of vacuolar transport(GO:1903336) |
0.4 | 1.5 | GO:2001256 | regulation of store-operated calcium entry(GO:2001256) |
0.4 | 0.8 | GO:1902534 | lysosomal microautophagy(GO:0016237) piecemeal microautophagy of nucleus(GO:0034727) late nucleophagy(GO:0044805) single-organism membrane invagination(GO:1902534) |
0.4 | 0.4 | GO:0070086 | ubiquitin-dependent endocytosis(GO:0070086) |
0.4 | 3.4 | GO:0030575 | nuclear body organization(GO:0030575) |
0.4 | 1.5 | GO:0032607 | interferon-alpha production(GO:0032607) |
0.4 | 0.4 | GO:0051790 | short-chain fatty acid biosynthetic process(GO:0051790) |
0.4 | 14.8 | GO:0001505 | regulation of neurotransmitter levels(GO:0001505) |
0.4 | 0.8 | GO:0001955 | blood vessel maturation(GO:0001955) |
0.4 | 1.1 | GO:0046629 | gamma-delta T cell activation(GO:0046629) |
0.4 | 3.0 | GO:0009404 | toxin metabolic process(GO:0009404) |
0.4 | 0.7 | GO:0051964 | negative regulation of synapse assembly(GO:0051964) |
0.4 | 4.1 | GO:0016601 | Rac protein signal transduction(GO:0016601) |
0.4 | 17.9 | GO:0035308 | negative regulation of protein dephosphorylation(GO:0035308) |
0.4 | 1.1 | GO:0036010 | protein localization to endosome(GO:0036010) |
0.4 | 0.7 | GO:0006600 | creatine metabolic process(GO:0006600) |
0.4 | 3.3 | GO:0046688 | response to copper ion(GO:0046688) |
0.4 | 0.7 | GO:0045161 | neuronal ion channel clustering(GO:0045161) |
0.4 | 1.1 | GO:0046167 | glycerol-3-phosphate biosynthetic process(GO:0046167) |
0.4 | 1.8 | GO:0090209 | negative regulation of triglyceride metabolic process(GO:0090209) |
0.4 | 1.1 | GO:0043923 | positive regulation by host of viral transcription(GO:0043923) |
0.4 | 0.4 | GO:1903899 | positive regulation of PERK-mediated unfolded protein response(GO:1903899) |
0.4 | 1.1 | GO:2001271 | negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001271) |
0.4 | 0.7 | GO:0072697 | protein localization to cell cortex(GO:0072697) |
0.4 | 1.1 | GO:0007194 | negative regulation of adenylate cyclase activity(GO:0007194) |
0.4 | 1.1 | GO:0032049 | cardiolipin biosynthetic process(GO:0032049) |
0.4 | 0.4 | GO:0008627 | intrinsic apoptotic signaling pathway in response to osmotic stress(GO:0008627) regulation of intrinsic apoptotic signaling pathway in response to osmotic stress(GO:1902218) negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress(GO:1902219) |
0.4 | 0.7 | GO:0010447 | response to acidic pH(GO:0010447) |
0.4 | 0.4 | GO:0002043 | blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:0002043) |
0.4 | 3.9 | GO:0015693 | magnesium ion transport(GO:0015693) |
0.4 | 1.1 | GO:0043615 | astrocyte cell migration(GO:0043615) |
0.4 | 0.7 | GO:0009649 | entrainment of circadian clock(GO:0009649) |
0.4 | 5.3 | GO:0050650 | chondroitin sulfate proteoglycan biosynthetic process(GO:0050650) |
0.3 | 1.0 | GO:1900273 | positive regulation of long-term synaptic potentiation(GO:1900273) |
0.3 | 2.4 | GO:0034389 | lipid particle organization(GO:0034389) |
0.3 | 1.0 | GO:0043654 | recognition of apoptotic cell(GO:0043654) |
0.3 | 3.5 | GO:0009208 | pyrimidine ribonucleoside triphosphate metabolic process(GO:0009208) |
0.3 | 1.7 | GO:0007212 | dopamine receptor signaling pathway(GO:0007212) |
0.3 | 1.0 | GO:0035622 | intrahepatic bile duct development(GO:0035622) |
0.3 | 1.0 | GO:0006072 | glycerol-3-phosphate metabolic process(GO:0006072) |
0.3 | 1.4 | GO:1901673 | regulation of mitotic spindle assembly(GO:1901673) |
0.3 | 0.7 | GO:0032074 | negative regulation of nuclease activity(GO:0032074) |
0.3 | 5.1 | GO:0038083 | peptidyl-tyrosine autophosphorylation(GO:0038083) |
0.3 | 5.1 | GO:0090280 | positive regulation of calcium ion import(GO:0090280) |
0.3 | 0.7 | GO:0071474 | cellular hyperosmotic response(GO:0071474) |
0.3 | 9.7 | GO:0007566 | embryo implantation(GO:0007566) |
0.3 | 4.3 | GO:0002028 | regulation of sodium ion transport(GO:0002028) |
0.3 | 0.3 | GO:0045875 | negative regulation of sister chromatid cohesion(GO:0045875) |
0.3 | 3.3 | GO:0046627 | negative regulation of insulin receptor signaling pathway(GO:0046627) |
0.3 | 1.6 | GO:0042373 | vitamin K metabolic process(GO:0042373) |
0.3 | 1.0 | GO:0071285 | cellular response to lithium ion(GO:0071285) |
0.3 | 0.7 | GO:2001181 | positive regulation of interleukin-10 secretion(GO:2001181) |
0.3 | 0.3 | GO:0045065 | cytotoxic T cell differentiation(GO:0045065) |
0.3 | 1.3 | GO:0035455 | response to interferon-alpha(GO:0035455) |
0.3 | 0.6 | GO:0032958 | inositol phosphate biosynthetic process(GO:0032958) |
0.3 | 1.9 | GO:0090073 | positive regulation of protein homodimerization activity(GO:0090073) |
0.3 | 1.3 | GO:0002759 | regulation of antimicrobial humoral response(GO:0002759) |
0.3 | 0.6 | GO:0070262 | peptidyl-serine dephosphorylation(GO:0070262) |
0.3 | 1.9 | GO:0006707 | cholesterol catabolic process(GO:0006707) sterol catabolic process(GO:0016127) |
0.3 | 0.6 | GO:1904252 | negative regulation of bile acid biosynthetic process(GO:0070858) negative regulation of bile acid metabolic process(GO:1904252) |
0.3 | 15.9 | GO:0046330 | positive regulation of JNK cascade(GO:0046330) |
0.3 | 3.4 | GO:0043984 | histone H4-K16 acetylation(GO:0043984) |
0.3 | 0.9 | GO:0070175 | positive regulation of enamel mineralization(GO:0070175) |
0.3 | 1.5 | GO:0042270 | protection from natural killer cell mediated cytotoxicity(GO:0042270) |
0.3 | 3.1 | GO:0010842 | retina layer formation(GO:0010842) |
0.3 | 0.6 | GO:2000836 | androgen secretion(GO:0035935) regulation of androgen secretion(GO:2000834) positive regulation of androgen secretion(GO:2000836) |
0.3 | 0.9 | GO:0015844 | monoamine transport(GO:0015844) |
0.3 | 0.6 | GO:0001692 | histamine metabolic process(GO:0001692) |
0.3 | 0.9 | GO:0071596 | ubiquitin-dependent protein catabolic process via the N-end rule pathway(GO:0071596) |
0.3 | 0.9 | GO:0000710 | meiotic mismatch repair(GO:0000710) |
0.3 | 0.6 | GO:0030718 | germ-line stem cell population maintenance(GO:0030718) |
0.3 | 5.8 | GO:0090662 | energy coupled proton transmembrane transport, against electrochemical gradient(GO:0015988) ATP hydrolysis coupled proton transport(GO:0015991) ATP hydrolysis coupled transmembrane transport(GO:0090662) |
0.3 | 1.2 | GO:0051482 | positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G-protein coupled signaling pathway(GO:0051482) |
0.3 | 28.7 | GO:0042787 | protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0042787) |
0.3 | 0.9 | GO:0030920 | N-terminal peptidyl-serine acetylation(GO:0017198) N-terminal peptidyl-glutamic acid acetylation(GO:0018002) peptidyl-serine acetylation(GO:0030920) |
0.3 | 3.0 | GO:0007032 | endosome organization(GO:0007032) |
0.3 | 0.6 | GO:0010446 | response to alkaline pH(GO:0010446) |
0.3 | 6.3 | GO:0045494 | photoreceptor cell maintenance(GO:0045494) |
0.3 | 0.6 | GO:2000402 | negative regulation of lymphocyte migration(GO:2000402) |
0.3 | 0.9 | GO:0048102 | autophagic cell death(GO:0048102) |
0.3 | 0.9 | GO:0070813 | hydrogen sulfide metabolic process(GO:0070813) |
0.3 | 1.2 | GO:0030309 | poly-N-acetyllactosamine metabolic process(GO:0030309) poly-N-acetyllactosamine biosynthetic process(GO:0030311) |
0.3 | 1.2 | GO:0045838 | positive regulation of membrane potential(GO:0045838) |
0.3 | 6.2 | GO:0010977 | negative regulation of neuron projection development(GO:0010977) |
0.3 | 1.2 | GO:0070900 | mitochondrial tRNA modification(GO:0070900) mitochondrial RNA modification(GO:1900864) |
0.3 | 1.2 | GO:0042796 | snRNA transcription from RNA polymerase III promoter(GO:0042796) |
0.3 | 0.6 | GO:0031584 | activation of phospholipase D activity(GO:0031584) |
0.3 | 1.2 | GO:0031113 | regulation of microtubule polymerization(GO:0031113) |
0.3 | 1.7 | GO:0048712 | negative regulation of astrocyte differentiation(GO:0048712) |
0.3 | 0.6 | GO:0006002 | fructose 6-phosphate metabolic process(GO:0006002) |
0.3 | 1.2 | GO:0070940 | dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
0.3 | 0.3 | GO:0007161 | calcium-independent cell-matrix adhesion(GO:0007161) |
0.3 | 0.3 | GO:0061156 | pulmonary artery morphogenesis(GO:0061156) |
0.3 | 0.9 | GO:0006851 | mitochondrial calcium ion transport(GO:0006851) |
0.3 | 0.9 | GO:0006295 | nucleotide-excision repair, DNA incision, 3'-to lesion(GO:0006295) |
0.3 | 3.1 | GO:0001829 | trophectodermal cell differentiation(GO:0001829) |
0.3 | 1.4 | GO:0043576 | regulation of respiratory gaseous exchange(GO:0043576) |
0.3 | 1.7 | GO:0090023 | positive regulation of neutrophil chemotaxis(GO:0090023) |
0.3 | 1.4 | GO:0090004 | positive regulation of establishment of protein localization to plasma membrane(GO:0090004) |
0.3 | 0.6 | GO:0007202 | activation of phospholipase C activity(GO:0007202) |
0.3 | 0.6 | GO:0046931 | pore complex assembly(GO:0046931) |
0.3 | 0.3 | GO:0045409 | negative regulation of interleukin-6 biosynthetic process(GO:0045409) |
0.3 | 1.4 | GO:0042749 | circadian sleep/wake cycle process(GO:0022410) regulation of circadian sleep/wake cycle(GO:0042749) |
0.3 | 4.7 | GO:0070897 | DNA-templated transcriptional preinitiation complex assembly(GO:0070897) |
0.3 | 0.6 | GO:0071498 | cellular response to fluid shear stress(GO:0071498) |
0.3 | 3.6 | GO:0070536 | protein K63-linked deubiquitination(GO:0070536) |
0.3 | 0.3 | GO:0003159 | morphogenesis of an endothelium(GO:0003159) endocardium morphogenesis(GO:0003160) endocardium formation(GO:0060214) |
0.3 | 0.3 | GO:0060750 | epithelial cell proliferation involved in mammary gland duct elongation(GO:0060750) branch elongation involved in mammary gland duct branching(GO:0060751) |
0.3 | 0.3 | GO:0046490 | isopentenyl diphosphate metabolic process(GO:0046490) |
0.3 | 0.3 | GO:1902913 | positive regulation of neuroepithelial cell differentiation(GO:1902913) |
0.3 | 1.6 | GO:0007200 | phospholipase C-activating G-protein coupled receptor signaling pathway(GO:0007200) |
0.3 | 1.1 | GO:0007603 | phototransduction, visible light(GO:0007603) |
0.3 | 2.7 | GO:1904376 | negative regulation of protein localization to plasma membrane(GO:1903077) negative regulation of protein localization to cell periphery(GO:1904376) |
0.3 | 1.1 | GO:0015813 | L-glutamate transport(GO:0015813) |
0.3 | 0.5 | GO:1903961 | positive regulation of anion transmembrane transport(GO:1903961) |
0.3 | 1.3 | GO:0006370 | 7-methylguanosine mRNA capping(GO:0006370) |
0.3 | 2.4 | GO:0060122 | inner ear receptor stereocilium organization(GO:0060122) |
0.3 | 0.3 | GO:2000409 | positive regulation of T cell extravasation(GO:2000409) |
0.3 | 0.8 | GO:0006004 | fucose metabolic process(GO:0006004) |
0.3 | 0.3 | GO:0032271 | regulation of protein polymerization(GO:0032271) |
0.3 | 0.3 | GO:0051660 | establishment of centrosome localization(GO:0051660) |
0.3 | 1.0 | GO:0006878 | cellular copper ion homeostasis(GO:0006878) |
0.3 | 1.0 | GO:0034080 | CENP-A containing nucleosome assembly(GO:0034080) CENP-A containing chromatin organization(GO:0061641) |
0.3 | 1.3 | GO:1902373 | negative regulation of mRNA catabolic process(GO:1902373) |
0.3 | 0.3 | GO:0035948 | positive regulation of gluconeogenesis by positive regulation of transcription from RNA polymerase II promoter(GO:0035948) |
0.3 | 0.8 | GO:0001561 | fatty acid alpha-oxidation(GO:0001561) |
0.3 | 0.3 | GO:0055098 | response to low-density lipoprotein particle(GO:0055098) |
0.3 | 0.5 | GO:0007176 | regulation of epidermal growth factor-activated receptor activity(GO:0007176) |
0.3 | 2.3 | GO:0006516 | glycoprotein catabolic process(GO:0006516) |
0.3 | 0.5 | GO:0002666 | positive regulation of T cell tolerance induction(GO:0002666) |
0.2 | 0.2 | GO:0097195 | pilomotor reflex(GO:0097195) |
0.2 | 0.5 | GO:0032495 | response to muramyl dipeptide(GO:0032495) |
0.2 | 0.2 | GO:0006183 | GTP biosynthetic process(GO:0006183) |
0.2 | 0.5 | GO:0006105 | succinate metabolic process(GO:0006105) |
0.2 | 0.2 | GO:0044062 | regulation of excretion(GO:0044062) |
0.2 | 0.7 | GO:0009217 | dGTP catabolic process(GO:0006203) purine deoxyribonucleoside triphosphate catabolic process(GO:0009217) |
0.2 | 0.7 | GO:0032066 | nucleolus to nucleoplasm transport(GO:0032066) |
0.2 | 0.7 | GO:0042447 | hormone catabolic process(GO:0042447) |
0.2 | 2.9 | GO:0051443 | positive regulation of ubiquitin-protein transferase activity(GO:0051443) |
0.2 | 1.2 | GO:0045724 | positive regulation of cilium assembly(GO:0045724) |
0.2 | 0.2 | GO:0010572 | positive regulation of platelet activation(GO:0010572) |
0.2 | 0.5 | GO:0010917 | negative regulation of mitochondrial membrane potential(GO:0010917) |
0.2 | 3.8 | GO:0001938 | positive regulation of endothelial cell proliferation(GO:0001938) |
0.2 | 0.5 | GO:0060718 | chorionic trophoblast cell differentiation(GO:0060718) |
0.2 | 0.5 | GO:0038089 | positive regulation of cell migration by vascular endothelial growth factor signaling pathway(GO:0038089) |
0.2 | 1.2 | GO:0006488 | dolichol-linked oligosaccharide biosynthetic process(GO:0006488) |
0.2 | 0.2 | GO:0007620 | copulation(GO:0007620) |
0.2 | 0.9 | GO:0014898 | muscle hypertrophy in response to stress(GO:0003299) cardiac muscle adaptation(GO:0014887) cardiac muscle hypertrophy in response to stress(GO:0014898) |
0.2 | 0.5 | GO:0042711 | maternal behavior(GO:0042711) |
0.2 | 2.1 | GO:0006182 | cGMP biosynthetic process(GO:0006182) |
0.2 | 0.2 | GO:0072174 | metanephric tubule formation(GO:0072174) |
0.2 | 0.9 | GO:0018406 | protein C-linked glycosylation(GO:0018103) peptidyl-tryptophan modification(GO:0018211) protein C-linked glycosylation via tryptophan(GO:0018317) protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan(GO:0018406) |
0.2 | 0.5 | GO:0009629 | response to gravity(GO:0009629) |
0.2 | 0.5 | GO:0042756 | drinking behavior(GO:0042756) |
0.2 | 0.5 | GO:0060510 | Type II pneumocyte differentiation(GO:0060510) |
0.2 | 0.2 | GO:2000479 | regulation of cAMP-dependent protein kinase activity(GO:2000479) |
0.2 | 0.5 | GO:0006490 | oligosaccharide-lipid intermediate biosynthetic process(GO:0006490) |
0.2 | 0.4 | GO:0090598 | male genitalia morphogenesis(GO:0048808) male anatomical structure morphogenesis(GO:0090598) |
0.2 | 0.7 | GO:0033299 | secretion of lysosomal enzymes(GO:0033299) |
0.2 | 0.4 | GO:2000189 | positive regulation of cholesterol homeostasis(GO:2000189) |
0.2 | 0.4 | GO:0003310 | pancreatic A cell differentiation(GO:0003310) |
0.2 | 0.2 | GO:0001951 | intestinal D-glucose absorption(GO:0001951) |
0.2 | 4.2 | GO:0019835 | cytolysis(GO:0019835) |
0.2 | 1.8 | GO:0048280 | vesicle fusion with Golgi apparatus(GO:0048280) |
0.2 | 1.3 | GO:0042989 | sequestering of actin monomers(GO:0042989) |
0.2 | 0.4 | GO:0042360 | vitamin E metabolic process(GO:0042360) |
0.2 | 11.1 | GO:0000910 | cytokinesis(GO:0000910) |
0.2 | 1.9 | GO:0036065 | fucosylation(GO:0036065) |
0.2 | 0.2 | GO:0071868 | cellular response to monoamine stimulus(GO:0071868) |
0.2 | 0.2 | GO:0003129 | heart induction(GO:0003129) |
0.2 | 0.2 | GO:0018377 | protein myristoylation(GO:0018377) |
0.2 | 1.1 | GO:0090140 | regulation of mitochondrial fission(GO:0090140) |
0.2 | 1.3 | GO:0043162 | ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043162) |
0.2 | 1.3 | GO:2000249 | regulation of actin cytoskeleton reorganization(GO:2000249) |
0.2 | 4.2 | GO:0008299 | isoprenoid biosynthetic process(GO:0008299) |
0.2 | 1.0 | GO:0009235 | cobalamin metabolic process(GO:0009235) |
0.2 | 0.4 | GO:0035425 | autocrine signaling(GO:0035425) |
0.2 | 0.6 | GO:0035331 | negative regulation of hippo signaling(GO:0035331) |
0.2 | 47.2 | GO:0007264 | small GTPase mediated signal transduction(GO:0007264) |
0.2 | 0.2 | GO:0097061 | dendritic spine organization(GO:0097061) |
0.2 | 0.6 | GO:0033275 | actin-myosin filament sliding(GO:0033275) |
0.2 | 4.1 | GO:0072384 | organelle transport along microtubule(GO:0072384) |
0.2 | 0.8 | GO:0010566 | regulation of ketone biosynthetic process(GO:0010566) |
0.2 | 0.4 | GO:0001887 | selenium compound metabolic process(GO:0001887) |
0.2 | 0.2 | GO:0019676 | ammonia assimilation cycle(GO:0019676) |
0.2 | 1.6 | GO:0006099 | tricarboxylic acid cycle(GO:0006099) |
0.2 | 0.6 | GO:0019695 | choline metabolic process(GO:0019695) |
0.2 | 0.6 | GO:0019244 | lactate biosynthetic process from pyruvate(GO:0019244) lactate biosynthetic process(GO:0019249) |
0.2 | 0.8 | GO:0032461 | positive regulation of protein oligomerization(GO:0032461) |
0.2 | 0.8 | GO:0009052 | pentose-phosphate shunt, non-oxidative branch(GO:0009052) |
0.2 | 2.0 | GO:0006910 | phagocytosis, recognition(GO:0006910) |
0.2 | 0.8 | GO:0035927 | RNA import into mitochondrion(GO:0035927) |
0.2 | 0.2 | GO:0051902 | negative regulation of mitochondrial depolarization(GO:0051902) negative regulation of membrane depolarization(GO:1904180) |
0.2 | 0.2 | GO:0097694 | establishment of RNA localization to telomere(GO:0097694) |
0.2 | 0.8 | GO:0046116 | queuosine biosynthetic process(GO:0008616) queuosine metabolic process(GO:0046116) |
0.2 | 1.4 | GO:0007608 | sensory perception of smell(GO:0007608) |
0.2 | 2.7 | GO:0019722 | calcium-mediated signaling(GO:0019722) |
0.2 | 0.4 | GO:0046952 | ketone body catabolic process(GO:0046952) |
0.2 | 0.4 | GO:0002888 | positive regulation of myeloid leukocyte mediated immunity(GO:0002888) |
0.2 | 0.6 | GO:0000711 | meiotic DNA repair synthesis(GO:0000711) |
0.2 | 0.6 | GO:0009298 | GDP-mannose biosynthetic process(GO:0009298) |
0.2 | 0.8 | GO:0010800 | positive regulation of peptidyl-threonine phosphorylation(GO:0010800) |
0.2 | 0.6 | GO:0050909 | sensory perception of taste(GO:0050909) |
0.2 | 12.5 | GO:0043547 | positive regulation of GTPase activity(GO:0043547) |
0.2 | 1.3 | GO:0072600 | establishment of protein localization to Golgi(GO:0072600) |
0.2 | 0.2 | GO:1900102 | negative regulation of endoplasmic reticulum unfolded protein response(GO:1900102) |
0.2 | 0.2 | GO:0061549 | sympathetic ganglion development(GO:0061549) |
0.2 | 1.3 | GO:0045292 | mRNA cis splicing, via spliceosome(GO:0045292) |
0.2 | 0.4 | GO:0006363 | termination of RNA polymerase I transcription(GO:0006363) |
0.2 | 0.4 | GO:0010640 | regulation of platelet-derived growth factor receptor signaling pathway(GO:0010640) |
0.2 | 0.4 | GO:0006393 | termination of mitochondrial transcription(GO:0006393) |
0.2 | 0.2 | GO:0001992 | regulation of systemic arterial blood pressure by vasopressin(GO:0001992) |
0.2 | 1.1 | GO:0001508 | action potential(GO:0001508) |
0.2 | 0.4 | GO:0080154 | regulation of fertilization(GO:0080154) |
0.2 | 0.4 | GO:0051534 | negative regulation of NFAT protein import into nucleus(GO:0051534) |
0.2 | 0.2 | GO:0060456 | positive regulation of digestive system process(GO:0060456) |
0.2 | 0.2 | GO:0071907 | determination of digestive tract left/right asymmetry(GO:0071907) determination of liver left/right asymmetry(GO:0071910) |
0.2 | 0.2 | GO:0036006 | response to macrophage colony-stimulating factor(GO:0036005) cellular response to macrophage colony-stimulating factor stimulus(GO:0036006) |
0.2 | 0.3 | GO:0097011 | cellular response to granulocyte macrophage colony-stimulating factor stimulus(GO:0097011) |
0.2 | 0.2 | GO:0016539 | intein-mediated protein splicing(GO:0016539) protein splicing(GO:0030908) |
0.2 | 0.5 | GO:0030889 | negative regulation of B cell proliferation(GO:0030889) |
0.2 | 0.3 | GO:0051350 | negative regulation of lyase activity(GO:0051350) |
0.2 | 0.3 | GO:0072530 | purine nucleoside transmembrane transport(GO:0015860) purine-containing compound transmembrane transport(GO:0072530) nucleoside transmembrane transport(GO:1901642) |
0.2 | 1.9 | GO:0043248 | proteasome assembly(GO:0043248) |
0.2 | 1.0 | GO:0006044 | N-acetylglucosamine metabolic process(GO:0006044) |
0.2 | 2.9 | GO:0033120 | positive regulation of RNA splicing(GO:0033120) |
0.2 | 0.2 | GO:0016078 | tRNA catabolic process(GO:0016078) |
0.2 | 0.3 | GO:0043988 | histone H3-S28 phosphorylation(GO:0043988) |
0.2 | 1.0 | GO:0008340 | determination of adult lifespan(GO:0008340) |
0.2 | 0.5 | GO:0006003 | fructose 2,6-bisphosphate metabolic process(GO:0006003) |
0.2 | 0.3 | GO:0060700 | regulation of ribonuclease activity(GO:0060700) |
0.2 | 0.3 | GO:0010880 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum(GO:0010880) |
0.2 | 1.1 | GO:0060628 | regulation of ER to Golgi vesicle-mediated transport(GO:0060628) |
0.2 | 0.3 | GO:0070278 | extracellular matrix constituent secretion(GO:0070278) |
0.2 | 0.3 | GO:0019243 | methylglyoxal catabolic process to D-lactate via S-lactoyl-glutathione(GO:0019243) methylglyoxal catabolic process(GO:0051596) methylglyoxal catabolic process to lactate(GO:0061727) |
0.2 | 0.5 | GO:0035627 | ceramide transport(GO:0035627) |
0.2 | 0.6 | GO:1903069 | regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903069) |
0.2 | 0.3 | GO:0036112 | medium-chain fatty-acyl-CoA metabolic process(GO:0036112) |
0.2 | 1.4 | GO:0000266 | mitochondrial fission(GO:0000266) |
0.2 | 7.7 | GO:0001676 | long-chain fatty acid metabolic process(GO:0001676) |
0.2 | 0.3 | GO:2000508 | regulation of dendritic cell chemotaxis(GO:2000508) positive regulation of dendritic cell chemotaxis(GO:2000510) |
0.2 | 0.3 | GO:0001827 | inner cell mass cell fate commitment(GO:0001827) |
0.2 | 0.5 | GO:0070966 | nuclear-transcribed mRNA catabolic process, no-go decay(GO:0070966) |
0.2 | 0.2 | GO:0032570 | response to progesterone(GO:0032570) |
0.2 | 1.5 | GO:0009620 | response to fungus(GO:0009620) |
0.2 | 2.4 | GO:0007340 | acrosome reaction(GO:0007340) |
0.2 | 0.5 | GO:0044091 | membrane biogenesis(GO:0044091) |
0.2 | 0.9 | GO:0051570 | regulation of histone H3-K9 methylation(GO:0051570) |
0.1 | 0.1 | GO:0033240 | positive regulation of cellular amine metabolic process(GO:0033240) |
0.1 | 0.4 | GO:0002949 | tRNA threonylcarbamoyladenosine modification(GO:0002949) |
0.1 | 0.4 | GO:0045780 | positive regulation of bone resorption(GO:0045780) positive regulation of bone remodeling(GO:0046852) |
0.1 | 0.3 | GO:0032328 | alanine transport(GO:0032328) |
0.1 | 0.4 | GO:0035582 | sequestering of BMP in extracellular matrix(GO:0035582) |
0.1 | 1.2 | GO:0001675 | acrosome assembly(GO:0001675) |
0.1 | 0.3 | GO:0038093 | Fc receptor signaling pathway(GO:0038093) |
0.1 | 2.5 | GO:0016358 | dendrite development(GO:0016358) |
0.1 | 1.0 | GO:0045026 | plasma membrane fusion(GO:0045026) |
0.1 | 1.6 | GO:0045071 | negative regulation of viral genome replication(GO:0045071) |
0.1 | 0.1 | GO:2000507 | positive regulation of energy homeostasis(GO:2000507) |
0.1 | 0.3 | GO:0035553 | oxidative RNA demethylation(GO:0035513) oxidative single-stranded RNA demethylation(GO:0035553) |
0.1 | 0.4 | GO:0015959 | diadenosine polyphosphate metabolic process(GO:0015959) |
0.1 | 0.9 | GO:0006699 | bile acid biosynthetic process(GO:0006699) |
0.1 | 0.4 | GO:0045603 | positive regulation of endothelial cell differentiation(GO:0045603) |
0.1 | 0.6 | GO:0046133 | pyrimidine ribonucleoside catabolic process(GO:0046133) pyrimidine nucleoside catabolic process(GO:0046135) |
0.1 | 0.3 | GO:0035093 | spermatogenesis, exchange of chromosomal proteins(GO:0035093) |
0.1 | 0.1 | GO:0010847 | regulation of chromatin assembly(GO:0010847) |
0.1 | 0.3 | GO:0050857 | positive regulation of antigen receptor-mediated signaling pathway(GO:0050857) positive regulation of B cell receptor signaling pathway(GO:0050861) |
0.1 | 0.4 | GO:0006597 | spermine biosynthetic process(GO:0006597) |
0.1 | 0.8 | GO:0019262 | N-acetylneuraminate catabolic process(GO:0019262) |
0.1 | 0.4 | GO:0021670 | lateral ventricle development(GO:0021670) |
0.1 | 0.6 | GO:0042780 | tRNA 3'-end processing(GO:0042780) |
0.1 | 0.8 | GO:0060259 | regulation of feeding behavior(GO:0060259) |
0.1 | 0.1 | GO:0002775 | antimicrobial peptide production(GO:0002775) antibacterial peptide production(GO:0002778) |
0.1 | 0.5 | GO:0046292 | formaldehyde metabolic process(GO:0046292) |
0.1 | 6.2 | GO:0008360 | regulation of cell shape(GO:0008360) |
0.1 | 1.5 | GO:0032008 | positive regulation of TOR signaling(GO:0032008) |
0.1 | 0.1 | GO:0009414 | response to water deprivation(GO:0009414) |
0.1 | 0.1 | GO:0002339 | B cell selection(GO:0002339) |
0.1 | 5.1 | GO:0001580 | detection of chemical stimulus involved in sensory perception of bitter taste(GO:0001580) |
0.1 | 1.2 | GO:0033138 | positive regulation of peptidyl-serine phosphorylation(GO:0033138) |
0.1 | 0.6 | GO:0090025 | regulation of monocyte chemotaxis(GO:0090025) |
0.1 | 0.4 | GO:0070633 | transepithelial transport(GO:0070633) |
0.1 | 3.1 | GO:1990138 | neuron projection extension(GO:1990138) |
0.1 | 1.6 | GO:1904062 | regulation of cation transmembrane transport(GO:1904062) |
0.1 | 0.2 | GO:0035902 | response to immobilization stress(GO:0035902) |
0.1 | 0.5 | GO:0042574 | retinal metabolic process(GO:0042574) |
0.1 | 0.1 | GO:0010727 | negative regulation of hydrogen peroxide metabolic process(GO:0010727) |
0.1 | 0.1 | GO:0051771 | negative regulation of nitric-oxide synthase biosynthetic process(GO:0051771) |
0.1 | 0.5 | GO:0006691 | leukotriene metabolic process(GO:0006691) |
0.1 | 0.1 | GO:0070669 | response to interleukin-2(GO:0070669) |
0.1 | 0.5 | GO:0000186 | activation of MAPKK activity(GO:0000186) |
0.1 | 0.4 | GO:0043537 | negative regulation of blood vessel endothelial cell migration(GO:0043537) |
0.1 | 0.1 | GO:0009438 | methylglyoxal metabolic process(GO:0009438) |
0.1 | 0.1 | GO:0061047 | positive regulation of branching involved in lung morphogenesis(GO:0061047) |
0.1 | 1.0 | GO:0010955 | negative regulation of protein processing(GO:0010955) negative regulation of protein maturation(GO:1903318) |
0.1 | 0.3 | GO:0051315 | attachment of mitotic spindle microtubules to kinetochore(GO:0051315) |
0.1 | 3.4 | GO:0033139 | regulation of peptidyl-serine phosphorylation of STAT protein(GO:0033139) positive regulation of peptidyl-serine phosphorylation of STAT protein(GO:0033141) |
0.1 | 0.2 | GO:0045124 | regulation of bone resorption(GO:0045124) |
0.1 | 0.2 | GO:0022417 | protein maturation by protein folding(GO:0022417) |
0.1 | 2.5 | GO:0007218 | neuropeptide signaling pathway(GO:0007218) |
0.1 | 0.2 | GO:0046149 | heme catabolic process(GO:0042167) pigment catabolic process(GO:0046149) |
0.1 | 0.1 | GO:0035336 | long-chain fatty-acyl-CoA metabolic process(GO:0035336) |
0.1 | 0.2 | GO:0051365 | cellular response to potassium ion starvation(GO:0051365) |
0.1 | 0.6 | GO:0090084 | negative regulation of inclusion body assembly(GO:0090084) |
0.1 | 0.7 | GO:0006465 | signal peptide processing(GO:0006465) |
0.1 | 0.3 | GO:1901836 | regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:1901836) |
0.1 | 0.6 | GO:0009253 | peptidoglycan metabolic process(GO:0000270) peptidoglycan catabolic process(GO:0009253) |
0.1 | 0.3 | GO:0033033 | negative regulation of myeloid cell apoptotic process(GO:0033033) |
0.1 | 0.1 | GO:0019374 | galactolipid metabolic process(GO:0019374) |
0.1 | 1.6 | GO:0090174 | organelle membrane fusion(GO:0090174) |
0.1 | 0.1 | GO:0009155 | purine deoxyribonucleotide catabolic process(GO:0009155) |
0.1 | 0.2 | GO:0051481 | negative regulation of cytosolic calcium ion concentration(GO:0051481) |
0.1 | 2.9 | GO:0008154 | actin polymerization or depolymerization(GO:0008154) |
0.1 | 0.5 | GO:0016266 | O-glycan processing(GO:0016266) |
0.1 | 0.2 | GO:1900165 | negative regulation of interleukin-6 secretion(GO:1900165) |
0.1 | 3.7 | GO:0050911 | detection of chemical stimulus involved in sensory perception of smell(GO:0050911) |
0.1 | 0.2 | GO:0045987 | positive regulation of smooth muscle contraction(GO:0045987) |
0.1 | 0.2 | GO:0033615 | mitochondrial proton-transporting ATP synthase complex assembly(GO:0033615) |
0.1 | 1.2 | GO:0034587 | piRNA metabolic process(GO:0034587) |
0.1 | 0.3 | GO:0034138 | toll-like receptor 3 signaling pathway(GO:0034138) |
0.1 | 0.5 | GO:0048011 | neurotrophin TRK receptor signaling pathway(GO:0048011) |
0.1 | 0.3 | GO:0009173 | UMP biosynthetic process(GO:0006222) pyrimidine ribonucleoside monophosphate metabolic process(GO:0009173) pyrimidine ribonucleoside monophosphate biosynthetic process(GO:0009174) UMP metabolic process(GO:0046049) |
0.1 | 0.3 | GO:0048505 | regulation of timing of cell differentiation(GO:0048505) |
0.1 | 0.3 | GO:0042755 | eating behavior(GO:0042755) |
0.1 | 0.8 | GO:0042345 | regulation of NF-kappaB import into nucleus(GO:0042345) NF-kappaB import into nucleus(GO:0042348) |
0.1 | 0.3 | GO:0006054 | N-acetylneuraminate metabolic process(GO:0006054) |
0.1 | 0.7 | GO:0050806 | positive regulation of synaptic transmission(GO:0050806) |
0.1 | 0.3 | GO:0034498 | early endosome to Golgi transport(GO:0034498) |
0.1 | 0.6 | GO:0015986 | energy coupled proton transport, down electrochemical gradient(GO:0015985) ATP synthesis coupled proton transport(GO:0015986) |
0.1 | 0.2 | GO:0044320 | cellular response to leptin stimulus(GO:0044320) |
0.1 | 1.0 | GO:0043968 | histone H2A acetylation(GO:0043968) |
0.1 | 0.1 | GO:0045657 | positive regulation of monocyte differentiation(GO:0045657) |
0.1 | 0.8 | GO:0090200 | positive regulation of release of cytochrome c from mitochondria(GO:0090200) |
0.1 | 0.2 | GO:0002328 | pro-B cell differentiation(GO:0002328) |
0.1 | 1.1 | GO:0046834 | lipid phosphorylation(GO:0046834) |
0.1 | 0.2 | GO:0007341 | penetration of zona pellucida(GO:0007341) |
0.1 | 0.2 | GO:0015770 | disaccharide transport(GO:0015766) sucrose transport(GO:0015770) oligosaccharide transport(GO:0015772) |
0.1 | 0.1 | GO:0009436 | glyoxylate catabolic process(GO:0009436) glyoxylate metabolic process(GO:0046487) |
0.1 | 0.2 | GO:0032620 | interleukin-17 production(GO:0032620) |
0.1 | 0.1 | GO:0001915 | negative regulation of T cell mediated cytotoxicity(GO:0001915) |
0.1 | 0.3 | GO:0006999 | nuclear pore organization(GO:0006999) |
0.1 | 0.7 | GO:0042462 | eye photoreceptor cell development(GO:0042462) |
0.1 | 0.3 | GO:0006527 | arginine catabolic process(GO:0006527) |
0.1 | 0.2 | GO:0006297 | nucleotide-excision repair, DNA gap filling(GO:0006297) |
0.1 | 0.1 | GO:0006655 | phosphatidylglycerol biosynthetic process(GO:0006655) phosphatidylglycerol metabolic process(GO:0046471) |
0.1 | 0.1 | GO:0044034 | negative stranded viral RNA replication(GO:0039689) multi-organism biosynthetic process(GO:0044034) |
0.1 | 0.1 | GO:2001179 | regulation of interleukin-10 secretion(GO:2001179) |
0.1 | 0.7 | GO:0051591 | response to cAMP(GO:0051591) |
0.1 | 0.1 | GO:1990168 | protein K29-linked deubiquitination(GO:0035523) protein K33-linked deubiquitination(GO:1990168) |
0.1 | 0.1 | GO:0051095 | regulation of helicase activity(GO:0051095) positive regulation of helicase activity(GO:0051096) |
0.1 | 0.5 | GO:0006474 | N-terminal protein amino acid acetylation(GO:0006474) |
0.1 | 2.1 | GO:0045454 | cell redox homeostasis(GO:0045454) |
0.1 | 0.1 | GO:0000393 | spliceosomal conformational changes to generate catalytic conformation(GO:0000393) |
0.1 | 0.1 | GO:0033762 | response to glucagon(GO:0033762) |
0.1 | 0.2 | GO:1903966 | monounsaturated fatty acid metabolic process(GO:1903964) monounsaturated fatty acid biosynthetic process(GO:1903966) |
0.1 | 0.1 | GO:0035581 | sequestering of extracellular ligand from receptor(GO:0035581) extracellular regulation of signal transduction(GO:1900115) extracellular negative regulation of signal transduction(GO:1900116) |
0.1 | 0.3 | GO:0050908 | detection of light stimulus involved in visual perception(GO:0050908) detection of light stimulus involved in sensory perception(GO:0050962) |
0.1 | 0.1 | GO:0019254 | carnitine metabolic process, CoA-linked(GO:0019254) |
0.1 | 0.1 | GO:2000721 | positive regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation(GO:2000721) |
0.1 | 0.1 | GO:0003025 | regulation of systemic arterial blood pressure by baroreceptor feedback(GO:0003025) |
0.1 | 0.2 | GO:0051182 | coenzyme transport(GO:0051182) |
0.1 | 0.1 | GO:0048312 | intracellular distribution of mitochondria(GO:0048312) |
0.1 | 0.2 | GO:2001198 | regulation of dendritic cell differentiation(GO:2001198) negative regulation of dendritic cell differentiation(GO:2001199) |
0.1 | 0.2 | GO:1900003 | regulation of serine-type endopeptidase activity(GO:1900003) negative regulation of serine-type endopeptidase activity(GO:1900004) regulation of serine-type peptidase activity(GO:1902571) negative regulation of serine-type peptidase activity(GO:1902572) |
0.1 | 0.2 | GO:0006177 | GMP biosynthetic process(GO:0006177) |
0.0 | 0.4 | GO:0052697 | xenobiotic glucuronidation(GO:0052697) |
0.0 | 0.2 | GO:0033169 | histone H3-K9 demethylation(GO:0033169) |
0.0 | 0.0 | GO:0032342 | aldosterone metabolic process(GO:0032341) aldosterone biosynthetic process(GO:0032342) cortisol metabolic process(GO:0034650) |
0.0 | 0.2 | GO:0051571 | positive regulation of histone H3-K4 methylation(GO:0051571) |
0.0 | 0.9 | GO:0006493 | protein O-linked glycosylation(GO:0006493) |
0.0 | 0.1 | GO:0032516 | positive regulation of phosphoprotein phosphatase activity(GO:0032516) |
0.0 | 1.3 | GO:0006506 | GPI anchor biosynthetic process(GO:0006506) |
0.0 | 0.0 | GO:0032815 | negative regulation of natural killer cell activation(GO:0032815) |
0.0 | 0.0 | GO:0045348 | positive regulation of MHC class II biosynthetic process(GO:0045348) |
0.0 | 0.1 | GO:0002584 | negative regulation of antigen processing and presentation of peptide antigen(GO:0002584) |
0.0 | 0.1 | GO:0016338 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
0.0 | 0.0 | GO:2001273 | glucose import in response to insulin stimulus(GO:0044381) regulation of glucose import in response to insulin stimulus(GO:2001273) |
0.0 | 0.1 | GO:0006591 | ornithine metabolic process(GO:0006591) |
0.0 | 0.0 | GO:0036498 | IRE1-mediated unfolded protein response(GO:0036498) |
0.0 | 0.2 | GO:0006348 | chromatin silencing at telomere(GO:0006348) |
0.0 | 45.9 | GO:0007186 | G-protein coupled receptor signaling pathway(GO:0007186) |
0.0 | 0.2 | GO:0044090 | positive regulation of vacuole organization(GO:0044090) |
0.0 | 0.1 | GO:0035990 | tendon cell differentiation(GO:0035990) tendon formation(GO:0035992) |
0.0 | 0.0 | GO:0070309 | lens fiber cell morphogenesis(GO:0070309) |
0.0 | 0.3 | GO:0014850 | response to muscle activity(GO:0014850) |
0.0 | 0.0 | GO:0051231 | mitotic spindle elongation(GO:0000022) spindle elongation(GO:0051231) mitotic spindle midzone assembly(GO:0051256) |
0.0 | 0.1 | GO:0006311 | meiotic gene conversion(GO:0006311) gene conversion(GO:0035822) |
0.0 | 0.1 | GO:0006020 | inositol metabolic process(GO:0006020) |
0.0 | 0.1 | GO:0046113 | purine nucleobase catabolic process(GO:0006145) nucleobase catabolic process(GO:0046113) |
0.0 | 0.0 | GO:1903208 | neuron death in response to hydrogen peroxide(GO:0036476) regulation of hydrogen peroxide-induced neuron death(GO:1903207) negative regulation of hydrogen peroxide-induced neuron death(GO:1903208) |
0.0 | 0.0 | GO:0051955 | regulation of amino acid transport(GO:0051955) |
0.0 | 0.0 | GO:0008065 | establishment of blood-nerve barrier(GO:0008065) |
0.0 | 0.1 | GO:0061025 | membrane fusion(GO:0061025) |
0.0 | 0.1 | GO:0007296 | vitellogenesis(GO:0007296) |
0.0 | 0.6 | GO:0007033 | vacuole organization(GO:0007033) |
0.0 | 0.1 | GO:0070197 | telomere tethering at nuclear periphery(GO:0034398) meiotic telomere tethering at nuclear periphery(GO:0044821) meiotic attachment of telomere to nuclear envelope(GO:0070197) chromosome attachment to the nuclear envelope(GO:0097240) |
0.0 | 0.0 | GO:0043476 | pigment accumulation(GO:0043476) |
0.0 | 0.1 | GO:0045116 | protein neddylation(GO:0045116) |
0.0 | 0.3 | GO:0006805 | xenobiotic metabolic process(GO:0006805) |
0.0 | 0.0 | GO:0060054 | positive regulation of epithelial cell proliferation involved in wound healing(GO:0060054) |
0.0 | 0.1 | GO:0002082 | regulation of oxidative phosphorylation(GO:0002082) |
0.0 | 0.1 | GO:0033683 | nucleotide-excision repair, DNA incision(GO:0033683) |
0.0 | 0.0 | GO:1990928 | response to amino acid starvation(GO:1990928) |
0.0 | 0.0 | GO:0006857 | oligopeptide transport(GO:0006857) |
0.0 | 0.0 | GO:0008078 | mesodermal cell migration(GO:0008078) |
0.0 | 0.1 | GO:0000467 | exonucleolytic trimming involved in rRNA processing(GO:0000459) exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000467) |
0.0 | 0.0 | GO:0051349 | positive regulation of lyase activity(GO:0051349) |
0.0 | 0.1 | GO:2001015 | negative regulation of skeletal muscle cell differentiation(GO:2001015) |
0.0 | 0.2 | GO:0000002 | mitochondrial genome maintenance(GO:0000002) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
9.8 | 29.5 | GO:0014701 | junctional sarcoplasmic reticulum membrane(GO:0014701) |
8.4 | 33.7 | GO:0044308 | axonal spine(GO:0044308) |
8.0 | 63.6 | GO:0043083 | synaptic cleft(GO:0043083) |
7.8 | 23.4 | GO:0030981 | cortical microtubule cytoskeleton(GO:0030981) |
6.8 | 47.4 | GO:0044300 | cerebellar mossy fiber(GO:0044300) |
6.3 | 6.3 | GO:0034750 | Scrib-APC-beta-catenin complex(GO:0034750) |
5.3 | 26.3 | GO:0032983 | kainate selective glutamate receptor complex(GO:0032983) |
4.5 | 4.5 | GO:0070032 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin I complex(GO:0070032) |
4.4 | 39.5 | GO:0044224 | juxtaparanode region of axon(GO:0044224) |
4.3 | 43.0 | GO:1990124 | messenger ribonucleoprotein complex(GO:1990124) |
4.1 | 12.4 | GO:0072534 | perineuronal net(GO:0072534) |
4.0 | 75.5 | GO:0060077 | inhibitory synapse(GO:0060077) |
3.9 | 23.5 | GO:1990454 | L-type voltage-gated calcium channel complex(GO:1990454) |
3.8 | 34.5 | GO:0005883 | neurofilament(GO:0005883) |
3.8 | 30.4 | GO:0042788 | polysomal ribosome(GO:0042788) |
3.7 | 11.2 | GO:0038037 | G-protein coupled receptor dimeric complex(GO:0038037) G-protein coupled receptor complex(GO:0097648) |
3.5 | 10.5 | GO:0005899 | insulin receptor complex(GO:0005899) |
3.5 | 170.9 | GO:0042734 | presynaptic membrane(GO:0042734) |
3.5 | 20.9 | GO:0005915 | zonula adherens(GO:0005915) |
3.5 | 34.7 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
3.4 | 10.2 | GO:0097512 | cardiac myofibril(GO:0097512) |
3.3 | 23.3 | GO:0036056 | filtration diaphragm(GO:0036056) slit diaphragm(GO:0036057) |
3.3 | 6.6 | GO:0044316 | cone cell pedicle(GO:0044316) |
3.3 | 13.2 | GO:0032541 | cortical endoplasmic reticulum(GO:0032541) |
3.3 | 16.5 | GO:0030122 | AP-2 adaptor complex(GO:0030122) |
3.3 | 39.3 | GO:0001518 | voltage-gated sodium channel complex(GO:0001518) |
3.3 | 9.8 | GO:0008282 | ATP-sensitive potassium channel complex(GO:0008282) |
3.2 | 87.2 | GO:0005891 | voltage-gated calcium channel complex(GO:0005891) |
3.2 | 29.0 | GO:0005859 | muscle myosin complex(GO:0005859) |
3.2 | 18.9 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
3.1 | 18.6 | GO:0030314 | junctional membrane complex(GO:0030314) |
3.1 | 33.6 | GO:0048786 | presynaptic active zone(GO:0048786) |
3.1 | 15.3 | GO:0031094 | platelet dense tubular network(GO:0031094) |
3.0 | 3.0 | GO:0070033 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin II complex(GO:0070033) |
3.0 | 9.0 | GO:1990696 | USH2 complex(GO:1990696) |
3.0 | 20.7 | GO:0016593 | Cdc73/Paf1 complex(GO:0016593) |
2.9 | 17.3 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
2.9 | 25.9 | GO:0030673 | axolemma(GO:0030673) |
2.8 | 5.6 | GO:0060053 | neurofilament cytoskeleton(GO:0060053) |
2.8 | 53.1 | GO:0043034 | costamere(GO:0043034) |
2.7 | 95.8 | GO:0043198 | dendritic shaft(GO:0043198) |
2.7 | 8.2 | GO:0097454 | Schwann cell microvillus(GO:0097454) |
2.6 | 5.3 | GO:0097451 | glial limiting end-foot(GO:0097451) |
2.6 | 59.9 | GO:0032281 | AMPA glutamate receptor complex(GO:0032281) |
2.6 | 15.6 | GO:0032584 | growth cone membrane(GO:0032584) |
2.5 | 7.4 | GO:0044294 | dendritic growth cone(GO:0044294) |
2.5 | 4.9 | GO:1990761 | growth cone lamellipodium(GO:1990761) |
2.4 | 26.4 | GO:0032809 | neuronal cell body membrane(GO:0032809) |
2.3 | 20.5 | GO:0002116 | semaphorin receptor complex(GO:0002116) |
2.3 | 6.8 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
2.3 | 31.8 | GO:1902711 | GABA receptor complex(GO:1902710) GABA-A receptor complex(GO:1902711) |
2.3 | 4.5 | GO:0044326 | dendritic spine neck(GO:0044326) |
2.3 | 6.8 | GO:0097441 | basilar dendrite(GO:0097441) |
2.2 | 26.1 | GO:0031045 | dense core granule(GO:0031045) |
2.2 | 17.3 | GO:0020005 | symbiont-containing vacuole membrane(GO:0020005) |
2.2 | 10.8 | GO:0097433 | dense body(GO:0097433) |
2.1 | 12.7 | GO:0043194 | axon initial segment(GO:0043194) |
2.1 | 31.4 | GO:0044295 | axonal growth cone(GO:0044295) |
2.1 | 2.1 | GO:0097418 | neurofibrillary tangle(GO:0097418) |
2.1 | 2.1 | GO:0031254 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
2.1 | 282.0 | GO:0045211 | postsynaptic membrane(GO:0045211) |
2.0 | 16.3 | GO:0031430 | M band(GO:0031430) |
2.0 | 108.1 | GO:0008076 | voltage-gated potassium channel complex(GO:0008076) |
2.0 | 201.3 | GO:0060076 | excitatory synapse(GO:0060076) |
2.0 | 4.0 | GO:0034666 | integrin alpha2-beta1 complex(GO:0034666) |
2.0 | 2.0 | GO:0020003 | symbiont-containing vacuole(GO:0020003) |
1.9 | 11.6 | GO:0005890 | sodium:potassium-exchanging ATPase complex(GO:0005890) |
1.9 | 17.0 | GO:0005916 | fascia adherens(GO:0005916) |
1.9 | 18.6 | GO:0032590 | dendrite membrane(GO:0032590) |
1.8 | 53.4 | GO:0031941 | filamentous actin(GO:0031941) |
1.8 | 1.8 | GO:0000835 | ER ubiquitin ligase complex(GO:0000835) Hrd1p ubiquitin ligase complex(GO:0000836) |
1.8 | 1.8 | GO:0097487 | multivesicular body, internal vesicle(GO:0097487) |
1.8 | 7.3 | GO:0071437 | invadopodium(GO:0071437) |
1.7 | 5.0 | GO:0043511 | inhibin complex(GO:0043511) |
1.6 | 13.1 | GO:0005861 | troponin complex(GO:0005861) |
1.6 | 9.8 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
1.6 | 8.1 | GO:0000220 | vacuolar proton-transporting V-type ATPase, V0 domain(GO:0000220) |
1.6 | 1.6 | GO:0005896 | interleukin-6 receptor complex(GO:0005896) |
1.6 | 22.3 | GO:0033017 | sarcoplasmic reticulum membrane(GO:0033017) |
1.6 | 3.2 | GO:0033648 | host intracellular organelle(GO:0033647) host intracellular membrane-bounded organelle(GO:0033648) |
1.6 | 4.7 | GO:0043259 | laminin-10 complex(GO:0043259) |
1.6 | 3.1 | GO:0035253 | ciliary rootlet(GO:0035253) |
1.6 | 12.5 | GO:0042587 | glycogen granule(GO:0042587) |
1.5 | 90.6 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
1.5 | 110.1 | GO:0030427 | site of polarized growth(GO:0030427) |
1.5 | 19.5 | GO:0070382 | exocytic vesicle(GO:0070382) |
1.5 | 4.5 | GO:0005853 | eukaryotic translation elongation factor 1 complex(GO:0005853) |
1.5 | 1.5 | GO:0097025 | MPP7-DLG1-LIN7 complex(GO:0097025) |
1.4 | 2.8 | GO:0043202 | lysosomal lumen(GO:0043202) |
1.4 | 1.4 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
1.4 | 1.4 | GO:0031209 | SCAR complex(GO:0031209) |
1.4 | 19.2 | GO:0071565 | nBAF complex(GO:0071565) |
1.4 | 5.5 | GO:0070688 | MLL5-L complex(GO:0070688) |
1.3 | 5.2 | GO:0097440 | apical dendrite(GO:0097440) |
1.2 | 14.9 | GO:0097038 | perinuclear endoplasmic reticulum(GO:0097038) |
1.2 | 16.1 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
1.2 | 19.1 | GO:0043235 | receptor complex(GO:0043235) |
1.2 | 3.6 | GO:0048179 | activin receptor complex(GO:0048179) |
1.2 | 4.7 | GO:0097425 | smooth endoplasmic reticulum membrane(GO:0030868) smooth endoplasmic reticulum part(GO:0097425) |
1.2 | 18.6 | GO:0043679 | axon terminus(GO:0043679) |
1.2 | 4.6 | GO:0030127 | COPII vesicle coat(GO:0030127) |
1.2 | 8.1 | GO:0033180 | proton-transporting V-type ATPase, V1 domain(GO:0033180) |
1.1 | 2.2 | GO:1990635 | proximal dendrite(GO:1990635) |
1.1 | 4.3 | GO:0032585 | multivesicular body membrane(GO:0032585) |
1.1 | 3.2 | GO:0051286 | cell tip(GO:0051286) |
1.1 | 3.2 | GO:0097629 | extrinsic component of omegasome membrane(GO:0097629) |
1.1 | 3.2 | GO:0005945 | 6-phosphofructokinase complex(GO:0005945) |
1.0 | 1.0 | GO:0034679 | integrin alpha9-beta1 complex(GO:0034679) |
1.0 | 16.7 | GO:0042101 | T cell receptor complex(GO:0042101) |
1.0 | 1.0 | GO:0044615 | nuclear pore nuclear basket(GO:0044615) |
1.0 | 11.2 | GO:0036379 | myofilament(GO:0036379) |
1.0 | 11.2 | GO:0014704 | intercalated disc(GO:0014704) |
1.0 | 3.0 | GO:0033179 | proton-transporting V-type ATPase, V0 domain(GO:0033179) |
1.0 | 4.0 | GO:0046930 | pore complex(GO:0046930) |
1.0 | 1.0 | GO:0097443 | sorting endosome(GO:0097443) |
1.0 | 27.7 | GO:0032420 | stereocilium(GO:0032420) |
1.0 | 4.9 | GO:0016012 | dystroglycan complex(GO:0016011) sarcoglycan complex(GO:0016012) |
1.0 | 22.2 | GO:0009925 | basal plasma membrane(GO:0009925) |
1.0 | 10.5 | GO:0042405 | nuclear inclusion body(GO:0042405) |
1.0 | 2.9 | GO:0042583 | chromaffin granule(GO:0042583) |
1.0 | 4.8 | GO:0030285 | integral component of synaptic vesicle membrane(GO:0030285) intrinsic component of synaptic vesicle membrane(GO:0098563) |
0.9 | 4.7 | GO:0097386 | glial cell projection(GO:0097386) |
0.9 | 6.5 | GO:0034464 | BBSome(GO:0034464) |
0.9 | 2.8 | GO:0005944 | phosphatidylinositol 3-kinase complex, class IB(GO:0005944) |
0.9 | 28.1 | GO:0005913 | cell-cell adherens junction(GO:0005913) |
0.9 | 9.0 | GO:0030315 | T-tubule(GO:0030315) |
0.9 | 9.8 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
0.9 | 8.0 | GO:0000137 | Golgi cis cisterna(GO:0000137) |
0.9 | 43.8 | GO:0044853 | plasma membrane raft(GO:0044853) |
0.9 | 47.9 | GO:0031674 | I band(GO:0031674) |
0.9 | 3.5 | GO:0043203 | axon hillock(GO:0043203) |
0.9 | 232.2 | GO:0045202 | synapse(GO:0045202) |
0.8 | 0.8 | GO:0020016 | ciliary pocket(GO:0020016) ciliary pocket membrane(GO:0020018) |
0.8 | 1.7 | GO:0032937 | SREBP-SCAP-Insig complex(GO:0032937) |
0.8 | 2.5 | GO:0045098 | type III intermediate filament(GO:0045098) |
0.8 | 5.7 | GO:0005885 | Arp2/3 protein complex(GO:0005885) |
0.8 | 1.6 | GO:0090498 | extrinsic component of Golgi membrane(GO:0090498) |
0.8 | 1.6 | GO:0031088 | platelet dense granule membrane(GO:0031088) |
0.8 | 4.7 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
0.8 | 0.8 | GO:0035748 | myelin sheath abaxonal region(GO:0035748) |
0.8 | 13.9 | GO:0030139 | endocytic vesicle(GO:0030139) |
0.8 | 3.1 | GO:0033503 | HULC complex(GO:0033503) |
0.8 | 5.4 | GO:0070419 | nonhomologous end joining complex(GO:0070419) |
0.8 | 6.0 | GO:0045254 | pyruvate dehydrogenase complex(GO:0045254) |
0.7 | 3.0 | GO:0001891 | phagocytic cup(GO:0001891) |
0.7 | 3.7 | GO:0035032 | phosphatidylinositol 3-kinase complex, class III(GO:0035032) |
0.7 | 3.0 | GO:0048237 | rough endoplasmic reticulum lumen(GO:0048237) |
0.7 | 11.0 | GO:0070822 | Sin3-type complex(GO:0070822) |
0.7 | 3.7 | GO:0070971 | endoplasmic reticulum exit site(GO:0070971) |
0.7 | 2.2 | GO:0043625 | delta DNA polymerase complex(GO:0043625) |
0.7 | 1.5 | GO:1990316 | ATG1/ULK1 kinase complex(GO:1990316) |
0.7 | 20.3 | GO:0005802 | trans-Golgi network(GO:0005802) |
0.7 | 18.5 | GO:0030016 | myofibril(GO:0030016) |
0.7 | 5.7 | GO:0061700 | GATOR2 complex(GO:0061700) |
0.7 | 6.3 | GO:0045334 | clathrin-coated endocytic vesicle(GO:0045334) |
0.7 | 2.1 | GO:0031084 | BLOC-2 complex(GO:0031084) |
0.7 | 39.7 | GO:0036477 | somatodendritic compartment(GO:0036477) |
0.7 | 2.0 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
0.7 | 1.3 | GO:0010009 | cytoplasmic side of endosome membrane(GO:0010009) |
0.7 | 2.0 | GO:0042582 | primary lysosome(GO:0005766) azurophil granule(GO:0042582) |
0.6 | 3.2 | GO:0044292 | dendrite terminus(GO:0044292) |
0.6 | 10.3 | GO:0005868 | cytoplasmic dynein complex(GO:0005868) |
0.6 | 42.3 | GO:0030027 | lamellipodium(GO:0030027) |
0.6 | 1.3 | GO:0098554 | integral component of cytoplasmic side of endoplasmic reticulum membrane(GO:0071458) integral component of lumenal side of endoplasmic reticulum membrane(GO:0071556) lumenal side of endoplasmic reticulum membrane(GO:0098553) cytoplasmic side of endoplasmic reticulum membrane(GO:0098554) lumenal side of membrane(GO:0098576) |
0.6 | 1.2 | GO:0097504 | Gemini of coiled bodies(GO:0097504) |
0.6 | 14.2 | GO:0005834 | heterotrimeric G-protein complex(GO:0005834) |
0.6 | 2.4 | GO:0070695 | FHF complex(GO:0070695) |
0.6 | 58.1 | GO:0045121 | membrane raft(GO:0045121) membrane microdomain(GO:0098857) |
0.6 | 0.6 | GO:0000439 | core TFIIH complex(GO:0000439) |
0.6 | 4.2 | GO:0030677 | nucleolar ribonuclease P complex(GO:0005655) ribonuclease P complex(GO:0030677) multimeric ribonuclease P complex(GO:0030681) |
0.6 | 17.1 | GO:0005801 | cis-Golgi network(GO:0005801) |
0.6 | 25.2 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
0.6 | 76.2 | GO:0031225 | anchored component of membrane(GO:0031225) |
0.6 | 3.5 | GO:0042622 | photoreceptor outer segment membrane(GO:0042622) |
0.6 | 0.6 | GO:0070044 | synaptobrevin 2-SNAP-25-syntaxin-1a complex(GO:0070044) |
0.6 | 0.6 | GO:0012507 | ER to Golgi transport vesicle membrane(GO:0012507) |
0.6 | 1.7 | GO:0036396 | MIS complex(GO:0036396) |
0.6 | 7.8 | GO:0055038 | recycling endosome membrane(GO:0055038) |
0.6 | 2.8 | GO:0032593 | insulin-responsive compartment(GO:0032593) |
0.5 | 1.6 | GO:0042719 | mitochondrial intermembrane space protein transporter complex(GO:0042719) |
0.5 | 22.9 | GO:0043204 | perikaryon(GO:0043204) |
0.5 | 2.1 | GO:0033270 | paranode region of axon(GO:0033270) |
0.5 | 6.4 | GO:0035098 | ESC/E(Z) complex(GO:0035098) |
0.5 | 1.6 | GO:0044233 | ER-mitochondrion membrane contact site(GO:0044233) |
0.5 | 161.7 | GO:0043005 | neuron projection(GO:0043005) |
0.5 | 2.6 | GO:0036513 | Derlin-1 retrotranslocation complex(GO:0036513) |
0.5 | 6.8 | GO:0036038 | MKS complex(GO:0036038) |
0.5 | 4.1 | GO:1990023 | mitotic spindle midzone(GO:1990023) |
0.5 | 1.0 | GO:0031315 | extrinsic component of mitochondrial outer membrane(GO:0031315) |
0.5 | 4.6 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
0.5 | 3.0 | GO:0033263 | CORVET complex(GO:0033263) |
0.5 | 1.4 | GO:1990851 | Wnt-Frizzled-LRP5/6 complex(GO:1990851) |
0.5 | 9.9 | GO:0032587 | ruffle membrane(GO:0032587) |
0.5 | 2.8 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
0.5 | 1.4 | GO:0045251 | mitochondrial electron transfer flavoprotein complex(GO:0017133) electron transfer flavoprotein complex(GO:0045251) |
0.5 | 0.5 | GO:0033178 | proton-transporting two-sector ATPase complex, catalytic domain(GO:0033178) |
0.5 | 1.4 | GO:0034706 | sodium channel complex(GO:0034706) |
0.5 | 5.5 | GO:0005797 | Golgi medial cisterna(GO:0005797) |
0.5 | 3.2 | GO:0097208 | alveolar lamellar body(GO:0097208) |
0.5 | 0.5 | GO:0032433 | filopodium tip(GO:0032433) |
0.4 | 4.0 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
0.4 | 7.6 | GO:0031306 | intrinsic component of mitochondrial outer membrane(GO:0031306) |
0.4 | 1.3 | GO:1990604 | IRE1-TRAF2-ASK1 complex(GO:1990604) |
0.4 | 1.8 | GO:0032982 | myosin filament(GO:0032982) |
0.4 | 1.3 | GO:0071203 | WASH complex(GO:0071203) |
0.4 | 2.2 | GO:0071547 | piP-body(GO:0071547) |
0.4 | 0.4 | GO:0030118 | clathrin coat(GO:0030118) |
0.4 | 0.4 | GO:0030123 | AP-3 adaptor complex(GO:0030123) |
0.4 | 1.3 | GO:0030891 | VCB complex(GO:0030891) |
0.4 | 3.5 | GO:0030131 | clathrin adaptor complex(GO:0030131) |
0.4 | 2.1 | GO:1990111 | spermatoproteasome complex(GO:1990111) |
0.4 | 0.8 | GO:1990909 | Wnt signalosome(GO:1990909) |
0.4 | 2.9 | GO:0045177 | apical part of cell(GO:0045177) |
0.4 | 2.9 | GO:0044437 | vacuolar part(GO:0044437) |
0.4 | 2.1 | GO:0042599 | lamellar body(GO:0042599) |
0.4 | 1.2 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
0.4 | 0.4 | GO:0005956 | protein kinase CK2 complex(GO:0005956) |
0.4 | 2.4 | GO:0005790 | smooth endoplasmic reticulum(GO:0005790) |
0.4 | 0.8 | GO:0042585 | germinal vesicle(GO:0042585) |
0.4 | 9.4 | GO:0005921 | gap junction(GO:0005921) |
0.4 | 1.2 | GO:0071942 | XPC complex(GO:0071942) |
0.4 | 0.4 | GO:0031227 | intrinsic component of endoplasmic reticulum membrane(GO:0031227) |
0.4 | 0.4 | GO:0005775 | vacuolar lumen(GO:0005775) |
0.4 | 2.6 | GO:0000276 | mitochondrial proton-transporting ATP synthase complex, coupling factor F(o)(GO:0000276) |
0.4 | 3.8 | GO:0072546 | ER membrane protein complex(GO:0072546) |
0.4 | 1.5 | GO:0002177 | manchette(GO:0002177) |
0.4 | 7.5 | GO:0005884 | actin filament(GO:0005884) |
0.4 | 3.3 | GO:0000815 | ESCRT III complex(GO:0000815) |
0.4 | 2.2 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
0.4 | 1.1 | GO:0030061 | mitochondrial crista(GO:0030061) |
0.4 | 1.5 | GO:0034448 | EGO complex(GO:0034448) Gtr1-Gtr2 GTPase complex(GO:1990131) |
0.4 | 0.7 | GO:0030134 | ER to Golgi transport vesicle(GO:0030134) |
0.4 | 1.1 | GO:0043293 | apoptosome(GO:0043293) |
0.4 | 2.5 | GO:0033391 | chromatoid body(GO:0033391) |
0.3 | 1.7 | GO:0060170 | ciliary membrane(GO:0060170) |
0.3 | 1.7 | GO:0042612 | MHC class I protein complex(GO:0042612) |
0.3 | 1.7 | GO:0005964 | phosphorylase kinase complex(GO:0005964) |
0.3 | 5.4 | GO:0016529 | sarcoplasmic reticulum(GO:0016529) |
0.3 | 2.4 | GO:0005637 | nuclear inner membrane(GO:0005637) |
0.3 | 1.0 | GO:0030140 | trans-Golgi network transport vesicle(GO:0030140) |
0.3 | 7.1 | GO:0019898 | extrinsic component of membrane(GO:0019898) |
0.3 | 4.4 | GO:0005791 | rough endoplasmic reticulum(GO:0005791) |
0.3 | 0.7 | GO:0045009 | melanosome membrane(GO:0033162) chitosome(GO:0045009) |
0.3 | 1.7 | GO:0031314 | extrinsic component of mitochondrial inner membrane(GO:0031314) |
0.3 | 0.3 | GO:1990357 | terminal web(GO:1990357) |
0.3 | 1.7 | GO:0008541 | proteasome regulatory particle, lid subcomplex(GO:0008541) |
0.3 | 6.3 | GO:0005905 | clathrin-coated pit(GO:0005905) |
0.3 | 1.6 | GO:0001940 | male pronucleus(GO:0001940) |
0.3 | 0.3 | GO:0000153 | cytoplasmic ubiquitin ligase complex(GO:0000153) |
0.3 | 1.9 | GO:0019773 | proteasome core complex, alpha-subunit complex(GO:0019773) |
0.3 | 0.3 | GO:0005850 | eukaryotic translation initiation factor 2 complex(GO:0005850) |
0.3 | 1.6 | GO:0005845 | mRNA cap binding complex(GO:0005845) RNA cap binding complex(GO:0034518) |
0.3 | 0.3 | GO:0045239 | tricarboxylic acid cycle enzyme complex(GO:0045239) |
0.3 | 1.9 | GO:0070847 | core mediator complex(GO:0070847) |
0.3 | 1.5 | GO:0045252 | oxoglutarate dehydrogenase complex(GO:0045252) |
0.3 | 3.6 | GO:0005779 | integral component of peroxisomal membrane(GO:0005779) |
0.3 | 4.1 | GO:0030014 | CCR4-NOT complex(GO:0030014) |
0.3 | 2.9 | GO:0031201 | SNARE complex(GO:0031201) |
0.3 | 1.2 | GO:0016589 | NURF complex(GO:0016589) |
0.3 | 0.9 | GO:0031983 | vesicle lumen(GO:0031983) |
0.3 | 1.2 | GO:0070876 | SOSS complex(GO:0070876) |
0.3 | 6.1 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
0.3 | 2.3 | GO:0035371 | microtubule plus-end(GO:0035371) |
0.3 | 0.9 | GO:0016471 | vacuolar proton-transporting V-type ATPase complex(GO:0016471) |
0.3 | 1.4 | GO:0005587 | collagen type IV trimer(GO:0005587) network-forming collagen trimer(GO:0098642) collagen network(GO:0098645) basement membrane collagen trimer(GO:0098651) |
0.3 | 3.4 | GO:0097225 | sperm midpiece(GO:0097225) |
0.3 | 1.1 | GO:0071546 | pi-body(GO:0071546) |
0.3 | 0.8 | GO:0044322 | endoplasmic reticulum quality control compartment(GO:0044322) |
0.3 | 1.6 | GO:0048770 | melanosome(GO:0042470) pigment granule(GO:0048770) |
0.3 | 2.2 | GO:0045275 | mitochondrial respiratory chain complex III(GO:0005750) respiratory chain complex III(GO:0045275) |
0.3 | 10.1 | GO:0097458 | neuron part(GO:0097458) |
0.3 | 27.1 | GO:0035068 | micro-ribonucleoprotein complex(GO:0035068) |
0.3 | 0.5 | GO:0016461 | unconventional myosin complex(GO:0016461) |
0.3 | 1.6 | GO:0031415 | NatA complex(GO:0031415) |
0.3 | 2.6 | GO:0000242 | pericentriolar material(GO:0000242) |
0.3 | 4.9 | GO:0008180 | COP9 signalosome(GO:0008180) |
0.3 | 4.9 | GO:0080008 | Cul4-RING E3 ubiquitin ligase complex(GO:0080008) |
0.3 | 2.5 | GO:0005776 | autophagosome(GO:0005776) |
0.3 | 1.0 | GO:0035363 | histone locus body(GO:0035363) |
0.3 | 2.3 | GO:0030867 | rough endoplasmic reticulum membrane(GO:0030867) |
0.3 | 2.3 | GO:0000813 | ESCRT I complex(GO:0000813) |
0.3 | 1.0 | GO:0072487 | MSL complex(GO:0072487) |
0.2 | 1.5 | GO:0033116 | endoplasmic reticulum-Golgi intermediate compartment membrane(GO:0033116) |
0.2 | 1.7 | GO:0032588 | trans-Golgi network membrane(GO:0032588) |
0.2 | 1.7 | GO:0042571 | immunoglobulin complex, circulating(GO:0042571) |
0.2 | 3.9 | GO:0005788 | endoplasmic reticulum lumen(GO:0005788) |
0.2 | 12.2 | GO:0005643 | nuclear pore(GO:0005643) |
0.2 | 1.4 | GO:0032421 | stereocilium bundle(GO:0032421) |
0.2 | 91.5 | GO:0005768 | endosome(GO:0005768) |
0.2 | 0.9 | GO:0005746 | mitochondrial respiratory chain(GO:0005746) |
0.2 | 0.5 | GO:0031527 | filopodium membrane(GO:0031527) |
0.2 | 10.8 | GO:0098852 | lysosomal membrane(GO:0005765) lytic vacuole membrane(GO:0098852) |
0.2 | 0.2 | GO:0070765 | gamma-secretase complex(GO:0070765) |
0.2 | 0.9 | GO:0070531 | BRCA1-A complex(GO:0070531) |
0.2 | 1.8 | GO:0030991 | intraciliary transport particle A(GO:0030991) |
0.2 | 0.9 | GO:0042611 | MHC protein complex(GO:0042611) |
0.2 | 0.7 | GO:0031933 | telomeric heterochromatin(GO:0031933) |
0.2 | 2.4 | GO:0034451 | centriolar satellite(GO:0034451) |
0.2 | 1.9 | GO:0032580 | Golgi cisterna membrane(GO:0032580) |
0.2 | 1.5 | GO:0044666 | MLL3/4 complex(GO:0044666) |
0.2 | 0.2 | GO:0098803 | respiratory chain complex(GO:0098803) |
0.2 | 9.0 | GO:0043209 | myelin sheath(GO:0043209) |
0.2 | 1.4 | GO:0005605 | basal lamina(GO:0005605) |
0.2 | 1.8 | GO:0035327 | transcriptionally active chromatin(GO:0035327) |
0.2 | 7.5 | GO:0005747 | mitochondrial respiratory chain complex I(GO:0005747) NADH dehydrogenase complex(GO:0030964) respiratory chain complex I(GO:0045271) |
0.2 | 6.7 | GO:0031228 | intrinsic component of Golgi membrane(GO:0031228) |
0.2 | 0.4 | GO:1990462 | omegasome(GO:1990462) |
0.2 | 6.2 | GO:0019897 | extrinsic component of plasma membrane(GO:0019897) |
0.2 | 0.4 | GO:0090543 | Flemming body(GO:0090543) |
0.2 | 1.5 | GO:0031597 | cytosolic proteasome complex(GO:0031597) |
0.2 | 2.4 | GO:0016459 | myosin complex(GO:0016459) |
0.2 | 7.7 | GO:0005811 | lipid particle(GO:0005811) |
0.2 | 1.0 | GO:0072669 | tRNA-splicing ligase complex(GO:0072669) |
0.2 | 0.5 | GO:0070939 | Dsl1p complex(GO:0070939) |
0.2 | 0.5 | GO:0043159 | acrosomal matrix(GO:0043159) |
0.2 | 2.7 | GO:0005782 | peroxisomal matrix(GO:0005782) microbody lumen(GO:0031907) |
0.2 | 1.3 | GO:0017119 | Golgi transport complex(GO:0017119) |
0.2 | 6.5 | GO:0099568 | cytoplasmic region(GO:0099568) |
0.2 | 1.3 | GO:0000124 | SAGA complex(GO:0000124) |
0.2 | 357.1 | GO:0005886 | plasma membrane(GO:0005886) |
0.2 | 2.1 | GO:0005614 | interstitial matrix(GO:0005614) |
0.1 | 0.3 | GO:0030289 | protein phosphatase 4 complex(GO:0030289) |
0.1 | 1.0 | GO:0000798 | nuclear cohesin complex(GO:0000798) |
0.1 | 0.1 | GO:0005971 | ribonucleoside-diphosphate reductase complex(GO:0005971) |
0.1 | 0.3 | GO:0035985 | senescence-associated heterochromatin focus(GO:0035985) |
0.1 | 330.8 | GO:0016021 | integral component of membrane(GO:0016021) |
0.1 | 0.3 | GO:0000802 | transverse filament(GO:0000802) |
0.1 | 0.1 | GO:0005640 | nuclear outer membrane(GO:0005640) |
0.1 | 3.6 | GO:0036064 | ciliary basal body(GO:0036064) |
0.1 | 2.8 | GO:0031513 | nonmotile primary cilium(GO:0031513) |
0.1 | 1.5 | GO:0005675 | holo TFIIH complex(GO:0005675) |
0.1 | 1.0 | GO:0071006 | U2-type catalytic step 1 spliceosome(GO:0071006) |
0.1 | 0.9 | GO:0030990 | intraciliary transport particle(GO:0030990) intraciliary transport particle B(GO:0030992) |
0.1 | 1.4 | GO:0098798 | mitochondrial protein complex(GO:0098798) |
0.1 | 0.1 | GO:0002081 | outer acrosomal membrane(GO:0002081) |
0.1 | 0.4 | GO:0048188 | Set1C/COMPASS complex(GO:0048188) |
0.1 | 0.5 | GO:0032797 | SMN complex(GO:0032797) |
0.1 | 0.1 | GO:0030175 | filopodium(GO:0030175) |
0.1 | 0.1 | GO:0016528 | sarcoplasm(GO:0016528) |
0.1 | 0.1 | GO:0070469 | respiratory chain(GO:0070469) |
0.1 | 0.3 | GO:0005793 | endoplasmic reticulum-Golgi intermediate compartment(GO:0005793) |
0.1 | 0.4 | GO:0000930 | gamma-tubulin complex(GO:0000930) |
0.0 | 4.4 | GO:0005635 | nuclear envelope(GO:0005635) |
0.0 | 0.2 | GO:0000408 | EKC/KEOPS complex(GO:0000408) |
0.0 | 2.8 | GO:0015629 | actin cytoskeleton(GO:0015629) |
0.0 | 0.2 | GO:0030008 | TRAPP complex(GO:0030008) |
0.0 | 0.3 | GO:0016272 | prefoldin complex(GO:0016272) |
0.0 | 0.5 | GO:0031252 | cell leading edge(GO:0031252) |
0.0 | 0.3 | GO:0031011 | Ino80 complex(GO:0031011) |
0.0 | 0.8 | GO:0035097 | histone methyltransferase complex(GO:0035097) |
0.0 | 0.1 | GO:0031371 | ubiquitin conjugating enzyme complex(GO:0031371) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
16.0 | 48.1 | GO:0031697 | beta-1 adrenergic receptor binding(GO:0031697) |
14.6 | 29.3 | GO:0097109 | neuroligin family protein binding(GO:0097109) |
14.1 | 56.2 | GO:0004971 | AMPA glutamate receptor activity(GO:0004971) |
13.5 | 40.4 | GO:0005519 | cytoskeletal regulatory protein binding(GO:0005519) |
9.8 | 29.3 | GO:0004351 | glutamate decarboxylase activity(GO:0004351) |
9.5 | 47.5 | GO:0044323 | retinoic acid-responsive element binding(GO:0044323) |
8.1 | 24.4 | GO:0048101 | calcium- and calmodulin-regulated 3',5'-cyclic-GMP phosphodiesterase activity(GO:0048101) |
7.5 | 22.6 | GO:0070538 | oleic acid binding(GO:0070538) |
7.4 | 59.0 | GO:0002162 | dystroglycan binding(GO:0002162) |
6.7 | 20.0 | GO:0005176 | ErbB-2 class receptor binding(GO:0005176) |
6.4 | 51.3 | GO:0000900 | translation repressor activity, nucleic acid binding(GO:0000900) |
5.6 | 22.3 | GO:0031433 | telethonin binding(GO:0031433) |
5.6 | 22.2 | GO:0015467 | G-protein activated inward rectifier potassium channel activity(GO:0015467) |
5.4 | 10.8 | GO:0042030 | ATPase inhibitor activity(GO:0042030) |
5.3 | 47.9 | GO:0001091 | RNA polymerase II basal transcription factor binding(GO:0001091) |
5.0 | 15.1 | GO:0001069 | regulatory region RNA binding(GO:0001069) |
5.0 | 35.1 | GO:0003680 | AT DNA binding(GO:0003680) |
4.8 | 9.6 | GO:0043423 | 3-phosphoinositide-dependent protein kinase binding(GO:0043423) |
4.8 | 14.3 | GO:0008597 | calcium-dependent protein serine/threonine phosphatase regulator activity(GO:0008597) |
4.7 | 33.2 | GO:0019870 | potassium channel inhibitor activity(GO:0019870) |
4.6 | 37.1 | GO:0004972 | NMDA glutamate receptor activity(GO:0004972) |
4.5 | 49.9 | GO:0008331 | high voltage-gated calcium channel activity(GO:0008331) |
4.5 | 22.5 | GO:0015185 | gamma-aminobutyric acid transmembrane transporter activity(GO:0015185) |
4.4 | 17.7 | GO:0015277 | kainate selective glutamate receptor activity(GO:0015277) |
4.2 | 25.5 | GO:0016933 | extracellular-glycine-gated ion channel activity(GO:0016933) extracellular-glycine-gated chloride channel activity(GO:0016934) |
4.2 | 21.1 | GO:0005432 | calcium:sodium antiporter activity(GO:0005432) |
4.2 | 8.4 | GO:0045503 | dynein light chain binding(GO:0045503) |
4.1 | 12.3 | GO:0035939 | microsatellite binding(GO:0035939) |
3.9 | 31.3 | GO:0098988 | G-protein coupled glutamate receptor activity(GO:0098988) |
3.9 | 15.5 | GO:0032051 | clathrin light chain binding(GO:0032051) |
3.8 | 83.0 | GO:0052714 | calmodulin-dependent cyclic-nucleotide phosphodiesterase activity(GO:0004117) cGMP-stimulated cyclic-nucleotide phosphodiesterase activity(GO:0004118) cGMP-inhibited cyclic-nucleotide phosphodiesterase activity(GO:0004119) photoreceptor cyclic-nucleotide phosphodiesterase activity(GO:0004120) 7,8-dihydro-D-neopterin 2',3'-cyclic phosphate phosphodiesterase activity(GO:0044688) inositol phosphosphingolipid phospholipase activity(GO:0052712) inositol phosphorylceramide phospholipase activity(GO:0052713) mannosyl-inositol phosphorylceramide phospholipase activity(GO:0052714) mannosyl-diinositol phosphorylceramide phospholipase activity(GO:0052715) |
3.7 | 41.2 | GO:0042043 | neurexin family protein binding(GO:0042043) |
3.7 | 18.4 | GO:0086080 | protein binding involved in heterotypic cell-cell adhesion(GO:0086080) |
3.7 | 7.3 | GO:0004698 | calcium-dependent protein kinase C activity(GO:0004698) |
3.6 | 10.9 | GO:0004691 | cAMP-dependent protein kinase activity(GO:0004691) |
3.6 | 18.0 | GO:0004985 | opioid receptor activity(GO:0004985) |
3.5 | 7.0 | GO:0030172 | troponin C binding(GO:0030172) |
3.4 | 6.8 | GO:0043125 | ErbB-3 class receptor binding(GO:0043125) |
3.3 | 26.8 | GO:0008599 | protein phosphatase type 1 regulator activity(GO:0008599) |
3.3 | 13.0 | GO:0043426 | MRF binding(GO:0043426) |
3.2 | 12.7 | GO:0008502 | melatonin receptor activity(GO:0008502) |
3.2 | 9.5 | GO:0048763 | calcium-induced calcium release activity(GO:0048763) |
3.1 | 37.4 | GO:0005313 | L-glutamate transmembrane transporter activity(GO:0005313) |
3.1 | 9.3 | GO:0031802 | type 5 metabotropic glutamate receptor binding(GO:0031802) |
3.1 | 3.1 | GO:0050780 | dopamine receptor binding(GO:0050780) |
3.1 | 43.1 | GO:0031402 | sodium ion binding(GO:0031402) |
3.1 | 21.5 | GO:0005004 | GPI-linked ephrin receptor activity(GO:0005004) |
3.0 | 9.0 | GO:1990239 | steroid hormone binding(GO:1990239) |
2.9 | 11.6 | GO:0005095 | GTPase inhibitor activity(GO:0005095) |
2.9 | 17.4 | GO:0004385 | guanylate kinase activity(GO:0004385) |
2.9 | 31.7 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
2.9 | 60.4 | GO:0005246 | calcium channel regulator activity(GO:0005246) |
2.9 | 8.6 | GO:0030899 | calcium-dependent ATPase activity(GO:0030899) |
2.9 | 14.3 | GO:0008499 | UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity(GO:0008499) |
2.9 | 14.3 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
2.8 | 22.2 | GO:0031432 | titin binding(GO:0031432) |
2.8 | 13.8 | GO:0051525 | NFAT protein binding(GO:0051525) |
2.8 | 8.3 | GO:0050816 | phosphothreonine binding(GO:0050816) |
2.7 | 10.9 | GO:0015272 | ATP-activated inward rectifier potassium channel activity(GO:0015272) |
2.7 | 13.3 | GO:0001515 | opioid peptide activity(GO:0001515) |
2.6 | 7.9 | GO:0000155 | phosphorelay sensor kinase activity(GO:0000155) |
2.6 | 21.1 | GO:0004862 | cAMP-dependent protein kinase inhibitor activity(GO:0004862) |
2.6 | 10.5 | GO:0005250 | A-type (transient outward) potassium channel activity(GO:0005250) |
2.6 | 5.2 | GO:0031013 | troponin I binding(GO:0031013) |
2.6 | 2.6 | GO:0035373 | chondroitin sulfate proteoglycan binding(GO:0035373) |
2.6 | 12.8 | GO:0008294 | calcium- and calmodulin-responsive adenylate cyclase activity(GO:0008294) |
2.5 | 7.6 | GO:0004937 | alpha1-adrenergic receptor activity(GO:0004937) |
2.5 | 12.6 | GO:0031849 | olfactory receptor binding(GO:0031849) |
2.5 | 25.0 | GO:0051378 | serotonin binding(GO:0051378) |
2.5 | 9.9 | GO:0001602 | pancreatic polypeptide receptor activity(GO:0001602) |
2.4 | 46.3 | GO:0004890 | GABA-A receptor activity(GO:0004890) |
2.4 | 26.1 | GO:0016909 | JUN kinase activity(GO:0004705) SAP kinase activity(GO:0016909) |
2.3 | 9.4 | GO:0030955 | potassium ion binding(GO:0030955) |
2.3 | 53.8 | GO:0042805 | actinin binding(GO:0042805) |
2.3 | 60.1 | GO:0015459 | potassium channel regulator activity(GO:0015459) |
2.3 | 27.6 | GO:0031005 | filamin binding(GO:0031005) |
2.3 | 27.0 | GO:0008179 | adenylate cyclase binding(GO:0008179) |
2.2 | 8.9 | GO:0004332 | fructose-bisphosphate aldolase activity(GO:0004332) |
2.2 | 2.2 | GO:0001601 | peptide YY receptor activity(GO:0001601) |
2.2 | 6.6 | GO:0004924 | oncostatin-M receptor activity(GO:0004924) |
2.2 | 8.7 | GO:0017034 | Rap guanyl-nucleotide exchange factor activity(GO:0017034) |
2.2 | 6.5 | GO:0004144 | diacylglycerol O-acyltransferase activity(GO:0004144) |
2.2 | 6.5 | GO:0008184 | glycogen phosphorylase activity(GO:0008184) |
2.1 | 6.4 | GO:0070052 | collagen V binding(GO:0070052) |
2.1 | 10.7 | GO:0004887 | thyroid hormone receptor activity(GO:0004887) |
2.1 | 10.7 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
2.1 | 4.2 | GO:0004706 | JUN kinase kinase kinase activity(GO:0004706) |
2.1 | 8.3 | GO:0001875 | lipopolysaccharide receptor activity(GO:0001875) |
2.0 | 6.1 | GO:0016842 | amidine-lyase activity(GO:0016842) |
2.0 | 16.2 | GO:0008113 | peptide-methionine (S)-S-oxide reductase activity(GO:0008113) |
2.0 | 6.1 | GO:0008066 | glutamate receptor activity(GO:0008066) |
2.0 | 4.0 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
1.9 | 3.9 | GO:0034040 | lipid-transporting ATPase activity(GO:0034040) |
1.9 | 5.8 | GO:0031852 | mu-type opioid receptor binding(GO:0031852) |
1.9 | 7.7 | GO:0005042 | netrin receptor activity(GO:0005042) |
1.9 | 5.8 | GO:0004949 | cannabinoid receptor activity(GO:0004949) |
1.9 | 20.9 | GO:0030552 | cAMP binding(GO:0030552) |
1.9 | 3.7 | GO:0005030 | neurotrophin receptor activity(GO:0005030) |
1.9 | 11.1 | GO:0001588 | dopamine neurotransmitter receptor activity, coupled via Gs(GO:0001588) |
1.9 | 48.2 | GO:0001786 | phosphatidylserine binding(GO:0001786) |
1.8 | 5.5 | GO:0016520 | growth hormone-releasing hormone receptor activity(GO:0016520) |
1.8 | 3.7 | GO:0036042 | long-chain fatty acyl-CoA binding(GO:0036042) |
1.8 | 5.5 | GO:0031752 | D5 dopamine receptor binding(GO:0031752) |
1.8 | 7.3 | GO:0071074 | eukaryotic initiation factor eIF2 binding(GO:0071074) |
1.8 | 1.8 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
1.8 | 3.6 | GO:0070699 | type II activin receptor binding(GO:0070699) |
1.8 | 50.7 | GO:0005251 | delayed rectifier potassium channel activity(GO:0005251) |
1.8 | 5.4 | GO:0070053 | thrombospondin receptor activity(GO:0070053) |
1.8 | 12.6 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
1.8 | 8.9 | GO:0086006 | voltage-gated sodium channel activity involved in cardiac muscle cell action potential(GO:0086006) |
1.8 | 8.9 | GO:0004994 | somatostatin receptor activity(GO:0004994) |
1.8 | 5.3 | GO:0033829 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity(GO:0033829) |
1.8 | 5.3 | GO:0016917 | GABA receptor activity(GO:0016917) |
1.7 | 1.7 | GO:0098632 | protein binding involved in cell-cell adhesion(GO:0098632) |
1.7 | 17.4 | GO:0031701 | angiotensin receptor binding(GO:0031701) |
1.7 | 5.2 | GO:0030160 | GKAP/Homer scaffold activity(GO:0030160) |
1.7 | 3.5 | GO:0015018 | galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity(GO:0015018) |
1.7 | 1.7 | GO:0048030 | disaccharide binding(GO:0048030) |
1.7 | 3.5 | GO:0004939 | beta-adrenergic receptor activity(GO:0004939) |
1.7 | 34.5 | GO:0003785 | actin monomer binding(GO:0003785) |
1.7 | 13.8 | GO:0015187 | glycine transmembrane transporter activity(GO:0015187) |
1.7 | 10.0 | GO:0015198 | oligopeptide transporter activity(GO:0015198) |
1.7 | 6.7 | GO:0036374 | gamma-glutamyltransferase activity(GO:0003840) glutathione hydrolase activity(GO:0036374) |
1.7 | 5.0 | GO:0004800 | thyroxine 5'-deiodinase activity(GO:0004800) |
1.7 | 5.0 | GO:0042731 | PH domain binding(GO:0042731) |
1.7 | 13.3 | GO:0015279 | store-operated calcium channel activity(GO:0015279) |
1.7 | 5.0 | GO:0016509 | long-chain-3-hydroxyacyl-CoA dehydrogenase activity(GO:0016509) |
1.7 | 3.3 | GO:0031711 | bradykinin receptor binding(GO:0031711) |
1.6 | 4.9 | GO:0003941 | L-serine ammonia-lyase activity(GO:0003941) |
1.6 | 6.5 | GO:0004740 | pyruvate dehydrogenase (acetyl-transferring) kinase activity(GO:0004740) |
1.6 | 6.3 | GO:0033192 | calmodulin-dependent protein phosphatase activity(GO:0033192) |
1.6 | 9.5 | GO:0004716 | receptor signaling protein tyrosine kinase activity(GO:0004716) |
1.5 | 9.2 | GO:0019992 | diacylglycerol binding(GO:0019992) |
1.5 | 3.0 | GO:0008545 | JUN kinase kinase activity(GO:0008545) |
1.5 | 15.1 | GO:0004143 | diacylglycerol kinase activity(GO:0004143) |
1.5 | 7.5 | GO:0000064 | L-ornithine transmembrane transporter activity(GO:0000064) |
1.5 | 6.0 | GO:0015016 | [heparan sulfate]-glucosamine N-sulfotransferase activity(GO:0015016) |
1.5 | 19.5 | GO:0045295 | gamma-catenin binding(GO:0045295) |
1.5 | 4.5 | GO:0004366 | glycerol-3-phosphate O-acyltransferase activity(GO:0004366) |
1.5 | 10.4 | GO:0030159 | receptor signaling complex scaffold activity(GO:0030159) |
1.5 | 2.9 | GO:0008330 | protein tyrosine/threonine phosphatase activity(GO:0008330) |
1.5 | 24.9 | GO:0017075 | syntaxin-1 binding(GO:0017075) |
1.5 | 2.9 | GO:0008440 | inositol-1,4,5-trisphosphate 3-kinase activity(GO:0008440) |
1.4 | 26.1 | GO:0080025 | phosphatidylinositol-3,5-bisphosphate binding(GO:0080025) |
1.4 | 5.8 | GO:0050693 | LBD domain binding(GO:0050693) |
1.4 | 5.8 | GO:0099528 | G-protein coupled neurotransmitter receptor activity(GO:0099528) |
1.4 | 4.3 | GO:0003726 | double-stranded RNA adenosine deaminase activity(GO:0003726) |
1.4 | 24.4 | GO:0004629 | phospholipase C activity(GO:0004629) |
1.4 | 5.7 | GO:0017162 | aryl hydrocarbon receptor binding(GO:0017162) |
1.4 | 12.7 | GO:0001206 | transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001206) |
1.4 | 30.7 | GO:0017080 | sodium channel regulator activity(GO:0017080) |
1.4 | 96.7 | GO:0019210 | kinase inhibitor activity(GO:0019210) |
1.4 | 8.2 | GO:0004708 | MAP kinase kinase activity(GO:0004708) |
1.4 | 6.9 | GO:0070728 | leucine binding(GO:0070728) |
1.4 | 2.7 | GO:0051425 | PTB domain binding(GO:0051425) |
1.4 | 16.3 | GO:0046625 | sphingolipid binding(GO:0046625) |
1.4 | 2.7 | GO:0031871 | proteinase activated receptor binding(GO:0031871) |
1.3 | 24.2 | GO:0031489 | myosin V binding(GO:0031489) |
1.3 | 29.3 | GO:0045499 | chemorepellent activity(GO:0045499) |
1.3 | 7.7 | GO:0005522 | profilin binding(GO:0005522) |
1.3 | 5.1 | GO:0005025 | transforming growth factor beta receptor activity, type I(GO:0005025) |
1.3 | 8.9 | GO:0043008 | ATP-dependent protein binding(GO:0043008) |
1.3 | 6.3 | GO:0004111 | creatine kinase activity(GO:0004111) |
1.3 | 20.1 | GO:0035255 | ionotropic glutamate receptor binding(GO:0035255) |
1.2 | 1.2 | GO:0086008 | voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization(GO:0086008) |
1.2 | 6.2 | GO:0099589 | G-protein coupled serotonin receptor activity(GO:0004993) serotonin receptor activity(GO:0099589) |
1.2 | 3.7 | GO:0004719 | protein-L-isoaspartate (D-aspartate) O-methyltransferase activity(GO:0004719) |
1.2 | 3.7 | GO:0004174 | electron-transferring-flavoprotein dehydrogenase activity(GO:0004174) oxidoreductase activity, acting on the CH-NH group of donors, quinone or similar compound as acceptor(GO:0016649) |
1.2 | 4.9 | GO:0016286 | small conductance calcium-activated potassium channel activity(GO:0016286) |
1.2 | 9.7 | GO:0005068 | transmembrane receptor protein tyrosine kinase adaptor activity(GO:0005068) |
1.2 | 8.5 | GO:0050811 | GABA receptor binding(GO:0050811) |
1.2 | 19.3 | GO:0045296 | cadherin binding(GO:0045296) |
1.2 | 3.6 | GO:0070679 | inositol 1,4,5 trisphosphate binding(GO:0070679) |
1.2 | 22.7 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
1.2 | 9.5 | GO:0015269 | calcium-activated potassium channel activity(GO:0015269) |
1.2 | 5.9 | GO:0070290 | N-acylphosphatidylethanolamine-specific phospholipase D activity(GO:0070290) |
1.2 | 27.3 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
1.2 | 3.5 | GO:0019153 | protein-disulfide reductase (glutathione) activity(GO:0019153) |
1.2 | 7.0 | GO:0030957 | Tat protein binding(GO:0030957) |
1.2 | 2.3 | GO:0005001 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) |
1.2 | 5.8 | GO:0042609 | CD4 receptor binding(GO:0042609) |
1.1 | 11.4 | GO:0071889 | 14-3-3 protein binding(GO:0071889) |
1.1 | 11.4 | GO:0042577 | lipid phosphatase activity(GO:0042577) |
1.1 | 3.4 | GO:0031748 | D1 dopamine receptor binding(GO:0031748) |
1.1 | 4.5 | GO:0071614 | linoleic acid epoxygenase activity(GO:0071614) |
1.1 | 4.5 | GO:0004969 | histamine receptor activity(GO:0004969) |
1.1 | 10.1 | GO:0004499 | N,N-dimethylaniline monooxygenase activity(GO:0004499) |
1.1 | 3.4 | GO:1990460 | leptin receptor binding(GO:1990460) |
1.1 | 2.2 | GO:0051032 | nucleic acid transmembrane transporter activity(GO:0051032) RNA transmembrane transporter activity(GO:0051033) |
1.1 | 4.5 | GO:0043237 | laminin-1 binding(GO:0043237) |
1.1 | 3.3 | GO:0071535 | RING-like zinc finger domain binding(GO:0071535) |
1.1 | 1.1 | GO:0030984 | kininogen binding(GO:0030984) |
1.1 | 7.7 | GO:0048156 | tau protein binding(GO:0048156) |
1.1 | 4.4 | GO:0015220 | choline transmembrane transporter activity(GO:0015220) |
1.1 | 3.3 | GO:0010314 | phosphatidylinositol-5-phosphate binding(GO:0010314) |
1.1 | 24.0 | GO:0046875 | ephrin receptor binding(GO:0046875) |
1.1 | 16.3 | GO:0005112 | Notch binding(GO:0005112) |
1.1 | 7.6 | GO:0015280 | ligand-gated sodium channel activity(GO:0015280) |
1.1 | 4.2 | GO:0098639 | collagen binding involved in cell-matrix adhesion(GO:0098639) |
1.1 | 3.2 | GO:0003872 | 6-phosphofructokinase activity(GO:0003872) |
1.1 | 3.2 | GO:0030158 | protein xylosyltransferase activity(GO:0030158) |
1.0 | 97.0 | GO:0017124 | SH3 domain binding(GO:0017124) |
1.0 | 3.1 | GO:0004359 | glutaminase activity(GO:0004359) |
1.0 | 5.1 | GO:0017049 | GTP-Rho binding(GO:0017049) |
1.0 | 3.1 | GO:0031694 | alpha-2A adrenergic receptor binding(GO:0031694) |
1.0 | 3.0 | GO:0015563 | uptake transmembrane transporter activity(GO:0015563) |
1.0 | 3.0 | GO:1990430 | extracellular matrix protein binding(GO:1990430) |
1.0 | 7.1 | GO:0019113 | 3-(3-hydroxyphenyl)propionate hydroxylase activity(GO:0008688) 4-chlorobenzaldehyde oxidase activity(GO:0018471) 3,5-xylenol methylhydroxylase activity(GO:0018630) phenylacetate hydroxylase activity(GO:0018631) 4-nitrophenol 4-monooxygenase activity(GO:0018632) dimethyl sulfide monooxygenase activity(GO:0018633) alpha-pinene monooxygenase [NADH] activity(GO:0018634) 1-hydroxy-2-naphthoate hydroxylase activity(GO:0018637) toluene 4-monooxygenase activity(GO:0018638) xylene monooxygenase activity(GO:0018639) dibenzothiophene monooxygenase activity(GO:0018640) 6-hydroxy-3-methyl-2-oxo-1,2-dihydroquinoline 6-monooxygenase activity(GO:0018641) chlorophenol 4-monooxygenase activity(GO:0018642) carbon disulfide oxygenase activity(GO:0018643) toluene 2-monooxygenase activity(GO:0018644) 1-hydroxy-2-oxolimonene 1,2-monooxygenase activity(GO:0018646) phenanthrene 1,2-monooxygenase activity(GO:0018647) tetrahydrofuran hydroxylase activity(GO:0018649) styrene monooxygenase activity(GO:0018650) toluene-4-sulfonate monooxygenase activity(GO:0018651) toluene-sulfonate methyl-monooxygenase activity(GO:0018652) 3-methyl-2-oxo-1,2-dihydroquinoline 6-monooxygenase activity(GO:0018653) 2-hydroxy-phenylacetate hydroxylase activity(GO:0018654) 2-oxo-delta3-4,5,5-trimethylcyclopentenylacetyl-CoA 1,2-monooxygenase activity(GO:0018655) phenanthrene 3,4-monooxygenase activity(GO:0018656) toluene 3-monooxygenase activity(GO:0018657) 4-hydroxyphenylacetate,NADH:oxygen oxidoreductase (3-hydroxylating) activity(GO:0018660) limonene monooxygenase activity(GO:0019113) 2-methylnaphthalene hydroxylase activity(GO:0034526) 1-methylnaphthalene hydroxylase activity(GO:0034534) bisphenol A hydroxylase A activity(GO:0034560) salicylate 5-hydroxylase activity(GO:0034785) isobutylamine N-hydroxylase activity(GO:0034791) branched-chain dodecylbenzene sulfonate monooxygenase activity(GO:0034802) 3-HSA hydroxylase activity(GO:0034819) 4-hydroxypyridine-3-hydroxylase activity(GO:0034894) 2-octaprenyl-3-methyl-6-methoxy-1,4-benzoquinol hydroxylase activity(GO:0043719) 6-hydroxynicotinate 3-monooxygenase activity(GO:0043731) thalianol hydroxylase activity(GO:0080014) |
1.0 | 21.2 | GO:0017091 | AU-rich element binding(GO:0017091) |
1.0 | 4.0 | GO:0047499 | calcium-independent phospholipase A2 activity(GO:0047499) |
1.0 | 3.0 | GO:0015180 | L-alanine transmembrane transporter activity(GO:0015180) alanine transmembrane transporter activity(GO:0022858) |
1.0 | 3.0 | GO:0004724 | magnesium-dependent protein serine/threonine phosphatase activity(GO:0004724) |
1.0 | 13.0 | GO:0008601 | protein phosphatase type 2A regulator activity(GO:0008601) |
1.0 | 4.0 | GO:0043262 | adenosine-diphosphatase activity(GO:0043262) |
1.0 | 3.0 | GO:0005275 | amine transmembrane transporter activity(GO:0005275) |
1.0 | 63.2 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
1.0 | 3.9 | GO:0008532 | N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity(GO:0008532) |
1.0 | 8.8 | GO:0016920 | pyroglutamyl-peptidase activity(GO:0016920) |
1.0 | 10.7 | GO:0008307 | structural constituent of muscle(GO:0008307) |
1.0 | 10.7 | GO:0031078 | histone deacetylase activity (H3-K14 specific)(GO:0031078) NAD-dependent histone deacetylase activity (H3-K14 specific)(GO:0032041) |
1.0 | 2.9 | GO:0070326 | very-low-density lipoprotein particle receptor binding(GO:0070326) |
1.0 | 2.9 | GO:0089720 | caspase binding(GO:0089720) |
1.0 | 5.8 | GO:0016421 | CoA carboxylase activity(GO:0016421) |
1.0 | 3.8 | GO:0052833 | inositol monophosphate 1-phosphatase activity(GO:0008934) inositol monophosphate 3-phosphatase activity(GO:0052832) inositol monophosphate 4-phosphatase activity(GO:0052833) inositol monophosphate phosphatase activity(GO:0052834) |
0.9 | 2.8 | GO:0004427 | inorganic diphosphatase activity(GO:0004427) |
0.9 | 2.8 | GO:2001070 | starch binding(GO:2001070) |
0.9 | 2.8 | GO:0016212 | kynurenine-oxoglutarate transaminase activity(GO:0016212) kynurenine aminotransferase activity(GO:0036137) |
0.9 | 2.8 | GO:0080130 | L-phenylalanine:2-oxoglutarate aminotransferase activity(GO:0080130) |
0.9 | 2.8 | GO:0004920 | interleukin-10 receptor activity(GO:0004920) |
0.9 | 4.6 | GO:0070300 | phosphatidic acid binding(GO:0070300) |
0.9 | 1.8 | GO:0050998 | nitric-oxide synthase binding(GO:0050998) |
0.9 | 0.9 | GO:0051373 | FATZ binding(GO:0051373) |
0.9 | 2.8 | GO:0004739 | pyruvate dehydrogenase (acetyl-transferring) activity(GO:0004739) |
0.9 | 5.5 | GO:0008889 | glycerophosphodiester phosphodiesterase activity(GO:0008889) |
0.9 | 1.8 | GO:1990459 | transferrin receptor binding(GO:1990459) |
0.9 | 23.3 | GO:0005184 | neuropeptide hormone activity(GO:0005184) |
0.9 | 2.6 | GO:0048248 | CXCR3 chemokine receptor binding(GO:0048248) |
0.9 | 0.9 | GO:0047192 | 1-alkylglycerophosphocholine O-acetyltransferase activity(GO:0047192) |
0.9 | 0.9 | GO:0004839 | ubiquitin activating enzyme activity(GO:0004839) |
0.9 | 8.7 | GO:0016868 | intramolecular transferase activity, phosphotransferases(GO:0016868) |
0.9 | 1.7 | GO:0038191 | neuropilin binding(GO:0038191) |
0.9 | 3.5 | GO:0003985 | acetyl-CoA C-acetyltransferase activity(GO:0003985) C-acetyltransferase activity(GO:0016453) |
0.9 | 14.6 | GO:0000993 | RNA polymerase II core binding(GO:0000993) |
0.9 | 6.8 | GO:0004438 | phosphatidylinositol-3-phosphatase activity(GO:0004438) |
0.9 | 1.7 | GO:0071253 | connexin binding(GO:0071253) |
0.8 | 8.4 | GO:0009881 | photoreceptor activity(GO:0009881) |
0.8 | 1.7 | GO:0030911 | TPR domain binding(GO:0030911) |
0.8 | 41.2 | GO:0044325 | ion channel binding(GO:0044325) |
0.8 | 2.5 | GO:0016262 | protein N-acetylglucosaminyltransferase activity(GO:0016262) |
0.8 | 2.5 | GO:0004995 | tachykinin receptor activity(GO:0004995) |
0.8 | 2.5 | GO:0098821 | BMP receptor activity(GO:0098821) |
0.8 | 4.1 | GO:0045545 | syndecan binding(GO:0045545) |
0.8 | 156.2 | GO:0005096 | GTPase activator activity(GO:0005096) |
0.8 | 4.1 | GO:0052850 | enoyl-[acyl-carrier-protein] reductase activity(GO:0016631) 2,3-dihydroxy-2,3-dihydro-phenylpropionate dehydrogenase activity(GO:0018498) cis-2,3-dihydrodiol DDT dehydrogenase activity(GO:0018499) trans-9R,10R-dihydrodiolphenanthrene dehydrogenase activity(GO:0018500) cis-chlorobenzene dihydrodiol dehydrogenase activity(GO:0018501) 2,5-dichloro-2,5-cyclohexadiene-1,4-diol dehydrogenase activity(GO:0018502) trans-1,2-dihydrodiolphenanthrene dehydrogenase activity(GO:0018503) 3,4-dihydroxy-3,4-dihydrofluorene dehydrogenase activity(GO:0034790) benzo(a)pyrene-trans-11,12-dihydrodiol dehydrogenase activity(GO:0034805) benzo(a)pyrene-cis-4,5-dihydrodiol dehydrogenase activity(GO:0034809) citronellyl-CoA dehydrogenase activity(GO:0034824) menthone dehydrogenase activity(GO:0034838) phthalate 3,4-cis-dihydrodiol dehydrogenase activity(GO:0034912) cinnamate reductase activity(GO:0043786) NADPH-dependent curcumin reductase activity(GO:0052849) NADPH-dependent dihydrocurcumin reductase activity(GO:0052850) |
0.8 | 0.8 | GO:0005502 | 11-cis retinal binding(GO:0005502) |
0.8 | 0.8 | GO:0008252 | nucleotidase activity(GO:0008252) |
0.8 | 13.8 | GO:0008327 | methyl-CpG binding(GO:0008327) |
0.8 | 2.4 | GO:0004090 | carbonyl reductase (NADPH) activity(GO:0004090) |
0.8 | 4.0 | GO:0016615 | malate dehydrogenase activity(GO:0016615) |
0.8 | 11.1 | GO:0017056 | structural constituent of nuclear pore(GO:0017056) |
0.8 | 3.9 | GO:0015349 | thyroid hormone transmembrane transporter activity(GO:0015349) |
0.8 | 0.8 | GO:0004980 | melanocyte-stimulating hormone receptor activity(GO:0004980) |
0.8 | 9.4 | GO:0070006 | metalloaminopeptidase activity(GO:0070006) |
0.8 | 3.9 | GO:0030550 | acetylcholine receptor inhibitor activity(GO:0030550) |
0.8 | 4.7 | GO:0016175 | superoxide-generating NADPH oxidase activity(GO:0016175) |
0.8 | 7.8 | GO:0004865 | protein serine/threonine phosphatase inhibitor activity(GO:0004865) |
0.8 | 2.3 | GO:0008853 | exodeoxyribonuclease III activity(GO:0008853) |
0.8 | 7.8 | GO:0022821 | sodium:proton antiporter activity(GO:0015385) potassium:proton antiporter activity(GO:0015386) potassium ion antiporter activity(GO:0022821) |
0.8 | 0.8 | GO:0000253 | 3-keto sterol reductase activity(GO:0000253) |
0.8 | 6.9 | GO:0005523 | tropomyosin binding(GO:0005523) |
0.8 | 3.8 | GO:0008504 | monoamine transmembrane transporter activity(GO:0008504) |
0.8 | 5.4 | GO:0004623 | phospholipase A2 activity(GO:0004623) |
0.8 | 6.8 | GO:0005242 | inward rectifier potassium channel activity(GO:0005242) |
0.8 | 4.5 | GO:0016936 | galactoside binding(GO:0016936) |
0.7 | 2.2 | GO:0004833 | tryptophan 2,3-dioxygenase activity(GO:0004833) |
0.7 | 1.5 | GO:0034186 | apolipoprotein A-I binding(GO:0034186) |
0.7 | 13.4 | GO:0005154 | epidermal growth factor receptor binding(GO:0005154) |
0.7 | 8.9 | GO:0015106 | bicarbonate transmembrane transporter activity(GO:0015106) |
0.7 | 7.4 | GO:0004707 | MAP kinase activity(GO:0004707) |
0.7 | 1.5 | GO:0033142 | progesterone receptor binding(GO:0033142) |
0.7 | 19.2 | GO:0001540 | beta-amyloid binding(GO:0001540) |
0.7 | 3.7 | GO:0043855 | intracellular cyclic nucleotide activated cation channel activity(GO:0005221) cyclic nucleotide-gated ion channel activity(GO:0043855) |
0.7 | 2.2 | GO:0019976 | interleukin-2 binding(GO:0019976) |
0.7 | 16.7 | GO:0016247 | channel regulator activity(GO:0016247) |
0.7 | 5.1 | GO:0102337 | fatty acid elongase activity(GO:0009922) 3-oxo-arachidoyl-CoA synthase activity(GO:0102336) 3-oxo-cerotoyl-CoA synthase activity(GO:0102337) 3-oxo-lignoceronyl-CoA synthase activity(GO:0102338) |
0.7 | 1.4 | GO:0050815 | phosphoserine binding(GO:0050815) |
0.7 | 5.0 | GO:0016443 | bidentate ribonuclease III activity(GO:0016443) |
0.7 | 9.3 | GO:0008253 | 5'-nucleotidase activity(GO:0008253) |
0.7 | 1.4 | GO:0015222 | serotonin transmembrane transporter activity(GO:0015222) |
0.7 | 6.4 | GO:0034237 | protein kinase A regulatory subunit binding(GO:0034237) |
0.7 | 6.4 | GO:0005388 | calcium-transporting ATPase activity(GO:0005388) |
0.7 | 30.4 | GO:0043621 | protein self-association(GO:0043621) |
0.7 | 2.1 | GO:0008142 | oxysterol binding(GO:0008142) |
0.7 | 2.1 | GO:0016015 | morphogen activity(GO:0016015) |
0.7 | 14.0 | GO:0004190 | aspartic-type endopeptidase activity(GO:0004190) aspartic-type peptidase activity(GO:0070001) |
0.7 | 1.4 | GO:0070996 | type 1 melanocortin receptor binding(GO:0070996) |
0.7 | 2.1 | GO:0046624 | sphingolipid transporter activity(GO:0046624) |
0.7 | 0.7 | GO:0022824 | transmitter-gated ion channel activity(GO:0022824) transmitter-gated channel activity(GO:0022835) |
0.7 | 5.6 | GO:0102391 | decanoate--CoA ligase activity(GO:0102391) |
0.7 | 8.3 | GO:0017128 | phospholipid scramblase activity(GO:0017128) |
0.7 | 3.4 | GO:0015288 | porin activity(GO:0015288) |
0.7 | 6.1 | GO:0015643 | toxic substance binding(GO:0015643) |
0.7 | 0.7 | GO:0071532 | ankyrin repeat binding(GO:0071532) |
0.7 | 5.4 | GO:0030898 | actin-dependent ATPase activity(GO:0030898) |
0.7 | 4.0 | GO:0019966 | interleukin-1 binding(GO:0019966) |
0.7 | 18.8 | GO:0097472 | cyclin-dependent protein serine/threonine kinase activity(GO:0004693) cyclin-dependent protein kinase activity(GO:0097472) |
0.7 | 2.7 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
0.7 | 3.3 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
0.7 | 7.3 | GO:0001608 | G-protein coupled nucleotide receptor activity(GO:0001608) G-protein coupled purinergic nucleotide receptor activity(GO:0045028) |
0.7 | 2.6 | GO:0004449 | isocitrate dehydrogenase (NAD+) activity(GO:0004449) |
0.7 | 11.1 | GO:0043015 | gamma-tubulin binding(GO:0043015) |
0.7 | 0.7 | GO:0001031 | RNA polymerase III type 1 promoter DNA binding(GO:0001030) RNA polymerase III type 2 promoter DNA binding(GO:0001031) RNA polymerase III type 3 promoter DNA binding(GO:0001032) 5S rDNA binding(GO:0080084) |
0.7 | 12.4 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
0.7 | 3.9 | GO:0046974 | histone methyltransferase activity (H3-K9 specific)(GO:0046974) |
0.7 | 2.6 | GO:0034902 | alkyl sulfatase activity(GO:0018741) endosulfan hemisulfate sulfatase activity(GO:0034889) endosulfan sulfate hydrolase activity(GO:0034902) |
0.6 | 1.9 | GO:0008310 | single-stranded DNA 3'-5' exodeoxyribonuclease activity(GO:0008310) |
0.6 | 16.7 | GO:0005546 | phosphatidylinositol-4,5-bisphosphate binding(GO:0005546) |
0.6 | 1.3 | GO:0048403 | brain-derived neurotrophic factor binding(GO:0048403) |
0.6 | 12.5 | GO:0043014 | alpha-tubulin binding(GO:0043014) |
0.6 | 1.3 | GO:0043495 | protein anchor(GO:0043495) |
0.6 | 3.1 | GO:0008242 | omega peptidase activity(GO:0008242) |
0.6 | 3.7 | GO:0008079 | translation release factor activity(GO:0003747) translation termination factor activity(GO:0008079) |
0.6 | 3.7 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
0.6 | 14.8 | GO:0017022 | myosin binding(GO:0017022) |
0.6 | 32.1 | GO:0005200 | structural constituent of cytoskeleton(GO:0005200) |
0.6 | 0.6 | GO:0005347 | ATP transmembrane transporter activity(GO:0005347) |
0.6 | 36.0 | GO:0005516 | calmodulin binding(GO:0005516) |
0.6 | 1.2 | GO:0004687 | myosin light chain kinase activity(GO:0004687) |
0.6 | 3.6 | GO:0032794 | GTPase activating protein binding(GO:0032794) |
0.6 | 4.1 | GO:0003691 | double-stranded telomeric DNA binding(GO:0003691) |
0.6 | 2.3 | GO:0034711 | inhibin binding(GO:0034711) |
0.6 | 1.7 | GO:0000309 | nicotinamide-nucleotide adenylyltransferase activity(GO:0000309) nicotinate-nucleotide adenylyltransferase activity(GO:0004515) |
0.6 | 2.9 | GO:0004983 | neuropeptide Y receptor activity(GO:0004983) |
0.6 | 2.3 | GO:0005024 | transforming growth factor beta-activated receptor activity(GO:0005024) |
0.6 | 1.7 | GO:0016716 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, another compound as one donor, and incorporation of one atom of oxygen(GO:0016716) |
0.6 | 5.1 | GO:0001846 | opsonin binding(GO:0001846) |
0.6 | 2.3 | GO:0035014 | phosphatidylinositol 3-kinase regulator activity(GO:0035014) |
0.6 | 1.7 | GO:0034056 | estrogen response element binding(GO:0034056) |
0.6 | 6.2 | GO:0001730 | 2'-5'-oligoadenylate synthetase activity(GO:0001730) |
0.6 | 3.4 | GO:0008469 | histone-arginine N-methyltransferase activity(GO:0008469) protein-arginine omega-N asymmetric methyltransferase activity(GO:0035242) |
0.6 | 3.9 | GO:0031681 | G-protein beta-subunit binding(GO:0031681) |
0.6 | 2.8 | GO:0003708 | retinoic acid receptor activity(GO:0003708) |
0.6 | 2.8 | GO:0046912 | transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer(GO:0046912) |
0.6 | 2.8 | GO:0004826 | phenylalanine-tRNA ligase activity(GO:0004826) |
0.6 | 1.7 | GO:0001075 | transcription factor activity, RNA polymerase II core promoter sequence-specific binding involved in preinitiation complex assembly(GO:0001075) |
0.6 | 1.7 | GO:0005134 | interleukin-2 receptor binding(GO:0005134) |
0.6 | 34.7 | GO:0005057 | receptor signaling protein activity(GO:0005057) |
0.5 | 1.6 | GO:0042134 | rRNA primary transcript binding(GO:0042134) |
0.5 | 6.5 | GO:0022841 | leak channel activity(GO:0022840) potassium ion leak channel activity(GO:0022841) narrow pore channel activity(GO:0022842) |
0.5 | 22.6 | GO:0048306 | calcium-dependent protein binding(GO:0048306) |
0.5 | 4.8 | GO:0042171 | lysophosphatidic acid acyltransferase activity(GO:0042171) |
0.5 | 2.7 | GO:0005272 | sodium channel activity(GO:0005272) |
0.5 | 1.1 | GO:0045118 | azole transporter activity(GO:0045118) azole transmembrane transporter activity(GO:1901474) |
0.5 | 0.5 | GO:0070883 | pre-miRNA binding(GO:0070883) |
0.5 | 5.3 | GO:0004526 | ribonuclease P activity(GO:0004526) |
0.5 | 0.5 | GO:0070051 | fibrinogen binding(GO:0070051) |
0.5 | 2.1 | GO:0016671 | oxidoreductase activity, acting on a sulfur group of donors, disulfide as acceptor(GO:0016671) |
0.5 | 1.0 | GO:0004367 | glycerol-3-phosphate dehydrogenase [NAD+] activity(GO:0004367) |
0.5 | 2.1 | GO:0004370 | glycerol kinase activity(GO:0004370) |
0.5 | 101.2 | GO:0003779 | actin binding(GO:0003779) |
0.5 | 4.6 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
0.5 | 3.1 | GO:0048018 | receptor agonist activity(GO:0048018) |
0.5 | 3.0 | GO:0005229 | intracellular calcium activated chloride channel activity(GO:0005229) |
0.5 | 3.6 | GO:0005041 | low-density lipoprotein receptor activity(GO:0005041) |
0.5 | 11.1 | GO:0019888 | protein phosphatase regulator activity(GO:0019888) |
0.5 | 1.0 | GO:0035612 | AP-2 adaptor complex binding(GO:0035612) |
0.5 | 2.0 | GO:0070579 | methylcytosine dioxygenase activity(GO:0070579) |
0.5 | 1.5 | GO:0004667 | prostaglandin-D synthase activity(GO:0004667) |
0.5 | 1.5 | GO:0070181 | small ribosomal subunit rRNA binding(GO:0070181) |
0.5 | 20.8 | GO:0015085 | calcium ion transmembrane transporter activity(GO:0015085) |
0.5 | 1.5 | GO:0032795 | heterotrimeric G-protein binding(GO:0032795) |
0.5 | 1.0 | GO:0017002 | activin-activated receptor activity(GO:0017002) |
0.5 | 6.4 | GO:0016312 | inositol bisphosphate phosphatase activity(GO:0016312) |
0.5 | 5.4 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
0.5 | 3.4 | GO:0050291 | sphingosine N-acyltransferase activity(GO:0050291) |
0.5 | 2.4 | GO:0015379 | potassium:chloride symporter activity(GO:0015379) potassium ion symporter activity(GO:0022820) |
0.5 | 7.7 | GO:0070412 | R-SMAD binding(GO:0070412) |
0.5 | 9.2 | GO:0046961 | proton-transporting ATPase activity, rotational mechanism(GO:0046961) |
0.5 | 4.3 | GO:0004774 | succinate-CoA ligase activity(GO:0004774) |
0.5 | 1.9 | GO:0004062 | aryl sulfotransferase activity(GO:0004062) |
0.5 | 1.0 | GO:0002134 | UTP binding(GO:0002134) pyrimidine ribonucleoside binding(GO:0032551) |
0.5 | 1.4 | GO:0001727 | lipid kinase activity(GO:0001727) |
0.5 | 1.9 | GO:0000268 | peroxisome targeting sequence binding(GO:0000268) |
0.5 | 1.9 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
0.5 | 6.1 | GO:0042923 | neuropeptide binding(GO:0042923) |
0.5 | 1.4 | GO:0016635 | oxidoreductase activity, acting on the CH-CH group of donors, quinone or related compound as acceptor(GO:0016635) |
0.5 | 1.4 | GO:0018479 | benzaldehyde dehydrogenase (NAD+) activity(GO:0018479) |
0.5 | 1.4 | GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity(GO:0004616) |
0.5 | 1.8 | GO:0019145 | aminobutyraldehyde dehydrogenase activity(GO:0019145) 4-trimethylammoniobutyraldehyde dehydrogenase activity(GO:0047105) |
0.5 | 1.4 | GO:0015377 | cation:chloride symporter activity(GO:0015377) |
0.5 | 3.2 | GO:0016670 | oxidoreductase activity, acting on a sulfur group of donors, oxygen as acceptor(GO:0016670) |
0.5 | 0.9 | GO:0032142 | single guanine insertion binding(GO:0032142) |
0.5 | 0.9 | GO:0043560 | insulin receptor substrate binding(GO:0043560) |
0.5 | 2.7 | GO:0008420 | CTD phosphatase activity(GO:0008420) |
0.5 | 2.3 | GO:0032184 | SUMO polymer binding(GO:0032184) |
0.5 | 1.8 | GO:0004095 | carnitine O-palmitoyltransferase activity(GO:0004095) |
0.5 | 4.5 | GO:0016717 | oxidoreductase activity, acting on paired donors, with oxidation of a pair of donors resulting in the reduction of molecular oxygen to two molecules of water(GO:0016717) |
0.5 | 7.2 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
0.4 | 1.8 | GO:0004558 | alpha-1,4-glucosidase activity(GO:0004558) |
0.4 | 0.4 | GO:0005283 | sodium:amino acid symporter activity(GO:0005283) |
0.4 | 3.1 | GO:0031996 | thioesterase binding(GO:0031996) |
0.4 | 0.9 | GO:0005227 | calcium activated cation channel activity(GO:0005227) |
0.4 | 0.4 | GO:0048408 | epidermal growth factor binding(GO:0048408) |
0.4 | 2.2 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
0.4 | 0.9 | GO:0003988 | acetyl-CoA C-acyltransferase activity(GO:0003988) |
0.4 | 0.9 | GO:0097602 | cullin family protein binding(GO:0097602) |
0.4 | 1.3 | GO:0030274 | LIM domain binding(GO:0030274) |
0.4 | 0.4 | GO:0043175 | RNA polymerase core enzyme binding(GO:0043175) |
0.4 | 0.9 | GO:0048531 | beta-1,3-galactosyltransferase activity(GO:0048531) |
0.4 | 11.7 | GO:0004722 | protein serine/threonine phosphatase activity(GO:0004722) |
0.4 | 0.4 | GO:0005167 | neurotrophin TRK receptor binding(GO:0005167) |
0.4 | 8.6 | GO:0050699 | WW domain binding(GO:0050699) |
0.4 | 9.9 | GO:0005080 | protein kinase C binding(GO:0005080) |
0.4 | 1.3 | GO:0003865 | 3-oxo-5-alpha-steroid 4-dehydrogenase activity(GO:0003865) cholestenone 5-alpha-reductase activity(GO:0047751) |
0.4 | 12.4 | GO:0008138 | protein tyrosine/serine/threonine phosphatase activity(GO:0008138) |
0.4 | 11.5 | GO:0031624 | ubiquitin conjugating enzyme binding(GO:0031624) |
0.4 | 3.8 | GO:0015301 | anion:anion antiporter activity(GO:0015301) |
0.4 | 1.3 | GO:0000340 | RNA 7-methylguanosine cap binding(GO:0000340) |
0.4 | 1.7 | GO:0052717 | N-cyclopropylmelamine deaminase activity(GO:0034547) N-cyclopropylammeline deaminase activity(GO:0034548) N-cyclopropylammelide alkylamino hydrolase activity(GO:0034549) 2,5-diamino-6-ribitylamino-4(3H)-pyrimidinone 5'-phosphate deaminase activity(GO:0043723) tRNA-specific adenosine-37 deaminase activity(GO:0043829) archaeal-specific GTP cyclohydrolase activity(GO:0044682) tRNA-specific adenosine-34 deaminase activity(GO:0052717) |
0.4 | 4.2 | GO:0070064 | proline-rich region binding(GO:0070064) |
0.4 | 0.4 | GO:0016941 | natriuretic peptide receptor activity(GO:0016941) |
0.4 | 5.0 | GO:0046703 | natural killer cell lectin-like receptor binding(GO:0046703) |
0.4 | 1.2 | GO:0061133 | endopeptidase activator activity(GO:0061133) |
0.4 | 1.7 | GO:0016530 | metallochaperone activity(GO:0016530) |
0.4 | 0.8 | GO:0004946 | bombesin receptor activity(GO:0004946) |
0.4 | 1.6 | GO:1904288 | BAT3 complex binding(GO:1904288) |
0.4 | 0.8 | GO:0070097 | delta-catenin binding(GO:0070097) |
0.4 | 2.4 | GO:0070991 | medium-chain-acyl-CoA dehydrogenase activity(GO:0070991) |
0.4 | 1.2 | GO:1904680 | peptide-transporting ATPase activity(GO:0015440) peptide transmembrane transporter activity(GO:1904680) |
0.4 | 2.4 | GO:0008508 | bile acid:sodium symporter activity(GO:0008508) |
0.4 | 1.2 | GO:0019166 | trans-2-enoyl-CoA reductase (NADPH) activity(GO:0019166) |
0.4 | 0.8 | GO:0019961 | interferon binding(GO:0019961) |
0.4 | 1.6 | GO:0004565 | beta-galactosidase activity(GO:0004565) |
0.4 | 1.2 | GO:0005483 | soluble NSF attachment protein activity(GO:0005483) |
0.4 | 13.1 | GO:0050840 | extracellular matrix binding(GO:0050840) |
0.4 | 1.2 | GO:0042289 | MHC class II protein binding(GO:0042289) |
0.4 | 1.6 | GO:0034584 | piRNA binding(GO:0034584) |
0.4 | 5.0 | GO:0010485 | H4 histone acetyltransferase activity(GO:0010485) |
0.4 | 1.5 | GO:0003956 | NAD(P)+-protein-arginine ADP-ribosyltransferase activity(GO:0003956) |
0.4 | 0.8 | GO:0016774 | phosphotransferase activity, carboxyl group as acceptor(GO:0016774) |
0.4 | 1.5 | GO:0008486 | diphosphoinositol-polyphosphate diphosphatase activity(GO:0008486) |
0.4 | 1.1 | GO:0015143 | urate transmembrane transporter activity(GO:0015143) salt transmembrane transporter activity(GO:1901702) |
0.4 | 3.0 | GO:0043531 | ADP binding(GO:0043531) |
0.4 | 2.3 | GO:0004982 | N-formyl peptide receptor activity(GO:0004982) |
0.4 | 15.1 | GO:0019003 | GDP binding(GO:0019003) |
0.4 | 1.5 | GO:0005092 | GDP-dissociation inhibitor activity(GO:0005092) |
0.4 | 2.2 | GO:0005000 | vasopressin receptor activity(GO:0005000) |
0.4 | 1.9 | GO:0032050 | clathrin heavy chain binding(GO:0032050) |
0.4 | 0.4 | GO:0016208 | AMP binding(GO:0016208) |
0.4 | 1.5 | GO:0004591 | oxoglutarate dehydrogenase (succinyl-transferring) activity(GO:0004591) |
0.4 | 2.2 | GO:0035198 | miRNA binding(GO:0035198) |
0.4 | 0.7 | GO:0005157 | macrophage colony-stimulating factor receptor binding(GO:0005157) |
0.4 | 0.4 | GO:0016775 | phosphotransferase activity, nitrogenous group as acceptor(GO:0016775) |
0.4 | 3.6 | GO:0090599 | alpha-glucosidase activity(GO:0090599) |
0.4 | 13.8 | GO:0042562 | hormone binding(GO:0042562) |
0.4 | 3.6 | GO:0001618 | virus receptor activity(GO:0001618) |
0.4 | 6.9 | GO:0015347 | sodium-independent organic anion transmembrane transporter activity(GO:0015347) |
0.4 | 1.8 | GO:0052724 | inositol hexakisphosphate kinase activity(GO:0000828) inositol hexakisphosphate 5-kinase activity(GO:0000832) inositol hexakisphosphate 1-kinase activity(GO:0052723) inositol hexakisphosphate 3-kinase activity(GO:0052724) |
0.4 | 1.1 | GO:0045505 | dynein intermediate chain binding(GO:0045505) |
0.4 | 1.1 | GO:0002054 | nucleobase binding(GO:0002054) |
0.4 | 2.5 | GO:0044183 | protein binding involved in protein folding(GO:0044183) |
0.4 | 9.6 | GO:0017137 | Rab GTPase binding(GO:0017137) |
0.4 | 1.1 | GO:0004300 | enoyl-CoA hydratase activity(GO:0004300) |
0.4 | 2.5 | GO:0015922 | aspartate oxidase activity(GO:0015922) |
0.4 | 2.1 | GO:0035254 | glutamate receptor binding(GO:0035254) |
0.4 | 6.0 | GO:0032947 | protein complex scaffold(GO:0032947) |
0.3 | 12.9 | GO:0034483 | heparan sulfate sulfotransferase activity(GO:0034483) |
0.3 | 1.0 | GO:0030345 | extracellular matrix structural constituent conferring compression resistance(GO:0030021) structural constituent of tooth enamel(GO:0030345) |
0.3 | 0.3 | GO:0061629 | RNA polymerase II sequence-specific DNA binding transcription factor binding(GO:0061629) |
0.3 | 0.3 | GO:0023029 | MHC class Ib protein binding(GO:0023029) |
0.3 | 0.3 | GO:0032557 | pyrimidine ribonucleotide binding(GO:0032557) |
0.3 | 0.3 | GO:0003933 | GTP cyclohydrolase activity(GO:0003933) |
0.3 | 22.8 | GO:0019902 | phosphatase binding(GO:0019902) |
0.3 | 1.0 | GO:0000403 | Y-form DNA binding(GO:0000403) |
0.3 | 0.7 | GO:0004571 | mannosyl-oligosaccharide 1,2-alpha-mannosidase activity(GO:0004571) |
0.3 | 3.3 | GO:0004176 | ATP-dependent peptidase activity(GO:0004176) |
0.3 | 3.3 | GO:0050308 | sugar-phosphatase activity(GO:0050308) |
0.3 | 2.0 | GO:0008479 | queuine tRNA-ribosyltransferase activity(GO:0008479) |
0.3 | 0.7 | GO:0034191 | apolipoprotein A-I receptor binding(GO:0034191) |
0.3 | 0.7 | GO:0033265 | choline binding(GO:0033265) |
0.3 | 0.3 | GO:0016508 | long-chain-enoyl-CoA hydratase activity(GO:0016508) |
0.3 | 0.6 | GO:0034648 | histone demethylase activity (H3-dimethyl-K4 specific)(GO:0034648) |
0.3 | 1.9 | GO:0005225 | volume-sensitive anion channel activity(GO:0005225) |
0.3 | 0.6 | GO:0004999 | vasoactive intestinal polypeptide receptor activity(GO:0004999) |
0.3 | 0.6 | GO:0045504 | dynein heavy chain binding(GO:0045504) |
0.3 | 3.8 | GO:0003756 | protein disulfide isomerase activity(GO:0003756) intramolecular oxidoreductase activity, transposing S-S bonds(GO:0016864) |
0.3 | 3.8 | GO:0015026 | coreceptor activity(GO:0015026) |
0.3 | 2.5 | GO:0015035 | protein disulfide oxidoreductase activity(GO:0015035) |
0.3 | 0.9 | GO:0004731 | purine-nucleoside phosphorylase activity(GO:0004731) |
0.3 | 0.6 | GO:0031750 | D3 dopamine receptor binding(GO:0031750) |
0.3 | 3.4 | GO:0035259 | glucocorticoid receptor binding(GO:0035259) |
0.3 | 0.9 | GO:0036033 | mediator complex binding(GO:0036033) |
0.3 | 1.5 | GO:0051959 | dynein light intermediate chain binding(GO:0051959) |
0.3 | 0.6 | GO:0070411 | I-SMAD binding(GO:0070411) |
0.3 | 4.8 | GO:0051059 | NF-kappaB binding(GO:0051059) |
0.3 | 0.9 | GO:1990189 | peptide-serine-N-acetyltransferase activity(GO:1990189) peptide-glutamate-N-acetyltransferase activity(GO:1990190) |
0.3 | 0.9 | GO:0005138 | interleukin-6 receptor binding(GO:0005138) |
0.3 | 59.2 | GO:0005525 | GTP binding(GO:0005525) |
0.3 | 0.3 | GO:0004065 | arylsulfatase activity(GO:0004065) |
0.3 | 89.6 | GO:0004842 | ubiquitin-protein transferase activity(GO:0004842) |
0.3 | 1.5 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
0.3 | 2.0 | GO:0016679 | oxidoreductase activity, acting on diphenols and related substances as donors(GO:0016679) |
0.3 | 0.6 | GO:0070548 | L-glutamine aminotransferase activity(GO:0070548) |
0.3 | 3.5 | GO:0030881 | beta-2-microglobulin binding(GO:0030881) |
0.3 | 2.3 | GO:0050649 | testosterone 6-beta-hydroxylase activity(GO:0050649) |
0.3 | 0.3 | GO:0052658 | inositol-1,4,5-trisphosphate 5-phosphatase activity(GO:0052658) |
0.3 | 1.4 | GO:0050750 | low-density lipoprotein particle receptor binding(GO:0050750) |
0.3 | 1.4 | GO:0031419 | cobalamin binding(GO:0031419) |
0.3 | 0.6 | GO:0000104 | succinate dehydrogenase activity(GO:0000104) |
0.3 | 0.8 | GO:0048045 | 4-hydroxybenzoate octaprenyltransferase activity(GO:0008412) protoheme IX farnesyltransferase activity(GO:0008495) (S)-2,3-di-O-geranylgeranylglyceryl phosphate synthase activity(GO:0043888) cadaverine aminopropyltransferase activity(GO:0043918) agmatine aminopropyltransferase activity(GO:0043919) 1,4-dihydroxy-2-naphthoate octaprenyltransferase activity(GO:0046428) trans-pentaprenyltranstransferase activity(GO:0048045) ATP dimethylallyltransferase activity(GO:0052622) ADP dimethylallyltransferase activity(GO:0052623) |
0.3 | 0.3 | GO:0004611 | phosphoenolpyruvate carboxykinase activity(GO:0004611) |
0.3 | 1.1 | GO:0004415 | hyalurononglucosaminidase activity(GO:0004415) |
0.3 | 0.3 | GO:0004676 | 3-phosphoinositide-dependent protein kinase activity(GO:0004676) |
0.3 | 97.1 | GO:0005509 | calcium ion binding(GO:0005509) |
0.3 | 1.9 | GO:0036310 | annealing helicase activity(GO:0036310) |
0.3 | 0.8 | GO:0003986 | acetyl-CoA hydrolase activity(GO:0003986) |
0.3 | 0.8 | GO:0035197 | siRNA binding(GO:0035197) |
0.3 | 0.8 | GO:0042284 | sphingolipid delta-4 desaturase activity(GO:0042284) |
0.3 | 3.8 | GO:0016863 | intramolecular oxidoreductase activity, transposing C=C bonds(GO:0016863) |
0.3 | 0.5 | GO:0005346 | adenine nucleotide transmembrane transporter activity(GO:0000295) purine ribonucleotide transmembrane transporter activity(GO:0005346) purine nucleotide transmembrane transporter activity(GO:0015216) |
0.3 | 0.8 | GO:0004096 | catalase activity(GO:0004096) |
0.3 | 1.1 | GO:0046975 | histone methyltransferase activity (H3-K36 specific)(GO:0046975) |
0.3 | 4.4 | GO:0032452 | histone demethylase activity(GO:0032452) |
0.3 | 0.5 | GO:0008035 | high-density lipoprotein particle binding(GO:0008035) |
0.3 | 1.0 | GO:0004738 | pyruvate dehydrogenase activity(GO:0004738) pyruvate dehydrogenase [NAD(P)+] activity(GO:0034603) pyruvate dehydrogenase (NAD+) activity(GO:0034604) |
0.3 | 1.3 | GO:0005391 | sodium:potassium-exchanging ATPase activity(GO:0005391) |
0.3 | 1.0 | GO:0061505 | DNA topoisomerase type II (ATP-hydrolyzing) activity(GO:0003918) DNA topoisomerase II activity(GO:0061505) |
0.3 | 0.5 | GO:0032357 | oxidized DNA binding(GO:0032356) oxidized purine DNA binding(GO:0032357) |
0.3 | 1.5 | GO:0030296 | protein tyrosine kinase activator activity(GO:0030296) |
0.3 | 0.5 | GO:0005315 | inorganic phosphate transmembrane transporter activity(GO:0005315) |
0.3 | 1.0 | GO:0000386 | second spliceosomal transesterification activity(GO:0000386) |
0.2 | 1.0 | GO:0047023 | androsterone dehydrogenase activity(GO:0047023) |
0.2 | 1.5 | GO:0016714 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced pteridine as one donor, and incorporation of one atom of oxygen(GO:0016714) |
0.2 | 0.5 | GO:0004935 | adrenergic receptor activity(GO:0004935) |
0.2 | 11.5 | GO:0046921 | UDP-glucose:glycoprotein glucosyltransferase activity(GO:0003980) dolichyl-phosphate-glucose-glycolipid alpha-glucosyltransferase activity(GO:0004583) O antigen polymerase activity(GO:0008755) lipopolysaccharide-1,6-galactosyltransferase activity(GO:0008921) cellulose synthase activity(GO:0016759) 9-phenanthrol UDP-glucuronosyltransferase activity(GO:0018715) 1-phenanthrol glycosyltransferase activity(GO:0018716) 9-phenanthrol glycosyltransferase activity(GO:0018717) 1,2-dihydroxy-phenanthrene glycosyltransferase activity(GO:0018718) phenanthrol glycosyltransferase activity(GO:0019112) alpha-1,2-galactosyltransferase activity(GO:0031278) dolichyl pyrophosphate Man7GlcNAc2 alpha-1,3-glucosyltransferase activity(GO:0033556) endogalactosaminidase activity(GO:0033931) lipopolysaccharide-1,5-galactosyltransferase activity(GO:0035496) dolichyl pyrophosphate Glc1Man9GlcNAc2 alpha-1,3-glucosyltransferase activity(GO:0042283) inositol phosphoceramide synthase activity(GO:0045140) alpha-(1->3)-fucosyltransferase activity(GO:0046920) alpha-(1->6)-fucosyltransferase activity(GO:0046921) indole-3-butyrate beta-glucosyltransferase activity(GO:0052638) salicylic acid glucosyltransferase (ester-forming) activity(GO:0052639) salicylic acid glucosyltransferase (glucoside-forming) activity(GO:0052640) benzoic acid glucosyltransferase activity(GO:0052641) chondroitin hydrolase activity(GO:0052757) dolichyl-pyrophosphate Man7GlcNAc2 alpha-1,6-mannosyltransferase activity(GO:0052824) cytokinin 9-beta-glucosyltransferase activity(GO:0080062) |
0.2 | 5.1 | GO:0050136 | NADH dehydrogenase (ubiquinone) activity(GO:0008137) NADH dehydrogenase (quinone) activity(GO:0050136) |
0.2 | 1.0 | GO:0042979 | ornithine decarboxylase regulator activity(GO:0042979) |
0.2 | 1.2 | GO:0004031 | aldehyde oxidase activity(GO:0004031) oxidoreductase activity, acting on the aldehyde or oxo group of donors, oxygen as acceptor(GO:0016623) |
0.2 | 1.2 | GO:0004957 | prostaglandin E receptor activity(GO:0004957) |
0.2 | 12.5 | GO:0008395 | steroid hydroxylase activity(GO:0008395) |
0.2 | 1.6 | GO:0036442 | hydrogen-exporting ATPase activity(GO:0036442) |
0.2 | 2.1 | GO:0016783 | sulfurtransferase activity(GO:0016783) |
0.2 | 2.0 | GO:0045236 | CXCR chemokine receptor binding(GO:0045236) |
0.2 | 0.2 | GO:0031628 | opioid receptor binding(GO:0031628) |
0.2 | 0.5 | GO:0042281 | dolichyl pyrophosphate Man9GlcNAc2 alpha-1,3-glucosyltransferase activity(GO:0042281) |
0.2 | 3.1 | GO:0016805 | dipeptidase activity(GO:0016805) |
0.2 | 0.9 | GO:0008808 | cardiolipin synthase activity(GO:0008808) phosphatidyltransferase activity(GO:0030572) |
0.2 | 0.7 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
0.2 | 10.0 | GO:0043773 | UDP-N-acetylmuramoylalanyl-D-glutamyl-2,6-diaminopimelate-D-alanyl-D-alanine ligase activity(GO:0008766) ribosomal S6-glutamic acid ligase activity(GO:0018169) coenzyme F420-0 gamma-glutamyl ligase activity(GO:0043773) coenzyme F420-2 alpha-glutamyl ligase activity(GO:0043774) protein-glycine ligase activity(GO:0070735) protein-glycine ligase activity, initiating(GO:0070736) protein-glycine ligase activity, elongating(GO:0070737) tubulin-glycine ligase activity(GO:0070738) |
0.2 | 0.7 | GO:0005547 | phosphatidylinositol-3,4,5-trisphosphate binding(GO:0005547) |
0.2 | 0.4 | GO:0097371 | MDM2/MDM4 family protein binding(GO:0097371) |
0.2 | 27.9 | GO:0003729 | mRNA binding(GO:0003729) |
0.2 | 0.2 | GO:0010857 | calcium-dependent protein kinase activity(GO:0010857) |
0.2 | 0.4 | GO:0015928 | fucosidase activity(GO:0015928) |
0.2 | 1.1 | GO:0004908 | interleukin-1 receptor activity(GO:0004908) |
0.2 | 0.6 | GO:0050833 | pyruvate transmembrane transporter activity(GO:0050833) |
0.2 | 0.8 | GO:0042809 | vitamin D receptor binding(GO:0042809) |
0.2 | 1.2 | GO:0031545 | peptidyl-proline 4-dioxygenase activity(GO:0031545) |
0.2 | 0.6 | GO:0051377 | mannose-ethanolamine phosphotransferase activity(GO:0051377) |
0.2 | 0.2 | GO:0048019 | receptor antagonist activity(GO:0048019) |
0.2 | 4.5 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
0.2 | 1.0 | GO:0015450 | P-P-bond-hydrolysis-driven protein transmembrane transporter activity(GO:0015450) |
0.2 | 1.0 | GO:0004457 | lactate dehydrogenase activity(GO:0004457) |
0.2 | 0.4 | GO:0097016 | L27 domain binding(GO:0097016) |
0.2 | 2.3 | GO:0004029 | aldehyde dehydrogenase (NAD) activity(GO:0004029) |
0.2 | 0.4 | GO:0050656 | 3'-phosphoadenosine 5'-phosphosulfate binding(GO:0050656) |
0.2 | 0.4 | GO:1901338 | catecholamine binding(GO:1901338) |
0.2 | 0.6 | GO:0035515 | oxidative RNA demethylase activity(GO:0035515) |
0.2 | 0.6 | GO:0015211 | purine nucleoside transmembrane transporter activity(GO:0015211) |
0.2 | 1.8 | GO:0032266 | phosphatidylinositol-3-phosphate binding(GO:0032266) |
0.2 | 1.6 | GO:0008378 | galactosyltransferase activity(GO:0008378) |
0.2 | 0.9 | GO:0036402 | proteasome-activating ATPase activity(GO:0036402) |
0.2 | 0.4 | GO:0046404 | ATP-dependent polydeoxyribonucleotide 5'-hydroxyl-kinase activity(GO:0046404) polydeoxyribonucleotide kinase activity(GO:0051733) |
0.2 | 1.4 | GO:0005351 | sugar:proton symporter activity(GO:0005351) |
0.2 | 0.5 | GO:0008260 | 3-oxoacid CoA-transferase activity(GO:0008260) |
0.2 | 2.4 | GO:0008376 | acetylgalactosaminyltransferase activity(GO:0008376) |
0.2 | 0.7 | GO:0051010 | microtubule plus-end binding(GO:0051010) |
0.2 | 0.8 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
0.2 | 2.3 | GO:0030594 | neurotransmitter receptor activity(GO:0030594) |
0.2 | 0.5 | GO:0030742 | GTP-dependent protein binding(GO:0030742) |
0.2 | 0.5 | GO:0031727 | CCR2 chemokine receptor binding(GO:0031727) |
0.2 | 0.5 | GO:0015319 | sodium:inorganic phosphate symporter activity(GO:0015319) |
0.2 | 0.8 | GO:0016500 | protein-hormone receptor activity(GO:0016500) |
0.2 | 2.5 | GO:0015149 | hexose transmembrane transporter activity(GO:0015149) |
0.2 | 0.3 | GO:0004699 | calcium-independent protein kinase C activity(GO:0004699) |
0.2 | 4.8 | GO:0033038 | bitter taste receptor activity(GO:0033038) |
0.1 | 0.4 | GO:0031435 | mitogen-activated protein kinase kinase kinase binding(GO:0031435) |
0.1 | 0.6 | GO:0030695 | GTPase regulator activity(GO:0030695) |
0.1 | 0.6 | GO:0042015 | interleukin-20 binding(GO:0042015) |
0.1 | 2.3 | GO:0008028 | monocarboxylic acid transmembrane transporter activity(GO:0008028) |
0.1 | 6.3 | GO:0016820 | hydrolase activity, acting on acid anhydrides, catalyzing transmembrane movement of substances(GO:0016820) |
0.1 | 9.5 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
0.1 | 0.4 | GO:0016715 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen(GO:0016715) |
0.1 | 0.4 | GO:0016840 | carbon-nitrogen lyase activity(GO:0016840) |
0.1 | 0.6 | GO:0070273 | phosphatidylinositol-4-phosphate binding(GO:0070273) |
0.1 | 1.2 | GO:0098599 | palmitoyl-(protein) hydrolase activity(GO:0008474) palmitoyl hydrolase activity(GO:0098599) |
0.1 | 0.4 | GO:0071987 | WD40-repeat domain binding(GO:0071987) |
0.1 | 0.7 | GO:0030371 | translation repressor activity(GO:0030371) |
0.1 | 1.2 | GO:0008308 | voltage-gated anion channel activity(GO:0008308) |
0.1 | 0.4 | GO:0043515 | kinetochore binding(GO:0043515) |
0.1 | 1.0 | GO:0051861 | glycolipid binding(GO:0051861) |
0.1 | 0.3 | GO:0004802 | transketolase activity(GO:0004802) |
0.1 | 0.8 | GO:0004534 | 5'-3' exoribonuclease activity(GO:0004534) |
0.1 | 2.5 | GO:0070003 | threonine-type endopeptidase activity(GO:0004298) threonine-type peptidase activity(GO:0070003) |
0.1 | 3.4 | GO:0030165 | PDZ domain binding(GO:0030165) |
0.1 | 0.4 | GO:0016838 | carbon-oxygen lyase activity, acting on phosphates(GO:0016838) |
0.1 | 0.2 | GO:0019776 | Atg8 ligase activity(GO:0019776) |
0.1 | 0.5 | GO:0102345 | 3-hydroxy-behenoyl-CoA dehydratase activity(GO:0102344) 3-hydroxy-lignoceroyl-CoA dehydratase activity(GO:0102345) |
0.1 | 0.1 | GO:0004677 | DNA-dependent protein kinase activity(GO:0004677) |
0.1 | 0.7 | GO:0016846 | carbon-sulfur lyase activity(GO:0016846) |
0.1 | 0.1 | GO:0004661 | protein geranylgeranyltransferase activity(GO:0004661) |
0.1 | 5.6 | GO:0035091 | phosphatidylinositol binding(GO:0035091) |
0.1 | 3.5 | GO:0005132 | type I interferon receptor binding(GO:0005132) |
0.1 | 1.0 | GO:0004535 | poly(A)-specific ribonuclease activity(GO:0004535) |
0.1 | 0.1 | GO:0051119 | sugar transmembrane transporter activity(GO:0051119) |
0.1 | 1.4 | GO:0042800 | histone methyltransferase activity (H3-K4 specific)(GO:0042800) |
0.1 | 0.1 | GO:0050252 | retinol O-fatty-acyltransferase activity(GO:0050252) |
0.1 | 0.1 | GO:0003954 | NADH dehydrogenase activity(GO:0003954) |
0.1 | 0.5 | GO:0004000 | adenosine deaminase activity(GO:0004000) |
0.1 | 0.3 | GO:0030976 | thiamine pyrophosphate binding(GO:0030976) |
0.1 | 1.7 | GO:0005186 | pheromone activity(GO:0005186) |
0.1 | 0.8 | GO:0016881 | acid-amino acid ligase activity(GO:0016881) |
0.1 | 0.3 | GO:0019808 | polyamine binding(GO:0019808) |
0.1 | 0.3 | GO:0036041 | long-chain fatty acid binding(GO:0036041) |
0.1 | 11.6 | GO:0015631 | tubulin binding(GO:0015631) |
0.1 | 0.1 | GO:0008391 | arachidonic acid monooxygenase activity(GO:0008391) |
0.1 | 0.4 | GO:0048365 | Rac GTPase binding(GO:0048365) |
0.1 | 0.3 | GO:0090482 | vitamin transmembrane transporter activity(GO:0090482) |
0.1 | 1.1 | GO:0016709 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen(GO:0016709) |
0.1 | 0.1 | GO:0004741 | [pyruvate dehydrogenase (lipoamide)] phosphatase activity(GO:0004741) |
0.1 | 3.1 | GO:0015923 | mannosidase activity(GO:0015923) |
0.1 | 0.7 | GO:0008188 | neuropeptide receptor activity(GO:0008188) |
0.1 | 0.3 | GO:0016019 | N-acetylmuramoyl-L-alanine amidase activity(GO:0008745) peptidoglycan receptor activity(GO:0016019) |
0.1 | 3.8 | GO:0005085 | guanyl-nucleotide exchange factor activity(GO:0005085) |
0.1 | 0.7 | GO:0070402 | NADPH binding(GO:0070402) |
0.1 | 0.2 | GO:0070697 | activin receptor binding(GO:0070697) |
0.1 | 0.9 | GO:0051879 | Hsp90 protein binding(GO:0051879) |
0.1 | 0.3 | GO:0000014 | single-stranded DNA endodeoxyribonuclease activity(GO:0000014) |
0.1 | 1.1 | GO:0016769 | transferase activity, transferring nitrogenous groups(GO:0016769) |
0.1 | 0.6 | GO:0017147 | Wnt-protein binding(GO:0017147) |
0.1 | 1.0 | GO:0001594 | trace-amine receptor activity(GO:0001594) |
0.1 | 0.2 | GO:0043199 | sulfate binding(GO:0043199) |
0.1 | 0.1 | GO:0098518 | polynucleotide phosphatase activity(GO:0098518) |
0.1 | 0.3 | GO:0051428 | peptide hormone receptor binding(GO:0051428) |
0.1 | 0.1 | GO:0030144 | alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase activity(GO:0030144) |
0.1 | 0.1 | GO:0042608 | T cell receptor binding(GO:0042608) |
0.1 | 0.1 | GO:0005005 | transmembrane-ephrin receptor activity(GO:0005005) |
0.1 | 0.2 | GO:0005343 | organic acid:sodium symporter activity(GO:0005343) |
0.1 | 0.1 | GO:0045134 | uridine-diphosphatase activity(GO:0045134) |
0.0 | 1.2 | GO:0030374 | ligand-dependent nuclear receptor transcription coactivator activity(GO:0030374) |
0.0 | 0.1 | GO:0005148 | prolactin receptor binding(GO:0005148) |
0.0 | 0.1 | GO:0031726 | CCR1 chemokine receptor binding(GO:0031726) |
0.0 | 0.0 | GO:0016937 | short-branched-chain-acyl-CoA dehydrogenase activity(GO:0016937) |
0.0 | 0.5 | GO:0034792 | sulfonate dioxygenase activity(GO:0000907) 2,4-dichlorophenoxyacetate alpha-ketoglutarate dioxygenase activity(GO:0018602) hypophosphite dioxygenase activity(GO:0034792) gibberellin 2-beta-dioxygenase activity(GO:0045543) C-19 gibberellin 2-beta-dioxygenase activity(GO:0052634) C-20 gibberellin 2-beta-dioxygenase activity(GO:0052635) |
0.0 | 0.1 | GO:0008484 | sulfuric ester hydrolase activity(GO:0008484) |
0.0 | 0.0 | GO:0043398 | HLH domain binding(GO:0043398) |
0.0 | 0.0 | GO:0004030 | aldehyde dehydrogenase [NAD(P)+] activity(GO:0004030) |
0.0 | 0.0 | GO:0003846 | 2-acylglycerol O-acyltransferase activity(GO:0003846) |
0.0 | 0.1 | GO:0004596 | peptide alpha-N-acetyltransferase activity(GO:0004596) |
0.0 | 0.0 | GO:0019187 | beta-1,4-mannosyltransferase activity(GO:0019187) |
0.0 | 10.0 | GO:0004930 | G-protein coupled receptor activity(GO:0004930) |
0.0 | 0.5 | GO:0005035 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
0.0 | 0.1 | GO:1901611 | phosphatidylglycerol binding(GO:1901611) |
0.0 | 0.0 | GO:0015193 | L-proline transmembrane transporter activity(GO:0015193) |
0.0 | 0.5 | GO:0019706 | protein-cysteine S-palmitoyltransferase activity(GO:0019706) |
0.0 | 6.5 | GO:0005549 | odorant binding(GO:0005549) |
0.0 | 0.1 | GO:0016303 | 1-phosphatidylinositol-3-kinase activity(GO:0016303) |
0.0 | 0.2 | GO:0003924 | GTPase activity(GO:0003924) |
0.0 | 0.3 | GO:0008009 | chemokine activity(GO:0008009) |
0.0 | 0.0 | GO:0042165 | neurotransmitter binding(GO:0042165) |
0.0 | 0.1 | GO:0005254 | chloride channel activity(GO:0005254) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.9 | 42.8 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
2.6 | 74.8 | PID REELIN PATHWAY | Reelin signaling pathway |
1.8 | 38.1 | PID VEGFR1 PATHWAY | VEGFR1 specific signals |
1.7 | 3.4 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
1.7 | 46.5 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
1.7 | 6.6 | ST G ALPHA S PATHWAY | G alpha s Pathway |
1.6 | 37.2 | ST GRANULE CELL SURVIVAL PATHWAY | Granule Cell Survival Pathway is a specific case of more general PAC1 Receptor Pathway. |
1.6 | 9.5 | ST G ALPHA I PATHWAY | G alpha i Pathway |
1.4 | 21.2 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
1.4 | 48.2 | PID TRKR PATHWAY | Neurotrophic factor-mediated Trk receptor signaling |
1.4 | 36.8 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
1.3 | 40.4 | PID HDAC CLASSII PATHWAY | Signaling events mediated by HDAC Class II |
1.3 | 15.4 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
1.3 | 7.7 | ST STAT3 PATHWAY | STAT3 Pathway |
1.3 | 45.2 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
1.2 | 15.6 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
1.2 | 28.9 | PID EPHB FWD PATHWAY | EPHB forward signaling |
1.1 | 51.5 | PID AR PATHWAY | Coregulation of Androgen receptor activity |
1.1 | 1.1 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
1.1 | 19.2 | PID INSULIN PATHWAY | Insulin Pathway |
1.1 | 14.3 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
1.1 | 9.6 | ST DIFFERENTIATION PATHWAY IN PC12 CELLS | Differentiation Pathway in PC12 Cells; this is a specific case of PAC1 Receptor Pathway. |
1.0 | 34.1 | ST T CELL SIGNAL TRANSDUCTION | T Cell Signal Transduction |
1.0 | 20.4 | PID EPHA FWDPATHWAY | EPHA forward signaling |
1.0 | 13.0 | SIG CD40PATHWAYMAP | Genes related to CD40 signaling |
1.0 | 15.0 | ST JNK MAPK PATHWAY | JNK MAPK Pathway |
1.0 | 17.9 | ST MYOCYTE AD PATHWAY | Myocyte Adrenergic Pathway is a specific case of the generalized Adrenergic Pathway. |
1.0 | 1.9 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
1.0 | 10.6 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
0.9 | 17.1 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
0.9 | 12.1 | ST GA13 PATHWAY | G alpha 13 Pathway |
0.9 | 10.1 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
0.9 | 8.3 | PID ER NONGENOMIC PATHWAY | Plasma membrane estrogen receptor signaling |
0.9 | 26.3 | PID CDC42 PATHWAY | CDC42 signaling events |
0.9 | 31.0 | PID LKB1 PATHWAY | LKB1 signaling events |
0.9 | 19.8 | PID TCR CALCIUM PATHWAY | Calcium signaling in the CD4+ TCR pathway |
0.8 | 13.5 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
0.8 | 10.6 | PID RAC1 REG PATHWAY | Regulation of RAC1 activity |
0.8 | 9.4 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
0.8 | 5.3 | PID NECTIN PATHWAY | Nectin adhesion pathway |
0.7 | 12.7 | PID SHP2 PATHWAY | SHP2 signaling |
0.7 | 16.1 | PID ARF6 TRAFFICKING PATHWAY | Arf6 trafficking events |
0.7 | 1.4 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
0.7 | 2.7 | PID TRAIL PATHWAY | TRAIL signaling pathway |
0.7 | 4.7 | PID CD40 PATHWAY | CD40/CD40L signaling |
0.7 | 17.0 | PID RHOA REG PATHWAY | Regulation of RhoA activity |
0.6 | 3.8 | PID PI3KCI AKT PATHWAY | Class I PI3K signaling events mediated by Akt |
0.6 | 9.7 | PID CD8 TCR PATHWAY | TCR signaling in naïve CD8+ T cells |
0.6 | 10.2 | PID INTEGRIN A4B1 PATHWAY | Alpha4 beta1 integrin signaling events |
0.6 | 24.4 | PID NOTCH PATHWAY | Notch signaling pathway |
0.6 | 1.8 | SIG IL4RECEPTOR IN B LYPHOCYTES | Genes related to IL4 rceptor signaling in B lymphocytes |
0.6 | 8.7 | PID FAS PATHWAY | FAS (CD95) signaling pathway |
0.6 | 4.6 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
0.6 | 8.6 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
0.5 | 9.2 | PID KIT PATHWAY | Signaling events mediated by Stem cell factor receptor (c-Kit) |
0.5 | 4.7 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
0.5 | 3.1 | PID CERAMIDE PATHWAY | Ceramide signaling pathway |
0.5 | 15.4 | PID PDGFRB PATHWAY | PDGFR-beta signaling pathway |
0.5 | 3.4 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
0.5 | 4.8 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
0.5 | 4.2 | PID ARF6 PATHWAY | Arf6 signaling events |
0.5 | 1.8 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
0.5 | 5.0 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
0.4 | 1.7 | ST GA12 PATHWAY | G alpha 12 Pathway |
0.4 | 0.4 | ST INTERFERON GAMMA PATHWAY | Interferon gamma pathway. |
0.4 | 5.9 | PID FAK PATHWAY | Signaling events mediated by focal adhesion kinase |
0.4 | 2.9 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
0.4 | 3.3 | PID IL12 STAT4 PATHWAY | IL12 signaling mediated by STAT4 |
0.4 | 3.7 | PID ECADHERIN STABILIZATION PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
0.4 | 14.8 | NABA BASEMENT MEMBRANES | Genes encoding structural components of basement membranes |
0.4 | 4.9 | PID ALPHA SYNUCLEIN PATHWAY | Alpha-synuclein signaling |
0.4 | 1.8 | PID THROMBIN PAR1 PATHWAY | PAR1-mediated thrombin signaling events |
0.4 | 4.0 | PID RAS PATHWAY | Regulation of Ras family activation |
0.4 | 1.1 | SIG PIP3 SIGNALING IN CARDIAC MYOCTES | Genes related to PIP3 signaling in cardiac myocytes |
0.4 | 1.4 | ST IL 13 PATHWAY | Interleukin 13 (IL-13) Pathway |
0.3 | 44.4 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.3 | 4.5 | PID TNF PATHWAY | TNF receptor signaling pathway |
0.3 | 2.2 | PID ALK2 PATHWAY | ALK2 signaling events |
0.3 | 2.2 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
0.3 | 0.9 | PID NFKAPPAB CANONICAL PATHWAY | Canonical NF-kappaB pathway |
0.3 | 2.6 | PID CXCR3 PATHWAY | CXCR3-mediated signaling events |
0.3 | 0.9 | PID PI3K PLC TRK PATHWAY | Trk receptor signaling mediated by PI3K and PLC-gamma |
0.3 | 1.4 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
0.3 | 4.6 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
0.3 | 3.7 | PID INTEGRIN3 PATHWAY | Beta3 integrin cell surface interactions |
0.3 | 2.6 | PID IL1 PATHWAY | IL1-mediated signaling events |
0.3 | 1.8 | PID AMB2 NEUTROPHILS PATHWAY | amb2 Integrin signaling |
0.2 | 2.2 | SIG BCR SIGNALING PATHWAY | Members of the BCR signaling pathway |
0.2 | 0.9 | PID TXA2PATHWAY | Thromboxane A2 receptor signaling |
0.2 | 5.4 | PID P75 NTR PATHWAY | p75(NTR)-mediated signaling |
0.2 | 1.6 | PID IL2 1PATHWAY | IL2-mediated signaling events |
0.2 | 0.6 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
0.2 | 0.2 | ST JAK STAT PATHWAY | Jak-STAT Pathway |
0.2 | 3.7 | PID CONE PATHWAY | Visual signal transduction: Cones |
0.2 | 2.7 | PID CD8 TCR DOWNSTREAM PATHWAY | Downstream signaling in naïve CD8+ T cells |
0.2 | 0.8 | ST TYPE I INTERFERON PATHWAY | Type I Interferon (alpha/beta IFN) Pathway |
0.2 | 4.7 | PID IL4 2PATHWAY | IL4-mediated signaling events |
0.2 | 1.8 | PID LIS1 PATHWAY | Lissencephaly gene (LIS1) in neuronal migration and development |
0.2 | 0.2 | PID TCR JNK PATHWAY | JNK signaling in the CD4+ TCR pathway |
0.2 | 0.7 | PID PI3KCI PATHWAY | Class I PI3K signaling events |
0.2 | 1.3 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
0.2 | 0.5 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
0.1 | 0.6 | PID MET PATHWAY | Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met) |
0.1 | 3.9 | PID MYC REPRESS PATHWAY | Validated targets of C-MYC transcriptional repression |
0.1 | 0.2 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
0.1 | 1.4 | PID UPA UPAR PATHWAY | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling |
0.1 | 2.2 | PID ILK PATHWAY | Integrin-linked kinase signaling |
0.1 | 0.9 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
0.1 | 1.4 | PID ARF 3PATHWAY | Arf1 pathway |
0.1 | 1.4 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
0.1 | 0.3 | PID AVB3 INTEGRIN PATHWAY | Integrins in angiogenesis |
0.1 | 0.2 | PID ALK1 PATHWAY | ALK1 signaling events |
0.1 | 0.1 | SIG PIP3 SIGNALING IN B LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes |
0.1 | 0.1 | PID SYNDECAN 1 PATHWAY | Syndecan-1-mediated signaling events |
0.1 | 0.1 | PID BETA CATENIN DEG PATHWAY | Degradation of beta catenin |
0.1 | 1.2 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
0.1 | 0.5 | SIG INSULIN RECEPTOR PATHWAY IN CARDIAC MYOCYTES | Genes related to the insulin receptor pathway |
0.1 | 0.7 | PID DNA PK PATHWAY | DNA-PK pathway in nonhomologous end joining |
0.1 | 12.5 | NABA SECRETED FACTORS | Genes encoding secreted soluble factors |
0.1 | 0.1 | PID TCPTP PATHWAY | Signaling events mediated by TCPTP |
0.0 | 0.4 | PID P38 ALPHA BETA DOWNSTREAM PATHWAY | Signaling mediated by p38-alpha and p38-beta |
0.0 | 0.1 | ST INTEGRIN SIGNALING PATHWAY | Integrin Signaling Pathway |
0.0 | 0.0 | PID IL5 PATHWAY | IL5-mediated signaling events |
0.0 | 0.0 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
7.1 | 105.9 | REACTOME UNBLOCKING OF NMDA RECEPTOR GLUTAMATE BINDING AND ACTIVATION | Genes involved in Unblocking of NMDA receptor, glutamate binding and activation |
4.4 | 52.4 | REACTOME GABA A RECEPTOR ACTIVATION | Genes involved in GABA A receptor activation |
3.6 | 28.4 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
3.5 | 59.5 | REACTOME GABA SYNTHESIS RELEASE REUPTAKE AND DEGRADATION | Genes involved in GABA synthesis, release, reuptake and degradation |
3.3 | 76.2 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
3.1 | 25.1 | REACTOME LIGAND GATED ION CHANNEL TRANSPORT | Genes involved in Ligand-gated ion channel transport |
3.1 | 72.1 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
3.1 | 40.7 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
3.0 | 3.0 | REACTOME ADP SIGNALLING THROUGH P2RY12 | Genes involved in ADP signalling through P2Y purinoceptor 12 |
2.8 | 27.7 | REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
2.7 | 24.7 | REACTOME ROLE OF SECOND MESSENGERS IN NETRIN1 SIGNALING | Genes involved in Role of second messengers in netrin-1 signaling |
2.7 | 50.4 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
2.5 | 27.4 | REACTOME SEROTONIN RECEPTORS | Genes involved in Serotonin receptors |
2.4 | 62.8 | REACTOME STRIATED MUSCLE CONTRACTION | Genes involved in Striated Muscle Contraction |
2.2 | 95.2 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
2.2 | 37.3 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
2.2 | 24.1 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
2.1 | 20.9 | REACTOME INHIBITION OF INSULIN SECRETION BY ADRENALINE NORADRENALINE | Genes involved in Inhibition of Insulin Secretion by Adrenaline/Noradrenaline |
2.1 | 2.1 | REACTOME PI3K EVENTS IN ERBB2 SIGNALING | Genes involved in PI3K events in ERBB2 signaling |
2.0 | 38.7 | REACTOME RNA POL III TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase III Transcription Termination |
2.0 | 25.9 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
2.0 | 4.0 | REACTOME NOREPINEPHRINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Norepinephrine Neurotransmitter Release Cycle |
1.8 | 23.1 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
1.7 | 24.4 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
1.7 | 6.9 | REACTOME DOPAMINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Dopamine Neurotransmitter Release Cycle |
1.7 | 11.8 | REACTOME G PROTEIN ACTIVATION | Genes involved in G-protein activation |
1.7 | 42.1 | REACTOME SIGNALING BY ROBO RECEPTOR | Genes involved in Signaling by Robo receptor |
1.7 | 28.6 | REACTOME DAG AND IP3 SIGNALING | Genes involved in DAG and IP3 signaling |
1.6 | 13.0 | REACTOME TRANSPORT OF ORGANIC ANIONS | Genes involved in Transport of organic anions |
1.6 | 20.4 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GIP | Genes involved in Synthesis, Secretion, and Inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) |
1.6 | 22.0 | REACTOME N GLYCAN ANTENNAE ELONGATION | Genes involved in N-Glycan antennae elongation |
1.6 | 20.2 | REACTOME PLATELET CALCIUM HOMEOSTASIS | Genes involved in Platelet calcium homeostasis |
1.5 | 1.5 | REACTOME ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC | Genes involved in Antigen Presentation: Folding, assembly and peptide loading of class I MHC |
1.5 | 3.0 | REACTOME JNK C JUN KINASES PHOSPHORYLATION AND ACTIVATION MEDIATED BY ACTIVATED HUMAN TAK1 | Genes involved in JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 |
1.5 | 1.5 | REACTOME SHC RELATED EVENTS | Genes involved in SHC-related events |
1.4 | 5.8 | REACTOME NEGATIVE REGULATION OF THE PI3K AKT NETWORK | Genes involved in Negative regulation of the PI3K/AKT network |
1.3 | 18.6 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
1.3 | 14.5 | REACTOME SIGNALING BY FGFR3 MUTANTS | Genes involved in Signaling by FGFR3 mutants |
1.3 | 27.4 | REACTOME SEMA4D INDUCED CELL MIGRATION AND GROWTH CONE COLLAPSE | Genes involved in Sema4D induced cell migration and growth-cone collapse |
1.3 | 21.7 | REACTOME TRAFFICKING OF AMPA RECEPTORS | Genes involved in Trafficking of AMPA receptors |
1.3 | 40.7 | REACTOME BMAL1 CLOCK NPAS2 ACTIVATES CIRCADIAN EXPRESSION | Genes involved in BMAL1:CLOCK/NPAS2 Activates Circadian Expression |
1.3 | 36.5 | REACTOME INWARDLY RECTIFYING K CHANNELS | Genes involved in Inwardly rectifying K+ channels |
1.2 | 3.7 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
1.2 | 20.0 | REACTOME EGFR DOWNREGULATION | Genes involved in EGFR downregulation |
1.2 | 14.7 | REACTOME REGULATION OF PYRUVATE DEHYDROGENASE PDH COMPLEX | Genes involved in Regulation of pyruvate dehydrogenase (PDH) complex |
1.2 | 1.2 | REACTOME GABA B RECEPTOR ACTIVATION | Genes involved in GABA B receptor activation |
1.2 | 6.0 | REACTOME PLC BETA MEDIATED EVENTS | Genes involved in PLC beta mediated events |
1.2 | 13.1 | REACTOME OXYGEN DEPENDENT PROLINE HYDROXYLATION OF HYPOXIA INDUCIBLE FACTOR ALPHA | Genes involved in Oxygen-dependent Proline Hydroxylation of Hypoxia-inducible Factor Alpha |
1.2 | 6.9 | REACTOME DCC MEDIATED ATTRACTIVE SIGNALING | Genes involved in DCC mediated attractive signaling |
1.2 | 26.5 | REACTOME POTASSIUM CHANNELS | Genes involved in Potassium Channels |
1.1 | 12.6 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
1.1 | 10.3 | REACTOME CTNNB1 PHOSPHORYLATION CASCADE | Genes involved in Beta-catenin phosphorylation cascade |
1.1 | 5.7 | REACTOME GRB2 EVENTS IN ERBB2 SIGNALING | Genes involved in GRB2 events in ERBB2 signaling |
1.1 | 104.0 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
1.1 | 9.0 | REACTOME GLUTAMATE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Glutamate Neurotransmitter Release Cycle |
1.1 | 3.4 | REACTOME PECAM1 INTERACTIONS | Genes involved in PECAM1 interactions |
1.1 | 7.7 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
1.1 | 8.5 | REACTOME G ALPHA1213 SIGNALLING EVENTS | Genes involved in G alpha (12/13) signalling events |
1.0 | 10.4 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
1.0 | 6.2 | REACTOME PHOSPHORYLATION OF CD3 AND TCR ZETA CHAINS | Genes involved in Phosphorylation of CD3 and TCR zeta chains |
1.0 | 3.1 | REACTOME ACETYLCHOLINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Acetylcholine Neurotransmitter Release Cycle |
1.0 | 32.5 | REACTOME NOTCH1 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | Genes involved in NOTCH1 Intracellular Domain Regulates Transcription |
1.0 | 3.9 | REACTOME IRAK1 RECRUITS IKK COMPLEX | Genes involved in IRAK1 recruits IKK complex |
0.9 | 11.2 | REACTOME SIGNALING BY NOTCH4 | Genes involved in Signaling by NOTCH4 |
0.9 | 15.8 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
0.9 | 15.8 | REACTOME THE ROLE OF NEF IN HIV1 REPLICATION AND DISEASE PATHOGENESIS | Genes involved in The role of Nef in HIV-1 replication and disease pathogenesis |
0.9 | 2.8 | REACTOME G PROTEIN BETA GAMMA SIGNALLING | Genes involved in G-protein beta:gamma signalling |
0.8 | 13.5 | REACTOME NITRIC OXIDE STIMULATES GUANYLATE CYCLASE | Genes involved in Nitric oxide stimulates guanylate cyclase |
0.8 | 4.2 | REACTOME PEPTIDE HORMONE BIOSYNTHESIS | Genes involved in Peptide hormone biosynthesis |
0.8 | 13.0 | REACTOME POST CHAPERONIN TUBULIN FOLDING PATHWAY | Genes involved in Post-chaperonin tubulin folding pathway |
0.8 | 12.9 | REACTOME BRANCHED CHAIN AMINO ACID CATABOLISM | Genes involved in Branched-chain amino acid catabolism |
0.8 | 6.4 | REACTOME REGULATION OF WATER BALANCE BY RENAL AQUAPORINS | Genes involved in Regulation of Water Balance by Renal Aquaporins |
0.8 | 6.4 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
0.8 | 26.6 | REACTOME L1CAM INTERACTIONS | Genes involved in L1CAM interactions |
0.8 | 7.0 | REACTOME LYSOSOME VESICLE BIOGENESIS | Genes involved in Lysosome Vesicle Biogenesis |
0.8 | 27.8 | REACTOME TRANSMISSION ACROSS CHEMICAL SYNAPSES | Genes involved in Transmission across Chemical Synapses |
0.8 | 0.8 | REACTOME IKK COMPLEX RECRUITMENT MEDIATED BY RIP1 | Genes involved in IKK complex recruitment mediated by RIP1 |
0.8 | 6.0 | REACTOME THE ACTIVATION OF ARYLSULFATASES | Genes involved in The activation of arylsulfatases |
0.7 | 4.5 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
0.7 | 11.5 | REACTOME SIGNALLING TO ERKS | Genes involved in Signalling to ERKs |
0.7 | 7.1 | REACTOME NA CL DEPENDENT NEUROTRANSMITTER TRANSPORTERS | Genes involved in Na+/Cl- dependent neurotransmitter transporters |
0.7 | 7.8 | REACTOME DOWNSTREAM TCR SIGNALING | Genes involved in Downstream TCR signaling |
0.7 | 2.1 | REACTOME CTLA4 INHIBITORY SIGNALING | Genes involved in CTLA4 inhibitory signaling |
0.7 | 3.5 | REACTOME G ALPHA Z SIGNALLING EVENTS | Genes involved in G alpha (z) signalling events |
0.7 | 9.8 | REACTOME SYNTHESIS OF VERY LONG CHAIN FATTY ACYL COAS | Genes involved in Synthesis of very long-chain fatty acyl-CoAs |
0.7 | 14.0 | REACTOME AMINE LIGAND BINDING RECEPTORS | Genes involved in Amine ligand-binding receptors |
0.7 | 7.7 | REACTOME TRAF6 MEDIATED INDUCTION OF TAK1 COMPLEX | Genes involved in TRAF6 mediated induction of TAK1 complex |
0.7 | 9.2 | REACTOME GLUCAGON TYPE LIGAND RECEPTORS | Genes involved in Glucagon-type ligand receptors |
0.6 | 1.3 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
0.6 | 20.7 | REACTOME AMINO ACID AND OLIGOPEPTIDE SLC TRANSPORTERS | Genes involved in Amino acid and oligopeptide SLC transporters |
0.6 | 6.3 | REACTOME SYNTHESIS OF PIPS AT THE LATE ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the late endosome membrane |
0.6 | 4.9 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 3 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 3 Promoter |
0.6 | 3.0 | REACTOME INTEGRATION OF PROVIRUS | Genes involved in Integration of provirus |
0.6 | 4.7 | REACTOME REGULATION OF IFNG SIGNALING | Genes involved in Regulation of IFNG signaling |
0.6 | 23.6 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
0.6 | 9.2 | REACTOME ABCA TRANSPORTERS IN LIPID HOMEOSTASIS | Genes involved in ABCA transporters in lipid homeostasis |
0.6 | 6.9 | REACTOME AMINE DERIVED HORMONES | Genes involved in Amine-derived hormones |
0.6 | 4.6 | REACTOME APOPTOTIC CLEAVAGE OF CELL ADHESION PROTEINS | Genes involved in Apoptotic cleavage of cell adhesion proteins |
0.6 | 1.7 | REACTOME ACTIVATION OF IRF3 IRF7 MEDIATED BY TBK1 IKK EPSILON | Genes involved in Activation of IRF3/IRF7 mediated by TBK1/IKK epsilon |
0.6 | 1.7 | REACTOME PD1 SIGNALING | Genes involved in PD-1 signaling |
0.6 | 0.6 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
0.6 | 14.2 | REACTOME GLUCONEOGENESIS | Genes involved in Gluconeogenesis |
0.6 | 2.3 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION IN TLR7 8 OR 9 SIGNALING | Genes involved in TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling |
0.6 | 6.8 | REACTOME PYRIMIDINE CATABOLISM | Genes involved in Pyrimidine catabolism |
0.6 | 24.8 | REACTOME G ALPHA S SIGNALLING EVENTS | Genes involved in G alpha (s) signalling events |
0.5 | 8.8 | REACTOME AMYLOIDS | Genes involved in Amyloids |
0.5 | 5.9 | REACTOME GROWTH HORMONE RECEPTOR SIGNALING | Genes involved in Growth hormone receptor signaling |
0.5 | 5.3 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
0.5 | 22.0 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
0.5 | 9.1 | REACTOME P75 NTR RECEPTOR MEDIATED SIGNALLING | Genes involved in p75 NTR receptor-mediated signalling |
0.5 | 3.5 | REACTOME PURINE CATABOLISM | Genes involved in Purine catabolism |
0.5 | 7.5 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
0.5 | 9.0 | REACTOME APOPTOTIC CLEAVAGE OF CELLULAR PROTEINS | Genes involved in Apoptotic cleavage of cellular proteins |
0.5 | 2.0 | REACTOME N GLYCAN ANTENNAE ELONGATION IN THE MEDIAL TRANS GOLGI | Genes involved in N-glycan antennae elongation in the medial/trans-Golgi |
0.5 | 5.5 | REACTOME NETRIN1 SIGNALING | Genes involved in Netrin-1 signaling |
0.5 | 67.6 | REACTOME PEPTIDE LIGAND BINDING RECEPTORS | Genes involved in Peptide ligand-binding receptors |
0.5 | 0.5 | REACTOME RNA POL I PROMOTER OPENING | Genes involved in RNA Polymerase I Promoter Opening |
0.5 | 5.1 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
0.5 | 8.7 | REACTOME IL 3 5 AND GM CSF SIGNALING | Genes involved in Interleukin-3, 5 and GM-CSF signaling |
0.4 | 8.1 | REACTOME GAP JUNCTION TRAFFICKING | Genes involved in Gap junction trafficking |
0.4 | 0.4 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
0.4 | 2.7 | REACTOME CD28 DEPENDENT PI3K AKT SIGNALING | Genes involved in CD28 dependent PI3K/Akt signaling |
0.4 | 12.2 | REACTOME TRANS GOLGI NETWORK VESICLE BUDDING | Genes involved in trans-Golgi Network Vesicle Budding |
0.4 | 3.0 | REACTOME GLYCOLYSIS | Genes involved in Glycolysis |
0.4 | 3.0 | REACTOME CREATION OF C4 AND C2 ACTIVATORS | Genes involved in Creation of C4 and C2 activators |
0.4 | 15.9 | REACTOME TRANSPORT OF INORGANIC CATIONS ANIONS AND AMINO ACIDS OLIGOPEPTIDES | Genes involved in Transport of inorganic cations/anions and amino acids/oligopeptides |
0.4 | 2.8 | REACTOME ACYL CHAIN REMODELLING OF PC | Genes involved in Acyl chain remodelling of PC |
0.4 | 2.7 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
0.4 | 10.8 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
0.4 | 8.3 | REACTOME GLYCOSPHINGOLIPID METABOLISM | Genes involved in Glycosphingolipid metabolism |
0.3 | 3.5 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
0.3 | 6.5 | REACTOME INSULIN RECEPTOR RECYCLING | Genes involved in Insulin receptor recycling |
0.3 | 3.0 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
0.3 | 4.4 | REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
0.3 | 9.4 | REACTOME INTERACTIONS OF VPR WITH HOST CELLULAR PROTEINS | Genes involved in Interactions of Vpr with host cellular proteins |
0.3 | 0.3 | REACTOME VIF MEDIATED DEGRADATION OF APOBEC3G | Genes involved in Vif-mediated degradation of APOBEC3G |
0.3 | 17.9 | REACTOME ANTIGEN PROCESSING CROSS PRESENTATION | Genes involved in Antigen processing-Cross presentation |
0.3 | 1.2 | REACTOME REGULATION OF HYPOXIA INDUCIBLE FACTOR HIF BY OXYGEN | Genes involved in Regulation of Hypoxia-inducible Factor (HIF) by Oxygen |
0.3 | 1.4 | REACTOME SIGNAL AMPLIFICATION | Genes involved in Signal amplification |
0.3 | 4.5 | REACTOME CITRIC ACID CYCLE TCA CYCLE | Genes involved in Citric acid cycle (TCA cycle) |
0.3 | 1.7 | REACTOME MRNA CAPPING | Genes involved in mRNA Capping |
0.3 | 2.6 | REACTOME REGULATION OF RHEB GTPASE ACTIVITY BY AMPK | Genes involved in Regulation of Rheb GTPase activity by AMPK |
0.3 | 0.8 | REACTOME XENOBIOTICS | Genes involved in Xenobiotics |
0.3 | 2.6 | REACTOME NOD1 2 SIGNALING PATHWAY | Genes involved in NOD1/2 Signaling Pathway |
0.3 | 4.4 | REACTOME SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE | Genes involved in Synthesis of PIPs at the plasma membrane |
0.2 | 33.0 | REACTOME ANTIGEN PROCESSING UBIQUITINATION PROTEASOME DEGRADATION | Genes involved in Antigen processing: Ubiquitination & Proteasome degradation |
0.2 | 0.2 | REACTOME ABORTIVE ELONGATION OF HIV1 TRANSCRIPT IN THE ABSENCE OF TAT | Genes involved in Abortive elongation of HIV-1 transcript in the absence of Tat |
0.2 | 2.0 | REACTOME OPSINS | Genes involved in Opsins |
0.2 | 2.7 | REACTOME IL1 SIGNALING | Genes involved in Interleukin-1 signaling |
0.2 | 1.0 | REACTOME ACYL CHAIN REMODELLING OF PG | Genes involved in Acyl chain remodelling of PG |
0.2 | 1.2 | REACTOME SYNTHESIS OF PIPS AT THE GOLGI MEMBRANE | Genes involved in Synthesis of PIPs at the Golgi membrane |
0.2 | 4.5 | REACTOME MHC CLASS II ANTIGEN PRESENTATION | Genes involved in MHC class II antigen presentation |
0.2 | 0.9 | REACTOME GLUCOSE METABOLISM | Genes involved in Glucose metabolism |
0.2 | 3.7 | REACTOME INTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Intrinsic Pathway for Apoptosis |
0.2 | 3.7 | REACTOME PEROXISOMAL LIPID METABOLISM | Genes involved in Peroxisomal lipid metabolism |
0.2 | 6.1 | REACTOME G ALPHA I SIGNALLING EVENTS | Genes involved in G alpha (i) signalling events |
0.2 | 0.2 | REACTOME ACYL CHAIN REMODELLING OF PE | Genes involved in Acyl chain remodelling of PE |
0.2 | 0.9 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
0.2 | 4.0 | REACTOME SYNTHESIS OF PA | Genes involved in Synthesis of PA |
0.2 | 0.9 | REACTOME ETHANOL OXIDATION | Genes involved in Ethanol oxidation |
0.2 | 0.5 | REACTOME FATTY ACYL COA BIOSYNTHESIS | Genes involved in Fatty Acyl-CoA Biosynthesis |
0.2 | 0.2 | REACTOME THROMBIN SIGNALLING THROUGH PROTEINASE ACTIVATED RECEPTORS PARS | Genes involved in Thrombin signalling through proteinase activated receptors (PARs) |
0.2 | 1.9 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS | Genes involved in Synthesis of bile acids and bile salts |
0.2 | 0.8 | REACTOME TETRAHYDROBIOPTERIN BH4 SYNTHESIS RECYCLING SALVAGE AND REGULATION | Genes involved in Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation |
0.1 | 3.0 | REACTOME TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES | Genes involved in Transport of vitamins, nucleosides, and related molecules |
0.1 | 0.7 | REACTOME CIRCADIAN CLOCK | Genes involved in Circadian Clock |
0.1 | 2.9 | REACTOME MITOCHONDRIAL TRNA AMINOACYLATION | Genes involved in Mitochondrial tRNA aminoacylation |
0.1 | 0.8 | REACTOME NFKB ACTIVATION THROUGH FADD RIP1 PATHWAY MEDIATED BY CASPASE 8 AND10 | Genes involved in NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 |
0.1 | 2.4 | REACTOME CHONDROITIN SULFATE BIOSYNTHESIS | Genes involved in Chondroitin sulfate biosynthesis |
0.1 | 1.2 | REACTOME INTERFERON GAMMA SIGNALING | Genes involved in Interferon gamma signaling |
0.1 | 2.9 | REACTOME GLUTATHIONE CONJUGATION | Genes involved in Glutathione conjugation |
0.1 | 0.1 | REACTOME RETROGRADE NEUROTROPHIN SIGNALLING | Genes involved in Retrograde neurotrophin signalling |
0.1 | 0.9 | REACTOME ANDROGEN BIOSYNTHESIS | Genes involved in Androgen biosynthesis |
0.1 | 1.8 | REACTOME TRANSPORT TO THE GOLGI AND SUBSEQUENT MODIFICATION | Genes involved in Transport to the Golgi and subsequent modification |
0.1 | 0.2 | REACTOME SEMA4D IN SEMAPHORIN SIGNALING | Genes involved in Sema4D in semaphorin signaling |
0.1 | 1.9 | REACTOME NGF SIGNALLING VIA TRKA FROM THE PLASMA MEMBRANE | Genes involved in NGF signalling via TRKA from the plasma membrane |
0.1 | 0.7 | REACTOME REGULATION OF ORNITHINE DECARBOXYLASE ODC | Genes involved in Regulation of ornithine decarboxylase (ODC) |
0.1 | 2.7 | REACTOME PHASE II CONJUGATION | Genes involved in Phase II conjugation |
0.1 | 4.1 | REACTOME LOSS OF NLP FROM MITOTIC CENTROSOMES | Genes involved in Loss of Nlp from mitotic centrosomes |
0.1 | 1.8 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
0.1 | 0.5 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.1 | 2.3 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
0.1 | 0.2 | REACTOME SIGNALING BY ERBB2 | Genes involved in Signaling by ERBB2 |
0.1 | 0.6 | REACTOME REGULATION OF COMPLEMENT CASCADE | Genes involved in Regulation of Complement cascade |
0.1 | 0.4 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
0.1 | 0.1 | REACTOME LATENT INFECTION OF HOMO SAPIENS WITH MYCOBACTERIUM TUBERCULOSIS | Genes involved in Latent infection of Homo sapiens with Mycobacterium tuberculosis |
0.1 | 0.2 | REACTOME ENOS ACTIVATION AND REGULATION | Genes involved in eNOS activation and regulation |
0.1 | 1.2 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
0.0 | 0.4 | REACTOME VITAMIN B5 PANTOTHENATE METABOLISM | Genes involved in Vitamin B5 (pantothenate) metabolism |
0.0 | 2.7 | REACTOME RESPIRATORY ELECTRON TRANSPORT | Genes involved in Respiratory electron transport |
0.0 | 0.3 | REACTOME SIGNALING BY FGFR1 FUSION MUTANTS | Genes involved in Signaling by FGFR1 fusion mutants |
0.0 | 0.8 | REACTOME DEPOSITION OF NEW CENPA CONTAINING NUCLEOSOMES AT THE CENTROMERE | Genes involved in Deposition of New CENPA-containing Nucleosomes at the Centromere |
0.0 | 1.0 | REACTOME POST TRANSLATIONAL MODIFICATION SYNTHESIS OF GPI ANCHORED PROTEINS | Genes involved in Post-translational modification: synthesis of GPI-anchored proteins |
0.0 | 0.0 | REACTOME SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION | Genes involved in SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion |
0.0 | 0.0 | REACTOME CONVERSION FROM APC C CDC20 TO APC C CDH1 IN LATE ANAPHASE | Genes involved in Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase |
0.0 | 0.5 | REACTOME METABOLISM OF STEROID HORMONES AND VITAMINS A AND D | Genes involved in Metabolism of steroid hormones and vitamins A and D |
0.0 | 0.5 | REACTOME FORMATION OF TRANSCRIPTION COUPLED NER TC NER REPAIR COMPLEX | Genes involved in Formation of transcription-coupled NER (TC-NER) repair complex |
0.0 | 0.1 | REACTOME REGULATION OF KIT SIGNALING | Genes involved in Regulation of KIT signaling |
0.0 | 0.7 | REACTOME PPARA ACTIVATES GENE EXPRESSION | Genes involved in PPARA Activates Gene Expression |